|
Lvl
|
Code
|
Display
|
| 1 |
A
|
ALIMENTARY TRACT AND METABOLISM |
| 2 |
A01
|
STOMATOLOGICAL PREPARATIONS |
| 3 |
A01A
|
STOMATOLOGICAL PREPARATIONS |
| 4 |
A01AA
|
Caries prophylactic agents |
| 5 |
A01AA01
|
sodium fluoride |
| 5 |
A01AA02
|
sodium monofluorophosphate |
| 5 |
A01AA03
|
olaflur |
| 5 |
A01AA04
|
stannous fluoride |
| 5 |
A01AA30
|
combinations |
| 5 |
A01AA51
|
sodium fluoride, combinations |
| 4 |
A01AB
|
Antiinfectives and antiseptics for local oral treatment |
| 5 |
A01AB02
|
hydrogen peroxide |
| 5 |
A01AB03
|
chlorhexidine |
| 5 |
A01AB04
|
amphotericin B |
| 5 |
A01AB05
|
polynoxylin |
| 5 |
A01AB06
|
domiphen |
| 5 |
A01AB07
|
oxyquinoline |
| 5 |
A01AB08
|
neomycin |
| 5 |
A01AB09
|
miconazole |
| 5 |
A01AB10
|
natamycin |
| 5 |
A01AB11
|
various |
| 5 |
A01AB12
|
hexetidine |
| 5 |
A01AB13
|
tetracycline |
| 5 |
A01AB14
|
benzoxonium chloride |
| 5 |
A01AB15
|
tibezonium iodide |
| 5 |
A01AB16
|
mepartricin |
| 5 |
A01AB17
|
metronidazole |
| 5 |
A01AB18
|
clotrimazole |
| 5 |
A01AB19
|
sodium perborate |
| 5 |
A01AB21
|
chlortetracycline |
| 5 |
A01AB22
|
doxycycline |
| 5 |
A01AB23
|
minocycline |
| 4 |
A01AC
|
Corticosteroids for local oral treatment |
| 5 |
A01AC01
|
triamcinolone |
| 5 |
A01AC02
|
dexamethasone |
| 5 |
A01AC03
|
hydrocortisone |
| 5 |
A01AC54
|
prednisolone, combinations |
| 4 |
A01AD
|
Other agents for local oral treatment |
| 5 |
A01AD01
|
epinephrine |
| 5 |
A01AD02
|
benzydamine |
| 5 |
A01AD05
|
acetylsalicylic acid |
| 5 |
A01AD06
|
adrenalone |
| 5 |
A01AD07
|
amlexanox |
| 5 |
A01AD08
|
becaplermin |
| 5 |
A01AD11
|
various |
| 2 |
A02
|
DRUGS FOR ACID RELATED DISORDERS |
| 3 |
A02A
|
ANTACIDS |
| 4 |
A02AA
|
Magnesium compounds |
| 5 |
A02AA01
|
magnesium carbonate |
| 5 |
A02AA02
|
magnesium oxide |
| 5 |
A02AA03
|
magnesium peroxide |
| 5 |
A02AA04
|
magnesium hydroxide |
| 5 |
A02AA05
|
magnesium silicate |
| 5 |
A02AA10
|
combinations |
| 4 |
A02AB
|
Aluminium compounds |
| 5 |
A02AB01
|
aluminium hydroxide |
| 5 |
A02AB02
|
algeldrate |
| 5 |
A02AB03
|
aluminium phosphate |
| 5 |
A02AB04
|
dihydroxialumini sodium carbonate |
| 5 |
A02AB05
|
aluminium acetoacetate |
| 5 |
A02AB06
|
aloglutamol |
| 5 |
A02AB07
|
aluminium glycinate |
| 5 |
A02AB10
|
combinations |
| 4 |
A02AC
|
Calcium compounds |
| 5 |
A02AC01
|
calcium carbonate |
| 5 |
A02AC02
|
calcium silicate |
| 5 |
A02AC10
|
combinations |
| 4 |
A02AD
|
Combinations and complexes of aluminium, calcium and magnesium compounds |
| 5 |
A02AD01
|
ordinary salt combinations |
| 5 |
A02AD02
|
magaldrate |
| 5 |
A02AD03
|
almagate |
| 5 |
A02AD04
|
hydrotalcite |
| 5 |
A02AD05
|
almasilate |
| 4 |
A02AF
|
Antacids with antiflatulents |
| 5 |
A02AF01
|
magaldrate and antiflatulents |
| 5 |
A02AF02
|
ordinary salt combinations and antiflatulents |
| 4 |
A02AG
|
Antacids with antispasmodics |
| 4 |
A02AH
|
Antacids with sodium bicarbonate |
| 4 |
A02AX
|
Antacids, other combinations |
| 3 |
A02B
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| 4 |
A02BA
|
H2-receptor antagonists |
| 5 |
A02BA01
|
cimetidine |
| 5 |
A02BA02
|
ranitidine |
| 5 |
A02BA03
|
famotidine |
| 5 |
A02BA04
|
nizatidine |
| 5 |
A02BA05
|
niperotidine |
| 5 |
A02BA06
|
roxatidine |
| 5 |
A02BA07
|
ranitidine bismuth citrate |
| 5 |
A02BA08
|
lafutidine |
| 5 |
A02BA51
|
cimetidine, combinations |
| 5 |
A02BA53
|
famotidine, combinations |
| 4 |
A02BB
|
Prostaglandins |
| 5 |
A02BB01
|
misoprostol |
| 5 |
A02BB02
|
enprostil |
| 4 |
A02BC
|
Proton pump inhibitors |
| 5 |
A02BC01
|
omeprazole |
| 5 |
A02BC02
|
pantoprazole |
| 5 |
A02BC03
|
lansoprazole |
| 5 |
A02BC04
|
rabeprazole |
| 5 |
A02BC05
|
esomeprazole |
| 5 |
A02BC06
|
dexlansoprazole |
| 5 |
A02BC07
|
dexrabeprazole |
| 5 |
A02BC08
|
vonoprazan |
| 5 |
A02BC53
|
lansoprazole, combinations |
| 5 |
A02BC54
|
rabeprazole, combinations |
| 4 |
A02BD
|
Combinations for eradication of Helicobacter pylori |
| 5 |
A02BD01
|
omeprazole, amoxicillin and metronidazole |
| 5 |
A02BD02
|
lansoprazole, tetracycline and metronidazole |
| 5 |
A02BD03
|
lansoprazole, amoxicillin and metronidazole |
| 5 |
A02BD04
|
pantoprazole, amoxicillin and clarithromycin |
| 5 |
A02BD05
|
omeprazole, amoxicillin and clarithromycin |
| 5 |
A02BD06
|
esomeprazole, amoxicillin and clarithromycin |
| 5 |
A02BD07
|
lansoprazole, amoxicillin and clarithromycin |
| 5 |
A02BD08
|
bismuth subcitrate, tetracycline and metronidazole |
| 5 |
A02BD09
|
lansoprazole, clarithromycin and tinidazole |
| 5 |
A02BD10
|
lansoprazole, amoxicillin and levofloxacin |
| 5 |
A02BD11
|
pantoprazole, amoxicillin, clarithromycin and metronidazole |
| 5 |
A02BD12
|
rabeprazole, amoxicillin and clarithromycin |
| 5 |
A02BD13
|
rabeprazole, amoxicillin and metronidazole |
| 5 |
A02BD14
|
vonoprazan, amoxicillin and clarithromycin |
| 5 |
A02BD15
|
vonoprazan, amoxicillin and metronidazole |
| 4 |
A02BX
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| 5 |
A02BX01
|
carbenoxolone |
| 5 |
A02BX02
|
sucralfate |
| 5 |
A02BX03
|
pirenzepine |
| 5 |
A02BX04
|
methiosulfonium chloride |
| 5 |
A02BX05
|
bismuth subcitrate |
| 5 |
A02BX06
|
proglumide |
| 5 |
A02BX07
|
gefarnate |
| 5 |
A02BX08
|
sulglicotide |
| 5 |
A02BX09
|
acetoxolone |
| 5 |
A02BX10
|
zolimidine |
| 5 |
A02BX11
|
troxipide |
| 5 |
A02BX12
|
bismuth subnitrate |
| 5 |
A02BX13
|
alginic acid |
| 5 |
A02BX14
|
rebamipide |
| 5 |
A02BX51
|
carbenoxolone, combinations excl. psycholeptics |
| 5 |
A02BX71
|
carbenoxolone, combinations with psycholeptics |
| 5 |
A02BX77
|
gefarnate, combinations with psycholeptics |
| 3 |
A02X
|
OTHER DRUGS FOR ACID RELATED DISORDERS |
| 2 |
A03
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| 3 |
A03A
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| 4 |
A03AA
|
Synthetic anticholinergics, esters with tertiary amino group |
| 5 |
A03AA01
|
oxyphencyclimine |
| 5 |
A03AA03
|
camylofin |
| 5 |
A03AA04
|
mebeverine |
| 5 |
A03AA05
|
trimebutine |
| 5 |
A03AA06
|
rociverine |
| 5 |
A03AA07
|
dicycloverine |
| 5 |
A03AA08
|
dihexyverine |
| 5 |
A03AA09
|
difemerine |
| 5 |
A03AA30
|
piperidolate |
| 4 |
A03AB
|
Synthetic anticholinergics, quaternary ammonium compounds |
| 5 |
A03AB01
|
benzilone |
| 5 |
A03AB02
|
glycopyrronium bromide |
| 5 |
A03AB03
|
oxyphenonium |
| 5 |
A03AB04
|
penthienate |
| 5 |
A03AB05
|
propantheline |
| 5 |
A03AB06
|
otilonium bromide |
| 5 |
A03AB07
|
methantheline |
| 5 |
A03AB08
|
tridihexethyl |
| 5 |
A03AB09
|
isopropamide |
| 5 |
A03AB10
|
hexocyclium |
| 5 |
A03AB11
|
poldine |
| 5 |
A03AB12
|
mepenzolate |
| 5 |
A03AB13
|
bevonium |
| 5 |
A03AB14
|
pipenzolate |
| 5 |
A03AB15
|
diphemanil |
| 5 |
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide |
| 5 |
A03AB17
|
tiemonium iodide |
| 5 |
A03AB18
|
prifinium bromide |
| 5 |
A03AB19
|
timepidium bromide |
| 5 |
A03AB21
|
fenpiverinium |
| 5 |
A03AB53
|
oxyphenonium, combinations |
| 4 |
A03AC
|
Synthetic antispasmodics, amides with tertiary amines |
| 5 |
A03AC02
|
dimethylaminopropionylphenothiazine |
| 5 |
A03AC04
|
nicofetamide |
| 5 |
A03AC05
|
tiropramide |
| 4 |
A03AD
|
Papaverine and derivatives |
| 5 |
A03AD01
|
papaverine |
| 5 |
A03AD02
|
drotaverine |
| 5 |
A03AD30
|
moxaverine |
| 4 |
A03AE
|
Serotonin receptor antagonists |
| 5 |
A03AE01
|
alosetron |
| 5 |
A03AE03
|
cilansetron |
| 4 |
A03AX
|
Other drugs for functional gastrointestinal disorders |
| 5 |
A03AX01
|
fenpiprane |
| 5 |
A03AX02
|
diisopromine |
| 5 |
A03AX03
|
chlorbenzoxamine |
| 5 |
A03AX04
|
pinaverium |
| 5 |
A03AX05
|
fenoverine |
| 5 |
A03AX06
|
idanpramine |
| 5 |
A03AX07
|
proxazole |
| 5 |
A03AX08
|
alverine |
| 5 |
A03AX09
|
trepibutone |
| 5 |
A03AX10
|
isometheptene |
| 5 |
A03AX11
|
caroverine |
| 5 |
A03AX12
|
phloroglucinol |
| 5 |
A03AX13
|
silicones |
| 5 |
A03AX14
|
valethamate |
| 5 |
A03AX15
|
menthae piperitae aetheroleum |
| 5 |
A03AX30
|
trimethyldiphenylpropylamine |
| 5 |
A03AX58
|
alverine, combinations |
| 3 |
A03B
|
BELLADONNA AND DERIVATIVES, PLAIN |
| 4 |
A03BA
|
Belladonna alkaloids, tertiary amines |
| 5 |
A03BA01
|
atropine |
| 5 |
A03BA03
|
hyoscyamine |
| 5 |
A03BA04
|
belladonna total alkaloids |
| 4 |
A03BB
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| 5 |
A03BB01
|
butylscopolamine |
| 5 |
A03BB02
|
methylatropine |
| 5 |
A03BB03
|
methylscopolamine |
| 5 |
A03BB04
|
fentonium |
| 5 |
A03BB05
|
cimetropium bromide |
| 5 |
A03BB06
|
homatropine methylbromide |
| 3 |
A03C
|
ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| 4 |
A03CA
|
Synthetic anticholinergic agents in combination with psycholeptics |
| 5 |
A03CA01
|
isopropamide and psycholeptics |
| 5 |
A03CA02
|
clidinium and psycholeptics |
| 5 |
A03CA03
|
oxyphencyclimine and psycholeptics |
| 5 |
A03CA04
|
otilonium bromide and psycholeptics |
| 5 |
A03CA05
|
glycopyrronium bromide and psycholeptics |
| 5 |
A03CA06
|
bevonium and psycholeptics |
| 5 |
A03CA07
|
ambutonium and psycholeptics |
| 5 |
A03CA08
|
diphemanil and psycholeptics |
| 5 |
A03CA09
|
pipenzolate and psycholeptics |
| 5 |
A03CA30
|
emepronium and psycholeptics |
| 5 |
A03CA34
|
propantheline and psycholeptics |
| 4 |
A03CB
|
Belladonna and derivatives in combination with psycholeptics |
| 5 |
A03CB01
|
methylscopolamine and psycholeptics |
| 5 |
A03CB02
|
belladonna total alkaloids and psycholeptics |
| 5 |
A03CB03
|
atropine and psycholeptics |
| 5 |
A03CB04
|
homatropine methylbromide and psycholeptics |
| 5 |
A03CB31
|
hyoscyamine and psycholeptics |
| 4 |
A03CC
|
Other antispasmodics in combination with psycholeptics |
| 3 |
A03D
|
ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| 4 |
A03DA
|
Synthetic anticholinergic agents in combination with analgesics |
| 5 |
A03DA01
|
tropenzilone and analgesics |
| 5 |
A03DA02
|
pitofenone and analgesics |
| 5 |
A03DA03
|
bevonium and analgesics |
| 5 |
A03DA04
|
ciclonium and analgesics |
| 5 |
A03DA05
|
camylofin and analgesics |
| 5 |
A03DA06
|
trospium and analgesics |
| 5 |
A03DA07
|
tiemonium iodide and analgesics |
| 4 |
A03DB
|
Belladonna and derivatives in combination with analgesics |
| 5 |
A03DB04
|
butylscopolamine and analgesics |
| 4 |
A03DC
|
Other antispasmodics in combination with analgesics |
| 3 |
A03E
|
ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| 4 |
A03EA
|
Antispasmodics, psycholeptics and analgesics in combination |
| 4 |
A03ED
|
Antispasmodics in combination with other drugs |
| 3 |
A03F
|
PROPULSIVES |
| 4 |
A03FA
|
Propulsives |
| 5 |
A03FA01
|
metoclopramide |
| 5 |
A03FA02
|
cisapride |
| 5 |
A03FA03
|
domperidone |
| 5 |
A03FA04
|
bromopride |
| 5 |
A03FA05
|
alizapride |
| 5 |
A03FA06
|
clebopride |
| 5 |
A03FA07
|
itopride |
| 5 |
A03FA08
|
cinitapride |
| 5 |
A03FA09
|
mosapride |
| 2 |
A04
|
ANTIEMETICS AND ANTINAUSEANTS |
| 3 |
A04A
|
ANTIEMETICS AND ANTINAUSEANTS |
| 4 |
A04AA
|
Serotonin (5HT3) antagonists |
| 5 |
A04AA01
|
ondansetron |
| 5 |
A04AA02
|
granisetron |
| 5 |
A04AA03
|
tropisetron |
| 5 |
A04AA04
|
dolasetron |
| 5 |
A04AA05
|
palonosetron |
| 5 |
A04AA55
|
palonosetron, combinations |
| 4 |
A04AD
|
Other antiemetics |
| 5 |
A04AD01
|
scopolamine |
| 5 |
A04AD02
|
cerium oxalate |
| 5 |
A04AD04
|
chlorobutanol |
| 5 |
A04AD05
|
metopimazine |
| 5 |
A04AD10
|
dronabinol |
| 5 |
A04AD11
|
nabilone |
| 5 |
A04AD12
|
aprepitant |
| 5 |
A04AD13
|
casopitant |
| 5 |
A04AD14
|
rolapitant |
| 5 |
A04AD51
|
scopolamine, combinations |
| 5 |
A04AD54
|
chlorobutanol, combinations |
| 2 |
A05
|
BILE AND LIVER THERAPY |
| 3 |
A05A
|
BILE THERAPY |
| 4 |
A05AA
|
Bile acids and derivatives |
| 5 |
A05AA01
|
chenodeoxycholic acid |
| 5 |
A05AA02
|
ursodeoxycholic acid |
| 5 |
A05AA03
|
cholic acid |
| 5 |
A05AA04
|
obeticholic acid |
| 4 |
A05AB
|
Preparations for biliary tract therapy |
| 5 |
A05AB01
|
nicotinyl methylamide |
| 4 |
A05AX
|
Other drugs for bile therapy |
| 5 |
A05AX01
|
piprozolin |
| 5 |
A05AX02
|
hymecromone |
| 5 |
A05AX03
|
cyclobutyrol |
| 3 |
A05B
|
LIVER THERAPY, LIPOTROPICS |
| 4 |
A05BA
|
Liver therapy |
| 5 |
A05BA01
|
arginine glutamate |
| 5 |
A05BA03
|
silymarin |
| 5 |
A05BA04
|
citiolone |
| 5 |
A05BA05
|
epomediol |
| 5 |
A05BA06
|
ornithine oxoglurate |
| 5 |
A05BA07
|
tidiacic arginine |
| 5 |
A05BA08
|
glycyrrhizic acid |
| 5 |
A05BA09
|
metadoxine |
| 3 |
A05C
|
DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| 2 |
A06
|
DRUGS FOR CONSTIPATION |
| 3 |
A06A
|
DRUGS FOR CONSTIPATION |
| 4 |
A06AA
|
Softeners, emollients |
| 5 |
A06AA01
|
liquid paraffin |
| 5 |
A06AA02
|
docusate sodium |
| 5 |
A06AA51
|
liquid paraffin, combinations |
| 4 |
A06AB
|
Contact laxatives |
| 5 |
A06AB01
|
oxyphenisatine |
| 5 |
A06AB02
|
bisacodyl |
| 5 |
A06AB03
|
dantron |
| 5 |
A06AB04
|
phenolphthalein |
| 5 |
A06AB05
|
castor oil |
| 5 |
A06AB06
|
senna glycosides |
| 5 |
A06AB07
|
cascara |
| 5 |
A06AB08
|
sodium picosulfate |
| 5 |
A06AB09
|
bisoxatin |
| 5 |
A06AB20
|
contact laxatives in combination |
| 5 |
A06AB30
|
contact laxatives in combination with belladonna alkaloids |
| 5 |
A06AB52
|
bisacodyl, combinations |
| 5 |
A06AB53
|
dantron, combinations |
| 5 |
A06AB56
|
senna glycosides, combinations |
| 5 |
A06AB57
|
cascara, combinations |
| 5 |
A06AB58
|
sodium picosulfate, combinations |
| 4 |
A06AC
|
Bulk-forming laxatives |
| 5 |
A06AC01
|
ispaghula (psylla seeds) |
| 5 |
A06AC02
|
ethulose |
| 5 |
A06AC03
|
sterculia |
| 5 |
A06AC05
|
linseed |
| 5 |
A06AC06
|
methylcellulose |
| 5 |
A06AC07
|
triticum (wheat fibre) |
| 5 |
A06AC08
|
polycarbophil calcium |
| 5 |
A06AC51
|
ispaghula, combinations |
| 5 |
A06AC53
|
sterculia, combinations |
| 5 |
A06AC55
|
linseed, combinations |
| 4 |
A06AD
|
Osmotically acting laxatives |
| 5 |
A06AD01
|
magnesium carbonate |
| 5 |
A06AD02
|
magnesium oxide |
| 5 |
A06AD03
|
magnesium peroxide |
| 5 |
A06AD04
|
magnesium sulfate |
| 5 |
A06AD10
|
mineral salts in combination |
| 5 |
A06AD11
|
lactulose |
| 5 |
A06AD12
|
lactitol |
| 5 |
A06AD13
|
sodium sulfate |
| 5 |
A06AD14
|
pentaerithrityl |
| 5 |
A06AD15
|
macrogol |
| 5 |
A06AD16
|
mannitol |
| 5 |
A06AD17
|
sodium phosphate |
| 5 |
A06AD18
|
sorbitol |
| 5 |
A06AD19
|
magnesium citrate |
| 5 |
A06AD21
|
sodium tartrate |
| 5 |
A06AD61
|
lactulose, combinations |
| 5 |
A06AD65
|
macrogol, combinations |
| 4 |
A06AG
|
Enemas |
| 5 |
A06AG01
|
sodium phosphate |
| 5 |
A06AG02
|
bisacodyl |
| 5 |
A06AG03
|
dantron, incl. combinations |
| 5 |
A06AG04
|
glycerol |
| 5 |
A06AG06
|
oil |
| 5 |
A06AG07
|
sorbitol |
| 5 |
A06AG10
|
docusate sodium, incl. combinations |
| 5 |
A06AG11
|
sodium lauryl sulfoacetate, incl. combinations |
| 5 |
A06AG20
|
combinations |
| 4 |
A06AH
|
Peripheral opioid receptor antagonists |
| 5 |
A06AH01
|
methylnaltrexone bromide |
| 5 |
A06AH02
|
alvimopan |
| 5 |
A06AH03
|
naloxegol |
| 5 |
A06AH04
|
naloxone |
| 5 |
A06AH05
|
naldemedine |
| 4 |
A06AX
|
Other drugs for constipation |
| 5 |
A06AX01
|
glycerol |
| 5 |
A06AX02
|
carbon dioxide producing drugs |
| 5 |
A06AX03
|
lubiprostone |
| 5 |
A06AX04
|
linaclotide |
| 5 |
A06AX05
|
prucalopride |
| 5 |
A06AX06
|
tegaserod |
| 5 |
A06AX07
|
plecanatide |
| 5 |
A06AX08
|
tenapanor |
| 2 |
A07
|
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| 3 |
A07A
|
INTESTINAL ANTIINFECTIVES |
| 4 |
A07AA
|
Antibiotics |
| 5 |
A07AA01
|
neomycin |
| 5 |
A07AA02
|
nystatin |
| 5 |
A07AA03
|
natamycin |
| 5 |
A07AA04
|
streptomycin |
| 5 |
A07AA05
|
polymyxin B |
| 5 |
A07AA06
|
paromomycin |
| 5 |
A07AA07
|
amphotericin B |
| 5 |
A07AA08
|
kanamycin |
| 5 |
A07AA09
|
vancomycin |
| 5 |
A07AA10
|
colistin |
| 5 |
A07AA11
|
rifaximin |
| 5 |
A07AA12
|
fidaxomicin |
| 5 |
A07AA13
|
rifamycin |
| 5 |
A07AA51
|
neomycin, combinations |
| 5 |
A07AA54
|
streptomycin, combinations |
| 4 |
A07AB
|
Sulfonamides |
| 5 |
A07AB02
|
phthalylsulfathiazole |
| 5 |
A07AB03
|
sulfaguanidine |
| 5 |
A07AB04
|
succinylsulfathiazole |
| 4 |
A07AC
|
Imidazole derivatives |
| 5 |
A07AC01
|
miconazole |
| 4 |
A07AX
|
Other intestinal antiinfectives |
| 5 |
A07AX01
|
broxyquinoline |
| 5 |
A07AX02
|
acetarsol |
| 5 |
A07AX03
|
nifuroxazide |
| 5 |
A07AX04
|
nifurzide |
| 3 |
A07B
|
INTESTINAL ADSORBENTS |
| 4 |
A07BA
|
Charcoal preparations |
| 5 |
A07BA01
|
medicinal charcoal |
| 5 |
A07BA51
|
medicinal charcoal, combinations |
| 4 |
A07BB
|
Bismuth preparations |
| 4 |
A07BC
|
Other intestinal adsorbents |
| 5 |
A07BC01
|
pectin |
| 5 |
A07BC02
|
kaolin |
| 5 |
A07BC03
|
crospovidone |
| 5 |
A07BC04
|
attapulgite |
| 5 |
A07BC05
|
diosmectite |
| 5 |
A07BC30
|
combinations |
| 5 |
A07BC54
|
attapulgite, combinations |
| 3 |
A07C
|
ELECTROLYTES WITH CARBOHYDRATES |
| 4 |
A07CA
|
Oral rehydration salt formulations |
| 3 |
A07D
|
ANTIPROPULSIVES |
| 4 |
A07DA
|
Antipropulsives |
| 5 |
A07DA01
|
diphenoxylate |
| 5 |
A07DA02
|
opium |
| 5 |
A07DA03
|
loperamide |
| 5 |
A07DA04
|
difenoxin |
| 5 |
A07DA05
|
loperamide oxide |
| 5 |
A07DA06
|
eluxadoline |
| 5 |
A07DA52
|
morphine, combinations |
| 5 |
A07DA53
|
loperamide, combinations |
| 3 |
A07E
|
INTESTINAL ANTIINFLAMMATORY AGENTS |
| 4 |
A07EA
|
Corticosteroids acting locally |
| 5 |
A07EA01
|
prednisolone |
| 5 |
A07EA02
|
hydrocortisone |
| 5 |
A07EA03
|
prednisone |
| 5 |
A07EA04
|
betamethasone |
| 5 |
A07EA05
|
tixocortol |
| 5 |
A07EA06
|
budesonide |
| 5 |
A07EA07
|
beclometasone |
| 4 |
A07EB
|
Antiallergic agents, excl. corticosteroids |
| 5 |
A07EB01
|
cromoglicic acid |
| 4 |
A07EC
|
Aminosalicylic acid and similar agents |
| 5 |
A07EC01
|
sulfasalazine |
| 5 |
A07EC02
|
mesalazine |
| 5 |
A07EC03
|
olsalazine |
| 5 |
A07EC04
|
balsalazide |
| 3 |
A07F
|
ANTIDIARRHEAL MICROORGANISMS |
| 4 |
A07FA
|
Antidiarrheal microorganisms |
| 5 |
A07FA01
|
lactic acid producing organisms |
| 5 |
A07FA02
|
saccharomyces boulardii |
| 5 |
A07FA51
|
lactic acid producing organisms, combinations |
| 3 |
A07X
|
OTHER ANTIDIARRHEALS |
| 4 |
A07XA
|
Other antidiarrheals |
| 5 |
A07XA01
|
albumin tannate |
| 5 |
A07XA02
|
ceratonia |
| 5 |
A07XA03
|
calcium compounds |
| 5 |
A07XA04
|
racecadotril |
| 5 |
A07XA06
|
crofelemer |
| 5 |
A07XA51
|
albumin tannate, combinations |
| 2 |
A08
|
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| 3 |
A08A
|
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| 4 |
A08AA
|
Centrally acting antiobesity products |
| 5 |
A08AA01
|
phentermine |
| 5 |
A08AA02
|
fenfluramine |
| 5 |
A08AA03
|
amfepramone |
| 5 |
A08AA04
|
dexfenfluramine |
| 5 |
A08AA05
|
mazindol |
| 5 |
A08AA06
|
etilamfetamine |
| 5 |
A08AA07
|
cathine |
| 5 |
A08AA08
|
clobenzorex |
| 5 |
A08AA09
|
mefenorex |
| 5 |
A08AA10
|
sibutramine |
| 5 |
A08AA11
|
lorcaserin |
| 5 |
A08AA56
|
ephedrine, combinations |
| 5 |
A08AA62
|
bupropion and naltrexone |
| 4 |
A08AB
|
Peripherally acting antiobesity products |
| 5 |
A08AB01
|
orlistat |
| 4 |
A08AX
|
Other antiobesity drugs |
| 5 |
A08AX01
|
rimonabant |
| 2 |
A09
|
DIGESTIVES, INCL. ENZYMES |
| 3 |
A09A
|
DIGESTIVES, INCL. ENZYMES |
| 4 |
A09AA
|
Enzyme preparations |
| 5 |
A09AA01
|
diastase |
| 5 |
A09AA02
|
multienzymes (lipase, protease etc.) |
| 5 |
A09AA03
|
pepsin |
| 5 |
A09AA04
|
tilactase |
| 4 |
A09AB
|
Acid preparations |
| 5 |
A09AB01
|
glutamic acid hydrochloride |
| 5 |
A09AB02
|
betaine hydrochloride |
| 5 |
A09AB03
|
hydrochloric acid |
| 5 |
A09AB04
|
citric acid |
| 4 |
A09AC
|
Enzyme and acid preparations, combinations |
| 5 |
A09AC01
|
pepsin and acid preparations |
| 5 |
A09AC02
|
multienzymes and acid preparations |
| 2 |
A10
|
DRUGS USED IN DIABETES |
| 3 |
A10A
|
INSULINS AND ANALOGUES |
| 4 |
A10AB
|
Insulins and analogues for injection, fast-acting |
| 5 |
A10AB01
|
insulin (human) |
| 5 |
A10AB02
|
insulin (beef) |
| 5 |
A10AB03
|
insulin (pork) |
| 5 |
A10AB04
|
insulin lispro |
| 5 |
A10AB05
|
insulin aspart |
| 5 |
A10AB06
|
insulin glulisine |
| 5 |
A10AB30
|
combinations |
| 4 |
A10AC
|
Insulins and analogues for injection, intermediate-acting |
| 5 |
A10AC01
|
insulin (human) |
| 5 |
A10AC02
|
insulin (beef) |
| 5 |
A10AC03
|
insulin (pork) |
| 5 |
A10AC04
|
insulin lispro |
| 5 |
A10AC30
|
combinations |
| 4 |
A10AD
|
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting |
| 5 |
A10AD01
|
insulin (human) |
| 5 |
A10AD02
|
insulin (beef) |
| 5 |
A10AD03
|
insulin (pork) |
| 5 |
A10AD04
|
insulin lispro |
| 5 |
A10AD05
|
insulin aspart |
| 5 |
A10AD06
|
insulin degludec and insulin aspart |
| 5 |
A10AD30
|
combinations |
| 4 |
A10AE
|
Insulins and analogues for injection, long-acting |
| 5 |
A10AE01
|
insulin (human) |
| 5 |
A10AE02
|
insulin (beef) |
| 5 |
A10AE03
|
insulin (pork) |
| 5 |
A10AE04
|
insulin glargine |
| 5 |
A10AE05
|
insulin detemir |
| 5 |
A10AE06
|
insulin degludec |
| 5 |
A10AE30
|
combinations |
| 5 |
A10AE54
|
insulin glargine and lixisenatide |
| 5 |
A10AE56
|
insulin degludec and liraglutide |
| 4 |
A10AF
|
Insulins and analogues for inhalation |
| 5 |
A10AF01
|
insulin (human) |
| 3 |
A10B
|
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| 4 |
A10BA
|
Biguanides |
| 5 |
A10BA01
|
phenformin |
| 5 |
A10BA02
|
metformin |
| 5 |
A10BA03
|
buformin |
| 4 |
A10BB
|
Sulfonylureas |
| 5 |
A10BB01
|
glibenclamide |
| 5 |
A10BB02
|
chlorpropamide |
| 5 |
A10BB03
|
tolbutamide |
| 5 |
A10BB04
|
glibornuride |
| 5 |
A10BB05
|
tolazamide |
| 5 |
A10BB06
|
carbutamide |
| 5 |
A10BB07
|
glipizide |
| 5 |
A10BB08
|
gliquidone |
| 5 |
A10BB09
|
gliclazide |
| 5 |
A10BB10
|
metahexamide |
| 5 |
A10BB11
|
glisoxepide |
| 5 |
A10BB12
|
glimepiride |
| 5 |
A10BB31
|
acetohexamide |
| 4 |
A10BC
|
Sulfonamides (heterocyclic) |
| 5 |
A10BC01
|
glymidine |
| 4 |
A10BD
|
Combinations of oral blood glucose lowering drugs |
| 5 |
A10BD01
|
phenformin and sulfonylureas |
| 5 |
A10BD02
|
metformin and sulfonylureas |
| 5 |
A10BD03
|
metformin and rosiglitazone |
| 5 |
A10BD04
|
glimepiride and rosiglitazone |
| 5 |
A10BD05
|
metformin and pioglitazone |
| 5 |
A10BD06
|
glimepiride and pioglitazone |
| 5 |
A10BD07
|
metformin and sitagliptin |
| 5 |
A10BD08
|
metformin and vildagliptin |
| 5 |
A10BD09
|
pioglitazone and alogliptin |
| 5 |
A10BD10
|
metformin and saxagliptin |
| 5 |
A10BD11
|
metformin and linagliptin |
| 5 |
A10BD12
|
pioglitazone and sitagliptin |
| 5 |
A10BD13
|
metformin and alogliptin |
| 5 |
A10BD14
|
metformin and repaglinide |
| 5 |
A10BD15
|
metformin and dapagliflozin |
| 5 |
A10BD16
|
metformin and canagliflozin |
| 5 |
A10BD17
|
metformin and acarbose |
| 5 |
A10BD18
|
metformin and gemigliptin |
| 5 |
A10BD19
|
linagliptin and empagliflozin |
| 5 |
A10BD20
|
metformin and empagliflozin |
| 5 |
A10BD21
|
saxagliptin and dapagliflozin |
| 5 |
A10BD22
|
metformin and evogliptin |
| 5 |
A10BD23
|
metformin and ertugliflozin |
| 5 |
A10BD24
|
sitagliptin and ertugliflozin |
| 5 |
A10BD25
|
metformin, saxagliptin and dapagliflozin |
| 5 |
A10BD26
|
metformin and lobeglitazone |
| 4 |
A10BF
|
Alpha glucosidase inhibitors |
| 5 |
A10BF01
|
acarbose |
| 5 |
A10BF02
|
miglitol |
| 5 |
A10BF03
|
voglibose |
| 4 |
A10BG
|
Thiazolidinediones |
| 5 |
A10BG01
|
troglitazone |
| 5 |
A10BG02
|
rosiglitazone |
| 5 |
A10BG03
|
pioglitazone |
| 5 |
A10BG04
|
lobeglitazone |
| 4 |
A10BH
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| 5 |
A10BH01
|
sitagliptin |
| 5 |
A10BH02
|
vildagliptin |
| 5 |
A10BH03
|
saxagliptin |
| 5 |
A10BH04
|
alogliptin |
| 5 |
A10BH05
|
linagliptin |
| 5 |
A10BH06
|
gemigliptin |
| 5 |
A10BH07
|
evogliptin |
| 5 |
A10BH08
|
teneligliptin |
| 5 |
A10BH51
|
sitagliptin and simvastatin |
| 5 |
A10BH52
|
gemigliptin and rosuvastatin |
| 4 |
A10BJ
|
Glucagon-like peptide-1 (GLP-1) analogues |
| 5 |
A10BJ01
|
exenatide |
| 5 |
A10BJ02
|
liraglutide |
| 5 |
A10BJ03
|
lixisenatide |
| 5 |
A10BJ04
|
albiglutide |
| 5 |
A10BJ05
|
dulaglutide |
| 5 |
A10BJ06
|
semaglutide |
| 5 |
A10BJ07
|
beinaglutide |
| 4 |
A10BK
|
Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| 5 |
A10BK01
|
dapagliflozin |
| 5 |
A10BK02
|
canagliflozin |
| 5 |
A10BK03
|
empagliflozin |
| 5 |
A10BK04
|
ertugliflozin |
| 5 |
A10BK05
|
ipragliflozin |
| 5 |
A10BK06
|
sotagliflozin |
| 5 |
A10BK07
|
luseogliflozin |
| 4 |
A10BX
|
Other blood glucose lowering drugs, excl. insulins |
| 5 |
A10BX01
|
guar gum |
| 5 |
A10BX02
|
repaglinide |
| 5 |
A10BX03
|
nateglinide |
| 5 |
A10BX05
|
pramlintide |
| 5 |
A10BX06
|
benfluorex |
| 5 |
A10BX08
|
mitiglinide |
| 3 |
A10X
|
OTHER DRUGS USED IN DIABETES |
| 4 |
A10XA
|
Aldose reductase inhibitors |
| 5 |
A10XA01
|
tolrestat |
| 2 |
A11
|
VITAMINS |
| 3 |
A11A
|
MULTIVITAMINS, COMBINATIONS |
| 4 |
A11AA
|
Multivitamins with minerals |
| 5 |
A11AA01
|
multivitamins and iron |
| 5 |
A11AA02
|
multivitamins and calcium |
| 5 |
A11AA03
|
multivitamins and other minerals, incl. combinations |
| 5 |
A11AA04
|
multivitamins and trace elements |
| 4 |
A11AB
|
Multivitamins, other combinations |
| 3 |
A11B
|
MULTIVITAMINS, PLAIN |
| 4 |
A11BA
|
Multivitamins, plain |
| 3 |
A11C
|
VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| 4 |
A11CA
|
Vitamin A, plain |
| 5 |
A11CA01
|
retinol (vit A) |
| 5 |
A11CA02
|
betacarotene |
| 4 |
A11CB
|
Vitamin A and D in combination |
| 4 |
A11CC
|
Vitamin D and analogues |
| 5 |
A11CC01
|
ergocalciferol |
| 5 |
A11CC02
|
dihydrotachysterol |
| 5 |
A11CC03
|
alfacalcidol |
| 5 |
A11CC04
|
calcitriol |
| 5 |
A11CC05
|
colecalciferol |
| 5 |
A11CC06
|
calcifediol |
| 5 |
A11CC20
|
combinations |
| 5 |
A11CC55
|
colecalciferol, combinations |
| 3 |
A11D
|
VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 |
| 4 |
A11DA
|
Vitamin B1, plain |
| 5 |
A11DA01
|
thiamine (vit B1) |
| 5 |
A11DA02
|
sulbutiamine |
| 5 |
A11DA03
|
benfotiamine |
| 4 |
A11DB
|
Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| 3 |
A11E
|
VITAMIN B-COMPLEX, INCL. COMBINATIONS |
| 4 |
A11EA
|
Vitamin B-complex, plain |
| 4 |
A11EB
|
Vitamin B-complex with vitamin C |
| 4 |
A11EC
|
Vitamin B-complex with minerals |
| 4 |
A11ED
|
Vitamin B-complex with anabolic steroids |
| 4 |
A11EX
|
Vitamin B-complex, other combinations |
| 3 |
A11G
|
ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| 4 |
A11GA
|
Ascorbic acid (vitamin C), plain |
| 5 |
A11GA01
|
ascorbic acid (vit C) |
| 4 |
A11GB
|
Ascorbic acid (vitamin C), combinations |
| 5 |
A11GB01
|
ascorbic acid (vit C) and calcium |
| 3 |
A11H
|
OTHER PLAIN VITAMIN PREPARATIONS |
| 4 |
A11HA
|
Other plain vitamin preparations |
| 5 |
A11HA01
|
nicotinamide |
| 5 |
A11HA02
|
pyridoxine (vit B6) |
| 5 |
A11HA03
|
tocopherol (vit E) |
| 5 |
A11HA04
|
riboflavin (vit B2) |
| 5 |
A11HA05
|
biotin |
| 5 |
A11HA06
|
pyridoxal phosphate |
| 5 |
A11HA07
|
inositol |
| 5 |
A11HA08
|
tocofersolan |
| 5 |
A11HA30
|
dexpanthenol |
| 5 |
A11HA31
|
calcium pantothenate |
| 5 |
A11HA32
|
pantethine |
| 3 |
A11J
|
OTHER VITAMIN PRODUCTS, COMBINATIONS |
| 4 |
A11JA
|
Combinations of vitamins |
| 4 |
A11JB
|
Vitamins with minerals |
| 4 |
A11JC
|
Vitamins, other combinations |
| 2 |
A12
|
MINERAL SUPPLEMENTS |
| 3 |
A12A
|
CALCIUM |
| 4 |
A12AA
|
Calcium |
| 5 |
A12AA01
|
calcium phosphate |
| 5 |
A12AA02
|
calcium glubionate |
| 5 |
A12AA03
|
calcium gluconate |
| 5 |
A12AA04
|
calcium carbonate |
| 5 |
A12AA05
|
calcium lactate |
| 5 |
A12AA06
|
calcium lactate gluconate |
| 5 |
A12AA07
|
calcium chloride |
| 5 |
A12AA08
|
calcium glycerylphosphate |
| 5 |
A12AA09
|
calcium citrate lysine complex |
| 5 |
A12AA10
|
calcium glucoheptonate |
| 5 |
A12AA11
|
calcium pangamate |
| 5 |
A12AA13
|
calcium citrate |
| 5 |
A12AA20
|
calcium (different salts in combination) |
| 5 |
A12AA30
|
calcium laevulate |
| 4 |
A12AX
|
Calcium, combinations with vitamin D and/or other drugs |
| 3 |
A12B
|
POTASSIUM |
| 4 |
A12BA
|
Potassium |
| 5 |
A12BA01
|
potassium chloride |
| 5 |
A12BA02
|
potassium citrate |
| 5 |
A12BA03
|
potassium hydrogentartrate |
| 5 |
A12BA04
|
potassium hydrogencarbonate |
| 5 |
A12BA05
|
potassium gluconate |
| 5 |
A12BA30
|
potassium (different salts in combination) |
| 5 |
A12BA51
|
potassium chloride, combinations |
| 3 |
A12C
|
OTHER MINERAL SUPPLEMENTS |
| 4 |
A12CA
|
Sodium |
| 5 |
A12CA01
|
sodium chloride |
| 5 |
A12CA02
|
sodium sulfate |
| 4 |
A12CB
|
Zinc |
| 5 |
A12CB01
|
zinc sulfate |
| 5 |
A12CB02
|
zinc gluconate |
| 5 |
A12CB03
|
zinc protein complex |
| 4 |
A12CC
|
Magnesium |
| 5 |
A12CC01
|
magnesium chloride |
| 5 |
A12CC02
|
magnesium sulfate |
| 5 |
A12CC03
|
magnesium gluconate |
| 5 |
A12CC04
|
magnesium citrate |
| 5 |
A12CC05
|
magnesium aspartate |
| 5 |
A12CC06
|
magnesium lactate |
| 5 |
A12CC07
|
magnesium levulinate |
| 5 |
A12CC08
|
magnesium pidolate |
| 5 |
A12CC09
|
magnesium orotate |
| 5 |
A12CC10
|
magnesium oxide |
| 5 |
A12CC30
|
magnesium (different salts in combination) |
| 4 |
A12CD
|
Fluoride |
| 5 |
A12CD01
|
sodium fluoride |
| 5 |
A12CD02
|
sodium monofluorophosphate |
| 5 |
A12CD51
|
fluoride, combinations |
| 4 |
A12CE
|
Selenium |
| 5 |
A12CE01
|
sodium selenate |
| 5 |
A12CE02
|
sodium selenite |
| 4 |
A12CX
|
Other mineral products |
| 2 |
A13
|
TONICS |
| 3 |
A13A
|
TONICS |
| 2 |
A14
|
ANABOLIC AGENTS FOR SYSTEMIC USE |
| 3 |
A14A
|
ANABOLIC STEROIDS |
| 4 |
A14AA
|
Androstan derivatives |
| 5 |
A14AA01
|
androstanolone |
| 5 |
A14AA02
|
stanozolol |
| 5 |
A14AA03
|
metandienone |
| 5 |
A14AA04
|
metenolone |
| 5 |
A14AA05
|
oxymetholone |
| 5 |
A14AA06
|
quinbolone |
| 5 |
A14AA07
|
prasterone |
| 5 |
A14AA08
|
oxandrolone |
| 5 |
A14AA09
|
norethandrolone |
| 4 |
A14AB
|
Estren derivatives |
| 5 |
A14AB01
|
nandrolone |
| 5 |
A14AB02
|
ethylestrenol |
| 5 |
A14AB03
|
oxabolone cipionate |
| 3 |
A14B
|
OTHER ANABOLIC AGENTS |
| 2 |
A15
|
APPETITE STIMULANTS |
| 2 |
A16
|
OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| 3 |
A16A
|
OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| 4 |
A16AA
|
Amino acids and derivatives |
| 5 |
A16AA01
|
levocarnitine |
| 5 |
A16AA02
|
ademetionine |
| 5 |
A16AA03
|
glutamine |
| 5 |
A16AA04
|
mercaptamine |
| 5 |
A16AA05
|
carglumic acid |
| 5 |
A16AA06
|
betaine |
| 5 |
A16AA07
|
metreleptin |
| 4 |
A16AB
|
Enzymes |
| 5 |
A16AB01
|
alglucerase |
| 5 |
A16AB02
|
imiglucerase |
| 5 |
A16AB03
|
agalsidase alfa |
| 5 |
A16AB04
|
agalsidase beta |
| 5 |
A16AB05
|
laronidase |
| 5 |
A16AB06
|
sacrosidase |
| 5 |
A16AB07
|
alglucosidase alfa |
| 5 |
A16AB08
|
galsulfase |
| 5 |
A16AB09
|
idursulfase |
| 5 |
A16AB10
|
velaglucerase alfa |
| 5 |
A16AB11
|
taliglucerase alfa |
| 5 |
A16AB12
|
elosulfase alfa |
| 5 |
A16AB13
|
asfotase alfa |
| 5 |
A16AB14
|
sebelipase alfa |
| 5 |
A16AB15
|
velmanase alfa |
| 5 |
A16AB16
|
idursulfase beta |
| 5 |
A16AB17
|
cerliponase alfa |
| 5 |
A16AB18
|
vestronidase alfa |
| 5 |
A16AB19
|
pegvaliase |
| 4 |
A16AX
|
Various alimentary tract and metabolism products |
| 5 |
A16AX01
|
thioctic acid |
| 5 |
A16AX02
|
anethole trithione |
| 5 |
A16AX03
|
sodium phenylbutyrate |
| 5 |
A16AX04
|
nitisinone |
| 5 |
A16AX05
|
zinc acetate |
| 5 |
A16AX06
|
miglustat |
| 5 |
A16AX07
|
sapropterin |
| 5 |
A16AX08
|
teduglutide |
| 5 |
A16AX09
|
glycerol phenylbutyrate |
| 5 |
A16AX10
|
eliglustat |
| 5 |
A16AX11
|
sodium benzoate |
| 5 |
A16AX12
|
trientine |
| 5 |
A16AX13
|
uridine triacetate |
| 5 |
A16AX14
|
migalastat |
| 5 |
A16AX15
|
telotristat |
| 5 |
A16AX16
|
givosiran |
| 5 |
A16AX17
|
triheptanoin |
| 5 |
A16AX18
|
lumasiran |
| 5 |
A16AX30
|
sodium benzoate and sodium phenylacetate |
| 1 |
B
|
BLOOD AND BLOOD FORMING ORGANS |
| 2 |
B01
|
ANTITHROMBOTIC AGENTS |
| 3 |
B01A
|
ANTITHROMBOTIC AGENTS |
| 4 |
B01AA
|
Vitamin K antagonists |
| 5 |
B01AA01
|
dicoumarol |
| 5 |
B01AA02
|
phenindione |
| 5 |
B01AA03
|
warfarin |
| 5 |
B01AA04
|
phenprocoumon |
| 5 |
B01AA07
|
acenocoumarol |
| 5 |
B01AA08
|
ethyl biscoumacetate |
| 5 |
B01AA09
|
clorindione |
| 5 |
B01AA10
|
diphenadione |
| 5 |
B01AA11
|
tioclomarol |
| 5 |
B01AA12
|
fluindione |
| 4 |
B01AB
|
Heparin group |
| 5 |
B01AB01
|
heparin |
| 5 |
B01AB02
|
antithrombin III |
| 5 |
B01AB04
|
dalteparin |
| 5 |
B01AB05
|
enoxaparin |
| 5 |
B01AB06
|
nadroparin |
| 5 |
B01AB07
|
parnaparin |
| 5 |
B01AB08
|
reviparin |
| 5 |
B01AB09
|
danaparoid |
| 5 |
B01AB10
|
tinzaparin |
| 5 |
B01AB11
|
sulodexide |
| 5 |
B01AB12
|
bemiparin |
| 5 |
B01AB51
|
heparin, combinations |
| 4 |
B01AC
|
Platelet aggregation inhibitors excl. heparin |
| 5 |
B01AC01
|
ditazole |
| 5 |
B01AC02
|
cloricromen |
| 5 |
B01AC03
|
picotamide |
| 5 |
B01AC04
|
clopidogrel |
| 5 |
B01AC05
|
ticlopidine |
| 5 |
B01AC06
|
acetylsalicylic acid |
| 5 |
B01AC07
|
dipyridamole |
| 5 |
B01AC08
|
carbasalate calcium |
| 5 |
B01AC09
|
epoprostenol |
| 5 |
B01AC10
|
indobufen |
| 5 |
B01AC11
|
iloprost |
| 5 |
B01AC13
|
abciximab |
| 5 |
B01AC15
|
aloxiprin |
| 5 |
B01AC16
|
eptifibatide |
| 5 |
B01AC17
|
tirofiban |
| 5 |
B01AC18
|
triflusal |
| 5 |
B01AC19
|
beraprost |
| 5 |
B01AC21
|
treprostinil |
| 5 |
B01AC22
|
prasugrel |
| 5 |
B01AC23
|
cilostazol |
| 5 |
B01AC24
|
ticagrelor |
| 5 |
B01AC25
|
cangrelor |
| 5 |
B01AC26
|
vorapaxar |
| 5 |
B01AC27
|
selexipag |
| 5 |
B01AC30
|
combinations |
| 5 |
B01AC56
|
acetylsalicylic acid, combinations with proton pump inhibitors |
| 4 |
B01AD
|
Enzymes |
| 5 |
B01AD01
|
streptokinase |
| 5 |
B01AD02
|
alteplase |
| 5 |
B01AD03
|
anistreplase |
| 5 |
B01AD04
|
urokinase |
| 5 |
B01AD05
|
fibrinolysin |
| 5 |
B01AD06
|
brinase |
| 5 |
B01AD07
|
reteplase |
| 5 |
B01AD08
|
saruplase |
| 5 |
B01AD09
|
ancrod |
| 5 |
B01AD10
|
drotrecogin alfa (activated) |
| 5 |
B01AD11
|
tenecteplase |
| 5 |
B01AD12
|
protein C |
| 4 |
B01AE
|
Direct thrombin inhibitors |
| 5 |
B01AE01
|
desirudin |
| 5 |
B01AE02
|
lepirudin |
| 5 |
B01AE03
|
argatroban |
| 5 |
B01AE04
|
melagatran |
| 5 |
B01AE05
|
ximelagatran |
| 5 |
B01AE06
|
bivalirudin |
| 5 |
B01AE07
|
dabigatran etexilate |
| 4 |
B01AF
|
Direct factor Xa inhibitors |
| 5 |
B01AF01
|
rivaroxaban |
| 5 |
B01AF02
|
apixaban |
| 5 |
B01AF03
|
edoxaban |
| 5 |
B01AF04
|
betrixaban |
| 4 |
B01AX
|
Other antithrombotic agents |
| 5 |
B01AX01
|
defibrotide |
| 5 |
B01AX04
|
dermatan sulfate |
| 5 |
B01AX05
|
fondaparinux |
| 5 |
B01AX07
|
caplacizumab |
| 2 |
B02
|
ANTIHEMORRHAGICS |
| 3 |
B02A
|
ANTIFIBRINOLYTICS |
| 4 |
B02AA
|
Amino acids |
| 5 |
B02AA01
|
aminocaproic acid |
| 5 |
B02AA02
|
tranexamic acid |
| 5 |
B02AA03
|
aminomethylbenzoic acid |
| 4 |
B02AB
|
Proteinase inhibitors |
| 5 |
B02AB01
|
aprotinin |
| 5 |
B02AB02
|
alfa1 antitrypsin |
| 5 |
B02AB04
|
camostat |
| 5 |
B02AB05
|
ulinastatin |
| 3 |
B02B
|
VITAMIN K AND OTHER HEMOSTATICS |
| 4 |
B02BA
|
Vitamin K |
| 5 |
B02BA01
|
phytomenadione |
| 5 |
B02BA02
|
menadione |
| 4 |
B02BB
|
Fibrinogen |
| 5 |
B02BB01
|
fibrinogen, human |
| 4 |
B02BC
|
Local hemostatics |
| 5 |
B02BC01
|
absorbable gelatin sponge |
| 5 |
B02BC02
|
oxidized cellulose |
| 5 |
B02BC03
|
tetragalacturonic acid hydroxymethylester |
| 5 |
B02BC05
|
adrenalone |
| 5 |
B02BC06
|
thrombin |
| 5 |
B02BC07
|
collagen |
| 5 |
B02BC08
|
calcium alginate |
| 5 |
B02BC09
|
epinephrine |
| 5 |
B02BC30
|
combinations |
| 4 |
B02BD
|
Blood coagulation factors |
| 5 |
B02BD01
|
coagulation factor IX, II, VII and X in combination |
| 5 |
B02BD02
|
coagulation factor VIII |
| 5 |
B02BD03
|
factor VIII inhibitor bypassing activity |
| 5 |
B02BD04
|
coagulation factor IX |
| 5 |
B02BD05
|
coagulation factor VII |
| 5 |
B02BD06
|
von Willebrand factor and coagulation factor VIII in combination |
| 5 |
B02BD07
|
coagulation factor XIII |
| 5 |
B02BD08
|
coagulation factor VIIa |
| 5 |
B02BD10
|
von Willebrand factor |
| 5 |
B02BD11
|
catridecacog |
| 5 |
B02BD13
|
coagulation factor X |
| 5 |
B02BD14
|
susoctocog alfa |
| 5 |
B02BD30
|
thrombin |
| 4 |
B02BX
|
Other systemic hemostatics |
| 5 |
B02BX01
|
etamsylate |
| 5 |
B02BX02
|
carbazochrome |
| 5 |
B02BX03
|
batroxobin |
| 5 |
B02BX04
|
romiplostim |
| 5 |
B02BX05
|
eltrombopag |
| 5 |
B02BX06
|
emicizumab |
| 5 |
B02BX07
|
lusutrombopag |
| 5 |
B02BX08
|
avatrombopag |
| 5 |
B02BX09
|
fostamatinib |
| 2 |
B03
|
ANTIANEMIC PREPARATIONS |
| 3 |
B03A
|
IRON PREPARATIONS |
| 4 |
B03AA
|
Iron bivalent, oral preparations |
| 5 |
B03AA01
|
ferrous glycine sulfate |
| 5 |
B03AA02
|
ferrous fumarate |
| 5 |
B03AA03
|
ferrous gluconate |
| 5 |
B03AA04
|
ferrous carbonate |
| 5 |
B03AA05
|
ferrous chloride |
| 5 |
B03AA06
|
ferrous succinate |
| 5 |
B03AA07
|
ferrous sulfate |
| 5 |
B03AA08
|
ferrous tartrate |
| 5 |
B03AA09
|
ferrous aspartate |
| 5 |
B03AA10
|
ferrous ascorbate |
| 5 |
B03AA11
|
ferrous iodine |
| 5 |
B03AA12
|
ferrous sodium citrate |
| 4 |
B03AB
|
Iron trivalent, oral preparations |
| 5 |
B03AB01
|
ferric sodium citrate |
| 5 |
B03AB02
|
saccharated iron oxide |
| 5 |
B03AB03
|
sodium feredetate |
| 5 |
B03AB04
|
ferric hydroxide |
| 5 |
B03AB05
|
ferric oxide polymaltose complexes |
| 5 |
B03AB07
|
chondroitin sulfate-iron complex |
| 5 |
B03AB08
|
ferric acetyl transferrin |
| 5 |
B03AB09
|
ferric proteinsuccinylate |
| 5 |
B03AB10
|
ferric maltol |
| 4 |
B03AC
|
Iron, parenteral preparations |
| 4 |
B03AD
|
Iron in combination with folic acid |
| 5 |
B03AD01
|
ferrous amino acid complex |
| 5 |
B03AD02
|
ferrous fumarate |
| 5 |
B03AD03
|
ferrous sulfate |
| 5 |
B03AD04
|
ferric oxide polymaltose complexes |
| 5 |
B03AD05
|
ferrous gluconate |
| 4 |
B03AE
|
Iron in other combinations |
| 5 |
B03AE01
|
iron, vitamin B12 and folic acid |
| 5 |
B03AE02
|
iron, multivitamins and folic acid |
| 5 |
B03AE03
|
iron and multivitamins |
| 5 |
B03AE04
|
iron, multivitamins and minerals |
| 5 |
B03AE10
|
various combinations |
| 3 |
B03B
|
VITAMIN B12 AND FOLIC ACID |
| 4 |
B03BA
|
Vitamin B12 (cyanocobalamin and analogues) |
| 5 |
B03BA01
|
cyanocobalamin |
| 5 |
B03BA02
|
cyanocobalamin tannin complex |
| 5 |
B03BA03
|
hydroxocobalamin |
| 5 |
B03BA04
|
cobamamide |
| 5 |
B03BA05
|
mecobalamin |
| 5 |
B03BA51
|
cyanocobalamin, combinations |
| 5 |
B03BA53
|
hydroxocobalamin, combinations |
| 4 |
B03BB
|
Folic acid and derivatives |
| 5 |
B03BB01
|
folic acid |
| 5 |
B03BB51
|
folic acid, combinations |
| 3 |
B03X
|
OTHER ANTIANEMIC PREPARATIONS |
| 4 |
B03XA
|
Other antianemic preparations |
| 5 |
B03XA01
|
erythropoietin |
| 5 |
B03XA02
|
darbepoetin alfa |
| 5 |
B03XA03
|
methoxy polyethylene glycol-epoetin beta |
| 5 |
B03XA04
|
peginesatide |
| 5 |
B03XA05
|
roxadustat |
| 5 |
B03XA06
|
luspatercept |
| 2 |
B05
|
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS |
| 3 |
B05A
|
BLOOD AND RELATED PRODUCTS |
| 4 |
B05AA
|
Blood substitutes and plasma protein fractions |
| 5 |
B05AA01
|
albumin |
| 5 |
B05AA02
|
other plasma protein fractions |
| 5 |
B05AA03
|
fluorocarbon blood substitutes |
| 5 |
B05AA05
|
dextran |
| 5 |
B05AA06
|
gelatin agents |
| 5 |
B05AA07
|
hydroxyethylstarch |
| 5 |
B05AA08
|
hemoglobin crosfumaril |
| 5 |
B05AA09
|
hemoglobin raffimer |
| 5 |
B05AA10
|
hemoglobin glutamer (bovine) |
| 4 |
B05AX
|
Other blood products |
| 5 |
B05AX01
|
erythrocytes |
| 5 |
B05AX02
|
thrombocytes |
| 5 |
B05AX03
|
blood plasma |
| 5 |
B05AX04
|
stem cells from umbilical cord blood |
| 3 |
B05B
|
I.V. SOLUTIONS |
| 4 |
B05BA
|
Solutions for parenteral nutrition |
| 5 |
B05BA01
|
amino acids |
| 5 |
B05BA02
|
fat emulsions |
| 5 |
B05BA03
|
carbohydrates |
| 5 |
B05BA04
|
protein hydrolysates |
| 5 |
B05BA10
|
combinations |
| 4 |
B05BB
|
Solutions affecting the electrolyte balance |
| 5 |
B05BB01
|
electrolytes |
| 5 |
B05BB02
|
electrolytes with carbohydrates |
| 5 |
B05BB03
|
trometamol |
| 5 |
B05BB04
|
electrolytes in combination with other drugs |
| 4 |
B05BC
|
Solutions producing osmotic diuresis |
| 5 |
B05BC01
|
mannitol |
| 5 |
B05BC02
|
carbamide |
| 3 |
B05C
|
IRRIGATING SOLUTIONS |
| 4 |
B05CA
|
Antiinfectives |
| 5 |
B05CA01
|
cetylpyridinium |
| 5 |
B05CA02
|
chlorhexidine |
| 5 |
B05CA03
|
nitrofural |
| 5 |
B05CA04
|
sulfamethizole |
| 5 |
B05CA05
|
taurolidine |
| 5 |
B05CA06
|
mandelic acid |
| 5 |
B05CA07
|
noxytiolin |
| 5 |
B05CA08
|
ethacridine lactate |
| 5 |
B05CA09
|
neomycin |
| 5 |
B05CA10
|
combinations |
| 4 |
B05CB
|
Salt solutions |
| 5 |
B05CB01
|
sodium chloride |
| 5 |
B05CB02
|
sodium citrate |
| 5 |
B05CB03
|
magnesium citrate |
| 5 |
B05CB04
|
sodium bicarbonate |
| 5 |
B05CB10
|
combinations |
| 4 |
B05CX
|
Other irrigating solutions |
| 5 |
B05CX01
|
glucose |
| 5 |
B05CX02
|
sorbitol |
| 5 |
B05CX03
|
glycine |
| 5 |
B05CX04
|
mannitol |
| 5 |
B05CX10
|
combinations |
| 3 |
B05D
|
PERITONEAL DIALYTICS |
| 4 |
B05DA
|
Isotonic solutions |
| 4 |
B05DB
|
Hypertonic solutions |
| 3 |
B05X
|
I.V. SOLUTION ADDITIVES |
| 4 |
B05XA
|
Electrolyte solutions |
| 5 |
B05XA01
|
potassium chloride |
| 5 |
B05XA02
|
sodium bicarbonate |
| 5 |
B05XA03
|
sodium chloride |
| 5 |
B05XA04
|
ammonium chloride |
| 5 |
B05XA05
|
magnesium sulfate |
| 5 |
B05XA06
|
potassium phosphate, incl. combinations with other potassium salts |
| 5 |
B05XA07
|
calcium chloride |
| 5 |
B05XA08
|
sodium acetate |
| 5 |
B05XA09
|
sodium phosphate |
| 5 |
B05XA10
|
magnesium phosphate |
| 5 |
B05XA11
|
magnesium chloride |
| 5 |
B05XA12
|
zinc chloride |
| 5 |
B05XA13
|
hydrochloric acid |
| 5 |
B05XA14
|
sodium glycerophosphate |
| 5 |
B05XA15
|
potassium lactate |
| 5 |
B05XA16
|
cardioplegia solutions |
| 5 |
B05XA17
|
potassium acetate |
| 5 |
B05XA18
|
zinc sulfate |
| 5 |
B05XA30
|
combinations of electrolytes |
| 5 |
B05XA31
|
electrolytes in combination with other drugs |
| 4 |
B05XB
|
Amino acids |
| 5 |
B05XB01
|
arginine hydrochloride |
| 5 |
B05XB02
|
alanyl glutamine |
| 5 |
B05XB03
|
lysine |
| 4 |
B05XC
|
Vitamins |
| 4 |
B05XX
|
Other i.v. solution additives |
| 5 |
B05XX02
|
trometamol |
| 3 |
B05Z
|
HEMODIALYTICS AND HEMOFILTRATES |
| 4 |
B05ZA
|
Hemodialytics, concentrates |
| 4 |
B05ZB
|
Hemofiltrates |
| 2 |
B06
|
OTHER HEMATOLOGICAL AGENTS |
| 3 |
B06A
|
OTHER HEMATOLOGICAL AGENTS |
| 4 |
B06AA
|
Enzymes |
| 5 |
B06AA02
|
fibrinolysin and desoxyribonuclease |
| 5 |
B06AA03
|
hyaluronidase |
| 5 |
B06AA04
|
chymotrypsin |
| 5 |
B06AA07
|
trypsin |
| 5 |
B06AA10
|
desoxyribonuclease |
| 5 |
B06AA55
|
streptokinase, combinations |
| 4 |
B06AB
|
Heme products |
| 5 |
B06AB01
|
hemin |
| 4 |
B06AC
|
Drugs used in hereditary angioedema |
| 5 |
B06AC01
|
c1-inhibitor, plasma derived |
| 5 |
B06AC02
|
icatibant |
| 5 |
B06AC03
|
ecallantide |
| 5 |
B06AC04
|
conestat alfa |
| 5 |
B06AC05
|
lanadelumab |
| 4 |
B06AX
|
Other hematological agents |
| 5 |
B06AX01
|
crizanlizumab |
| 5 |
B06AX02
|
betibeglogene autotemcel |
| 1 |
C
|
CARDIOVASCULAR SYSTEM |
| 2 |
C01
|
CARDIAC THERAPY |
| 3 |
C01A
|
CARDIAC GLYCOSIDES |
| 4 |
C01AA
|
Digitalis glycosides |
| 5 |
C01AA01
|
acetyldigitoxin |
| 5 |
C01AA02
|
acetyldigoxin |
| 5 |
C01AA03
|
digitalis leaves |
| 5 |
C01AA04
|
digitoxin |
| 5 |
C01AA05
|
digoxin |
| 5 |
C01AA06
|
lanatoside C |
| 5 |
C01AA07
|
deslanoside |
| 5 |
C01AA08
|
metildigoxin |
| 5 |
C01AA09
|
gitoformate |
| 5 |
C01AA52
|
acetyldigoxin, combinations |
| 4 |
C01AB
|
Scilla glycosides |
| 5 |
C01AB01
|
proscillaridin |
| 5 |
C01AB51
|
proscillaridin, combinations |
| 4 |
C01AC
|
Strophanthus glycosides |
| 5 |
C01AC01
|
g-strophanthin |
| 5 |
C01AC03
|
cymarin |
| 4 |
C01AX
|
Other cardiac glycosides |
| 5 |
C01AX02
|
peruvoside |
| 3 |
C01B
|
ANTIARRHYTHMICS, CLASS I AND III |
| 4 |
C01BA
|
Antiarrhythmics, class Ia |
| 5 |
C01BA01
|
quinidine |
| 5 |
C01BA02
|
procainamide |
| 5 |
C01BA03
|
disopyramide |
| 5 |
C01BA04
|
sparteine |
| 5 |
C01BA05
|
ajmaline |
| 5 |
C01BA08
|
prajmaline |
| 5 |
C01BA12
|
lorajmine |
| 5 |
C01BA13
|
hydroquinidine |
| 5 |
C01BA51
|
quinidine, combinations excl. psycholeptics |
| 5 |
C01BA71
|
quinidine, combinations with psycholeptics |
| 4 |
C01BB
|
Antiarrhythmics, class Ib |
| 5 |
C01BB01
|
lidocaine |
| 5 |
C01BB02
|
mexiletine |
| 5 |
C01BB03
|
tocainide |
| 5 |
C01BB04
|
aprindine |
| 4 |
C01BC
|
Antiarrhythmics, class Ic |
| 5 |
C01BC03
|
propafenone |
| 5 |
C01BC04
|
flecainide |
| 5 |
C01BC07
|
lorcainide |
| 5 |
C01BC08
|
encainide |
| 5 |
C01BC09
|
ethacizine |
| 4 |
C01BD
|
Antiarrhythmics, class III |
| 5 |
C01BD01
|
amiodarone |
| 5 |
C01BD02
|
bretylium tosilate |
| 5 |
C01BD03
|
bunaftine |
| 5 |
C01BD04
|
dofetilide |
| 5 |
C01BD05
|
ibutilide |
| 5 |
C01BD06
|
tedisamil |
| 5 |
C01BD07
|
dronedarone |
| 4 |
C01BG
|
Other antiarrhythmics, class I and III |
| 5 |
C01BG01
|
moracizine |
| 5 |
C01BG07
|
cibenzoline |
| 5 |
C01BG11
|
vernakalant |
| 3 |
C01C
|
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| 4 |
C01CA
|
Adrenergic and dopaminergic agents |
| 5 |
C01CA01
|
etilefrine |
| 5 |
C01CA02
|
isoprenaline |
| 5 |
C01CA03
|
norepinephrine |
| 5 |
C01CA04
|
dopamine |
| 5 |
C01CA05
|
norfenefrine |
| 5 |
C01CA06
|
phenylephrine |
| 5 |
C01CA07
|
dobutamine |
| 5 |
C01CA08
|
oxedrine |
| 5 |
C01CA09
|
metaraminol |
| 5 |
C01CA10
|
methoxamine |
| 5 |
C01CA11
|
mephentermine |
| 5 |
C01CA12
|
dimetofrine |
| 5 |
C01CA13
|
prenalterol |
| 5 |
C01CA14
|
dopexamine |
| 5 |
C01CA15
|
gepefrine |
| 5 |
C01CA16
|
ibopamine |
| 5 |
C01CA17
|
midodrine |
| 5 |
C01CA18
|
octopamine |
| 5 |
C01CA19
|
fenoldopam |
| 5 |
C01CA21
|
cafedrine |
| 5 |
C01CA22
|
arbutamine |
| 5 |
C01CA23
|
theodrenaline |
| 5 |
C01CA24
|
epinephrine |
| 5 |
C01CA25
|
amezinium metilsulfate |
| 5 |
C01CA26
|
ephedrine |
| 5 |
C01CA27
|
droxidopa |
| 5 |
C01CA30
|
combinations |
| 5 |
C01CA51
|
etilefrine, combinations |
| 4 |
C01CE
|
Phosphodiesterase inhibitors |
| 5 |
C01CE01
|
amrinone |
| 5 |
C01CE02
|
milrinone |
| 5 |
C01CE03
|
enoximone |
| 5 |
C01CE04
|
bucladesine |
| 4 |
C01CX
|
Other cardiac stimulants |
| 5 |
C01CX06
|
angiotensinamide |
| 5 |
C01CX07
|
xamoterol |
| 5 |
C01CX08
|
levosimendan |
| 5 |
C01CX09
|
angiotensin II |
| 3 |
C01D
|
VASODILATORS USED IN CARDIAC DISEASES |
| 4 |
C01DA
|
Organic nitrates |
| 5 |
C01DA02
|
glyceryl trinitrate |
| 5 |
C01DA04
|
methylpropylpropanediol dinitrate |
| 5 |
C01DA05
|
pentaerithrityl tetranitrate |
| 5 |
C01DA07
|
propatylnitrate |
| 5 |
C01DA08
|
isosorbide dinitrate |
| 5 |
C01DA09
|
trolnitrate |
| 5 |
C01DA13
|
eritrityl tetranitrate |
| 5 |
C01DA14
|
isosorbide mononitrate |
| 5 |
C01DA20
|
organic nitrates in combination |
| 5 |
C01DA38
|
tenitramine |
| 5 |
C01DA52
|
glyceryl trinitrate, combinations |
| 5 |
C01DA54
|
methylpropylpropanediol dinitrate, combinations |
| 5 |
C01DA55
|
pentaerithrityl tetranitrate, combinations |
| 5 |
C01DA57
|
propatylnitrate, combinations |
| 5 |
C01DA58
|
isosorbide dinitrate, combinations |
| 5 |
C01DA59
|
trolnitrate, combinations |
| 5 |
C01DA63
|
eritrityl tetranitrate, combinations |
| 5 |
C01DA70
|
organic nitrates in combination with psycholeptics |
| 4 |
C01DB
|
Quinolone vasodilators |
| 5 |
C01DB01
|
flosequinan |
| 4 |
C01DX
|
Other vasodilators used in cardiac diseases |
| 5 |
C01DX01
|
itramin tosilate |
| 5 |
C01DX02
|
prenylamine |
| 5 |
C01DX03
|
oxyfedrine |
| 5 |
C01DX04
|
benziodarone |
| 5 |
C01DX05
|
carbocromen |
| 5 |
C01DX06
|
hexobendine |
| 5 |
C01DX07
|
etafenone |
| 5 |
C01DX08
|
heptaminol |
| 5 |
C01DX09
|
imolamine |
| 5 |
C01DX10
|
dilazep |
| 5 |
C01DX11
|
trapidil |
| 5 |
C01DX12
|
molsidomine |
| 5 |
C01DX13
|
efloxate |
| 5 |
C01DX14
|
cinepazet |
| 5 |
C01DX15
|
cloridarol |
| 5 |
C01DX16
|
nicorandil |
| 5 |
C01DX18
|
linsidomine |
| 5 |
C01DX19
|
nesiritide |
| 5 |
C01DX21
|
serelaxin |
| 5 |
C01DX22
|
vericiguat |
| 5 |
C01DX51
|
itramin tosilate, combinations |
| 5 |
C01DX52
|
prenylamine, combinations |
| 5 |
C01DX53
|
oxyfedrine, combinations |
| 5 |
C01DX54
|
benziodarone, combinations |
| 3 |
C01E
|
OTHER CARDIAC PREPARATIONS |
| 4 |
C01EA
|
Prostaglandins |
| 5 |
C01EA01
|
alprostadil |
| 4 |
C01EB
|
Other cardiac preparations |
| 5 |
C01EB02
|
camphora |
| 5 |
C01EB03
|
indometacin |
| 5 |
C01EB04
|
crataegus glycosides |
| 5 |
C01EB05
|
creatinolfosfate |
| 5 |
C01EB06
|
fosfocreatine |
| 5 |
C01EB07
|
fructose 1,6-diphosphate |
| 5 |
C01EB09
|
ubidecarenone |
| 5 |
C01EB10
|
adenosine |
| 5 |
C01EB11
|
tiracizine |
| 5 |
C01EB13
|
acadesine |
| 5 |
C01EB15
|
trimetazidine |
| 5 |
C01EB16
|
ibuprofen |
| 5 |
C01EB17
|
ivabradine |
| 5 |
C01EB18
|
ranolazine |
| 5 |
C01EB21
|
regadenoson |
| 5 |
C01EB22
|
meldonium |
| 5 |
C01EB23
|
tiazotic acid |
| 4 |
C01EX
|
Other cardiac combination products |
| 2 |
C02
|
ANTIHYPERTENSIVES |
| 3 |
C02A
|
ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
| 4 |
C02AA
|
Rauwolfia alkaloids |
| 5 |
C02AA01
|
rescinnamine |
| 5 |
C02AA02
|
reserpine |
| 5 |
C02AA03
|
combinations of rauwolfia alkaloids |
| 5 |
C02AA04
|
rauwolfia alkaloids, whole root |
| 5 |
C02AA05
|
deserpidine |
| 5 |
C02AA06
|
methoserpidine |
| 5 |
C02AA07
|
bietaserpine |
| 5 |
C02AA52
|
reserpine, combinations |
| 5 |
C02AA53
|
combinations of rauwolfia alkoloids, combinations |
| 5 |
C02AA57
|
bietaserpine, combinations |
| 4 |
C02AB
|
Methyldopa |
| 5 |
C02AB01
|
methyldopa (levorotatory) |
| 5 |
C02AB02
|
methyldopa (racemic) |
| 4 |
C02AC
|
Imidazoline receptor agonists |
| 5 |
C02AC01
|
clonidine |
| 5 |
C02AC02
|
guanfacine |
| 5 |
C02AC04
|
tolonidine |
| 5 |
C02AC05
|
moxonidine |
| 5 |
C02AC06
|
rilmenidine |
| 3 |
C02B
|
ANTIADRENERGIC AGENTS, GANGLION-BLOCKING |
| 4 |
C02BA
|
Sulfonium derivatives |
| 5 |
C02BA01
|
trimetaphan |
| 4 |
C02BB
|
Secondary and tertiary amines |
| 5 |
C02BB01
|
mecamylamine |
| 4 |
C02BC
|
Bisquaternary ammonium compounds |
| 3 |
C02C
|
ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
| 4 |
C02CA
|
Alpha-adrenoreceptor antagonists |
| 5 |
C02CA01
|
prazosin |
| 5 |
C02CA02
|
indoramin |
| 5 |
C02CA03
|
trimazosin |
| 5 |
C02CA04
|
doxazosin |
| 5 |
C02CA06
|
urapidil |
| 4 |
C02CC
|
Guanidine derivatives |
| 5 |
C02CC01
|
betanidine |
| 5 |
C02CC02
|
guanethidine |
| 5 |
C02CC03
|
guanoxan |
| 5 |
C02CC04
|
debrisoquine |
| 5 |
C02CC05
|
guanoclor |
| 5 |
C02CC06
|
guanazodine |
| 5 |
C02CC07
|
guanoxabenz |
| 3 |
C02D
|
ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON |
| 4 |
C02DA
|
Thiazide derivatives |
| 5 |
C02DA01
|
diazoxide |
| 4 |
C02DB
|
Hydrazinophthalazine derivatives |
| 5 |
C02DB01
|
dihydralazine |
| 5 |
C02DB02
|
hydralazine |
| 5 |
C02DB03
|
endralazine |
| 5 |
C02DB04
|
cadralazine |
| 4 |
C02DC
|
Pyrimidine derivatives |
| 5 |
C02DC01
|
minoxidil |
| 4 |
C02DD
|
Nitroferricyanide derivatives |
| 5 |
C02DD01
|
nitroprusside |
| 4 |
C02DG
|
Guanidine derivatives |
| 5 |
C02DG01
|
pinacidil |
| 3 |
C02K
|
OTHER ANTIHYPERTENSIVES |
| 4 |
C02KA
|
Alkaloids, excl. rauwolfia |
| 5 |
C02KA01
|
veratrum |
| 4 |
C02KB
|
Tyrosine hydroxylase inhibitors |
| 5 |
C02KB01
|
metirosine |
| 4 |
C02KC
|
MAO inhibitors |
| 5 |
C02KC01
|
pargyline |
| 4 |
C02KD
|
Serotonin antagonists |
| 5 |
C02KD01
|
ketanserin |
| 4 |
C02KX
|
Antihypertensives for pulmonary arterial hypertension |
| 5 |
C02KX01
|
bosentan |
| 5 |
C02KX02
|
ambrisentan |
| 5 |
C02KX03
|
sitaxentan |
| 5 |
C02KX04
|
macitentan |
| 5 |
C02KX05
|
riociguat |
| 5 |
C02KX52
|
ambrisentan and tadalafil |
| 3 |
C02L
|
ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION |
| 4 |
C02LA
|
Rauwolfia alkaloids and diuretics in combination |
| 5 |
C02LA01
|
reserpine and diuretics |
| 5 |
C02LA02
|
rescinnamine and diuretics |
| 5 |
C02LA03
|
deserpidine and diuretics |
| 5 |
C02LA04
|
methoserpidine and diuretics |
| 5 |
C02LA07
|
bietaserpine and diuretics |
| 5 |
C02LA08
|
rauwolfia alkaloids, whole root and diuretics |
| 5 |
C02LA09
|
syrosingopine and diuretics |
| 5 |
C02LA50
|
combination of rauwolfia alkaloids and diuretics incl. other combinations |
| 5 |
C02LA51
|
reserpine and diuretics, combinations with other drugs |
| 5 |
C02LA52
|
rescinnamine and diuretics, combinations with other drugs |
| 5 |
C02LA71
|
reserpine and diuretics, combinations with psycholeptics |
| 4 |
C02LB
|
Methyldopa and diuretics in combination |
| 5 |
C02LB01
|
methyldopa (levorotatory) and diuretics |
| 4 |
C02LC
|
Imidazoline receptor agonists in combination with diuretics |
| 5 |
C02LC01
|
clonidine and diuretics |
| 5 |
C02LC05
|
moxonidine and diuretics |
| 5 |
C02LC51
|
clonidine and diuretics, combinations with other drugs |
| 4 |
C02LE
|
Alpha-adrenoreceptor antagonists and diuretics |
| 5 |
C02LE01
|
prazosin and diuretics |
| 4 |
C02LF
|
Guanidine derivatives and diuretics |
| 5 |
C02LF01
|
guanethidine and diuretics |
| 4 |
C02LG
|
Hydrazinophthalazine derivatives and diuretics |
| 5 |
C02LG01
|
dihydralazine and diuretics |
| 5 |
C02LG02
|
hydralazine and diuretics |
| 5 |
C02LG03
|
picodralazine and diuretics |
| 5 |
C02LG51
|
dihydralazine and diuretics, combinations with other drugs |
| 5 |
C02LG73
|
picodralazine and diuretics, combinations with psycholeptics |
| 4 |
C02LK
|
Alkaloids, excl. rauwolfia, in combination with diuretics |
| 5 |
C02LK01
|
veratrum and diuretics |
| 4 |
C02LL
|
MAO inhibitors and diuretics |
| 5 |
C02LL01
|
pargyline and diuretics |
| 4 |
C02LN
|
Serotonin antagonists and diuretics |
| 4 |
C02LX
|
Other antihypertensives and diuretics |
| 5 |
C02LX01
|
pinacidil and diuretics |
| 3 |
C02N
|
COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 |
| 2 |
C03
|
DIURETICS |
| 3 |
C03A
|
LOW-CEILING DIURETICS, THIAZIDES |
| 4 |
C03AA
|
Thiazides, plain |
| 5 |
C03AA01
|
bendroflumethiazide |
| 5 |
C03AA02
|
hydroflumethiazide |
| 5 |
C03AA03
|
hydrochlorothiazide |
| 5 |
C03AA04
|
chlorothiazide |
| 5 |
C03AA05
|
polythiazide |
| 5 |
C03AA06
|
trichlormethiazide |
| 5 |
C03AA07
|
cyclopenthiazide |
| 5 |
C03AA08
|
methyclothiazide |
| 5 |
C03AA09
|
cyclothiazide |
| 5 |
C03AA13
|
mebutizide |
| 4 |
C03AB
|
Thiazides and potassium in combination |
| 5 |
C03AB01
|
bendroflumethiazide and potassium |
| 5 |
C03AB02
|
hydroflumethiazide and potassium |
| 5 |
C03AB03
|
hydrochlorothiazide and potassium |
| 5 |
C03AB04
|
chlorothiazide and potassium |
| 5 |
C03AB05
|
polythiazide and potassium |
| 5 |
C03AB06
|
trichlormethiazide and potassium |
| 5 |
C03AB07
|
cyclopenthiazide and potassium |
| 5 |
C03AB08
|
methyclothiazide and potassium |
| 5 |
C03AB09
|
cyclothiazide and potassium |
| 4 |
C03AH
|
Thiazides, combinations with psycholeptics and/or analgesics |
| 5 |
C03AH01
|
chlorothiazide, combinations |
| 5 |
C03AH02
|
hydroflumethiazide, combinations |
| 4 |
C03AX
|
Thiazides, combinations with other drugs |
| 5 |
C03AX01
|
hydrochlorothiazide, combinations |
| 3 |
C03B
|
LOW-CEILING DIURETICS, EXCL. THIAZIDES |
| 4 |
C03BA
|
Sulfonamides, plain |
| 5 |
C03BA02
|
quinethazone |
| 5 |
C03BA03
|
clopamide |
| 5 |
C03BA04
|
chlortalidone |
| 5 |
C03BA05
|
mefruside |
| 5 |
C03BA07
|
clofenamide |
| 5 |
C03BA08
|
metolazone |
| 5 |
C03BA09
|
meticrane |
| 5 |
C03BA10
|
xipamide |
| 5 |
C03BA11
|
indapamide |
| 5 |
C03BA12
|
clorexolone |
| 5 |
C03BA13
|
fenquizone |
| 5 |
C03BA82
|
clorexolone, combinations with psycholeptics |
| 4 |
C03BB
|
Sulfonamides and potassium in combination |
| 5 |
C03BB02
|
quinethazone and potassium |
| 5 |
C03BB03
|
clopamide and potassium |
| 5 |
C03BB04
|
chlortalidone and potassium |
| 5 |
C03BB05
|
mefruside and potassium |
| 5 |
C03BB07
|
clofenamide and potassium |
| 4 |
C03BC
|
Mercurial diuretics |
| 5 |
C03BC01
|
mersalyl |
| 4 |
C03BD
|
Xanthine derivatives |
| 5 |
C03BD01
|
theobromine |
| 4 |
C03BK
|
Sulfonamides, combinations with other drugs |
| 4 |
C03BX
|
Other low-ceiling diuretics |
| 5 |
C03BX03
|
cicletanine |
| 3 |
C03C
|
HIGH-CEILING DIURETICS |
| 4 |
C03CA
|
Sulfonamides, plain |
| 5 |
C03CA01
|
furosemide |
| 5 |
C03CA02
|
bumetanide |
| 5 |
C03CA03
|
piretanide |
| 5 |
C03CA04
|
torasemide |
| 4 |
C03CB
|
Sulfonamides and potassium in combination |
| 5 |
C03CB01
|
furosemide and potassium |
| 5 |
C03CB02
|
bumetanide and potassium |
| 4 |
C03CC
|
Aryloxyacetic acid derivatives |
| 5 |
C03CC01
|
etacrynic acid |
| 5 |
C03CC02
|
tienilic acid |
| 4 |
C03CD
|
Pyrazolone derivatives |
| 5 |
C03CD01
|
muzolimine |
| 4 |
C03CX
|
Other high-ceiling diuretics |
| 5 |
C03CX01
|
etozolin |
| 3 |
C03D
|
POTASSIUM-SPARING AGENTS |
| 4 |
C03DA
|
Aldosterone antagonists |
| 5 |
C03DA01
|
spironolactone |
| 5 |
C03DA02
|
potassium canrenoate |
| 5 |
C03DA03
|
canrenone |
| 5 |
C03DA04
|
eplerenone |
| 4 |
C03DB
|
Other potassium-sparing agents |
| 5 |
C03DB01
|
amiloride |
| 5 |
C03DB02
|
triamterene |
| 3 |
C03E
|
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION |
| 4 |
C03EA
|
Low-ceiling diuretics and potassium-sparing agents |
| 5 |
C03EA01
|
hydrochlorothiazide and potassium-sparing agents |
| 5 |
C03EA02
|
trichlormethiazide and potassium-sparing agents |
| 5 |
C03EA03
|
epitizide and potassium-sparing agents |
| 5 |
C03EA04
|
altizide and potassium-sparing agents |
| 5 |
C03EA05
|
mebutizide and potassium-sparing agents |
| 5 |
C03EA06
|
chlortalidone and potassium-sparing agents |
| 5 |
C03EA07
|
cyclopenthiazide and potassium-sparing agents |
| 5 |
C03EA12
|
metolazone and potassium-sparing agents |
| 5 |
C03EA13
|
bendroflumethiazide and potassium-sparing agents |
| 5 |
C03EA14
|
butizide and potassium-sparing agents |
| 4 |
C03EB
|
High-ceiling diuretics and potassium-sparing agents |
| 5 |
C03EB01
|
furosemide and potassium-sparing agents |
| 5 |
C03EB02
|
bumetanide and potassium-sparing agents |
| 3 |
C03X
|
OTHER DIURETICS |
| 4 |
C03XA
|
Vasopressin antagonists |
| 5 |
C03XA01
|
tolvaptan |
| 5 |
C03XA02
|
conivaptan |
| 2 |
C04
|
PERIPHERAL VASODILATORS |
| 3 |
C04A
|
PERIPHERAL VASODILATORS |
| 4 |
C04AA
|
2-amino-1-phenylethanol derivatives |
| 5 |
C04AA01
|
isoxsuprine |
| 5 |
C04AA02
|
buphenine |
| 5 |
C04AA31
|
bamethan |
| 4 |
C04AB
|
Imidazoline derivatives |
| 5 |
C04AB01
|
phentolamine |
| 5 |
C04AB02
|
tolazoline |
| 4 |
C04AC
|
Nicotinic acid and derivatives |
| 5 |
C04AC01
|
nicotinic acid |
| 5 |
C04AC02
|
nicotinyl alcohol (pyridylcarbinol) |
| 5 |
C04AC03
|
inositol nicotinate |
| 5 |
C04AC07
|
ciclonicate |
| 4 |
C04AD
|
Purine derivatives |
| 5 |
C04AD01
|
pentifylline |
| 5 |
C04AD02
|
xantinol nicotinate |
| 5 |
C04AD03
|
pentoxifylline |
| 5 |
C04AD04
|
etofylline nicotinate |
| 4 |
C04AE
|
Ergot alkaloids |
| 5 |
C04AE01
|
ergoloid mesylates |
| 5 |
C04AE02
|
nicergoline |
| 5 |
C04AE04
|
dihydroergocristine |
| 5 |
C04AE51
|
ergoloid mesylates, combinations |
| 5 |
C04AE54
|
dihydroergocristine, combinations |
| 4 |
C04AF
|
Enzymes |
| 5 |
C04AF01
|
kallidinogenase |
| 4 |
C04AX
|
Other peripheral vasodilators |
| 5 |
C04AX01
|
cyclandelate |
| 5 |
C04AX02
|
phenoxybenzamine |
| 5 |
C04AX07
|
vincamine |
| 5 |
C04AX10
|
moxisylyte |
| 5 |
C04AX11
|
bencyclane |
| 5 |
C04AX17
|
vinburnine |
| 5 |
C04AX19
|
suloctidil |
| 5 |
C04AX20
|
buflomedil |
| 5 |
C04AX21
|
naftidrofuryl |
| 5 |
C04AX23
|
butalamine |
| 5 |
C04AX24
|
visnadine |
| 5 |
C04AX26
|
cetiedil |
| 5 |
C04AX27
|
cinepazide |
| 5 |
C04AX28
|
ifenprodil |
| 5 |
C04AX30
|
azapetine |
| 5 |
C04AX32
|
fasudil |
| 2 |
C05
|
VASOPROTECTIVES |
| 3 |
C05A
|
AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| 4 |
C05AA
|
Corticosteroids |
| 5 |
C05AA01
|
hydrocortisone |
| 5 |
C05AA04
|
prednisolone |
| 5 |
C05AA05
|
betamethasone |
| 5 |
C05AA06
|
fluorometholone |
| 5 |
C05AA08
|
fluocortolone |
| 5 |
C05AA09
|
dexamethasone |
| 5 |
C05AA10
|
fluocinolone acetonide |
| 5 |
C05AA11
|
fluocinonide |
| 5 |
C05AA12
|
triamcinolone |
| 4 |
C05AB
|
Antibiotics |
| 4 |
C05AD
|
Local anesthetics |
| 5 |
C05AD01
|
lidocaine |
| 5 |
C05AD02
|
tetracaine |
| 5 |
C05AD03
|
benzocaine |
| 5 |
C05AD04
|
cinchocaine |
| 5 |
C05AD05
|
procaine |
| 5 |
C05AD06
|
oxetacaine |
| 5 |
C05AD07
|
pramocaine |
| 4 |
C05AE
|
Muscle relaxants |
| 5 |
C05AE01
|
glyceryl trinitrate |
| 5 |
C05AE02
|
isosorbide dinitrate |
| 5 |
C05AE03
|
diltiazem |
| 4 |
C05AX
|
Other agents for treatment of hemorrhoids and anal fissures for topical use |
| 5 |
C05AX01
|
aluminium preparations |
| 5 |
C05AX02
|
bismuth preparations, combinations |
| 5 |
C05AX03
|
other preparations, combinations |
| 5 |
C05AX04
|
zinc preparations |
| 5 |
C05AX05
|
tribenoside |
| 3 |
C05B
|
ANTIVARICOSE THERAPY |
| 4 |
C05BA
|
Heparins or heparinoids for topical use |
| 5 |
C05BA01
|
organo-heparinoid |
| 5 |
C05BA02
|
sodium apolate |
| 5 |
C05BA03
|
heparin |
| 5 |
C05BA04
|
pentosan polysulfate sodium |
| 5 |
C05BA51
|
heparinoid, combinations |
| 5 |
C05BA53
|
heparin, combinations |
| 4 |
C05BB
|
Sclerosing agents for local injection |
| 5 |
C05BB01
|
monoethanolamine oleate |
| 5 |
C05BB02
|
polidocanol |
| 5 |
C05BB03
|
invert sugar |
| 5 |
C05BB04
|
sodium tetradecyl sulfate |
| 5 |
C05BB05
|
phenol |
| 5 |
C05BB56
|
glucose, combinations |
| 4 |
C05BX
|
Other sclerosing agents |
| 5 |
C05BX01
|
calcium dobesilate |
| 5 |
C05BX51
|
calcium dobesilate, combinations |
| 3 |
C05C
|
CAPILLARY STABILIZING AGENTS |
| 4 |
C05CA
|
Bioflavonoids |
| 5 |
C05CA01
|
rutoside |
| 5 |
C05CA02
|
monoxerutin |
| 5 |
C05CA03
|
diosmin |
| 5 |
C05CA04
|
troxerutin |
| 5 |
C05CA05
|
hidrosmin |
| 5 |
C05CA51
|
rutoside, combinations |
| 5 |
C05CA53
|
diosmin, combinations |
| 5 |
C05CA54
|
troxerutin, combinations |
| 4 |
C05CX
|
Other capillary stabilizing agents |
| 5 |
C05CX01
|
tribenoside |
| 5 |
C05CX02
|
naftazone |
| 5 |
C05CX03
|
Hippocastani semen |
| 2 |
C07
|
BETA BLOCKING AGENTS |
| 3 |
C07A
|
BETA BLOCKING AGENTS |
| 4 |
C07AA
|
Beta blocking agents, non-selective |
| 5 |
C07AA01
|
alprenolol |
| 5 |
C07AA02
|
oxprenolol |
| 5 |
C07AA03
|
pindolol |
| 5 |
C07AA05
|
propranolol |
| 5 |
C07AA06
|
timolol |
| 5 |
C07AA07
|
sotalol |
| 5 |
C07AA12
|
nadolol |
| 5 |
C07AA14
|
mepindolol |
| 5 |
C07AA15
|
carteolol |
| 5 |
C07AA16
|
tertatolol |
| 5 |
C07AA17
|
bopindolol |
| 5 |
C07AA19
|
bupranolol |
| 5 |
C07AA23
|
penbutolol |
| 5 |
C07AA27
|
cloranolol |
| 4 |
C07AB
|
Beta blocking agents, selective |
| 5 |
C07AB01
|
practolol |
| 5 |
C07AB02
|
metoprolol |
| 5 |
C07AB03
|
atenolol |
| 5 |
C07AB04
|
acebutolol |
| 5 |
C07AB05
|
betaxolol |
| 5 |
C07AB06
|
bevantolol |
| 5 |
C07AB07
|
bisoprolol |
| 5 |
C07AB08
|
celiprolol |
| 5 |
C07AB09
|
esmolol |
| 5 |
C07AB10
|
epanolol |
| 5 |
C07AB11
|
s-atenolol |
| 5 |
C07AB12
|
nebivolol |
| 5 |
C07AB13
|
talinolol |
| 5 |
C07AB14
|
landiolol |
| 4 |
C07AG
|
Alpha and beta blocking agents |
| 5 |
C07AG01
|
labetalol |
| 5 |
C07AG02
|
carvedilol |
| 3 |
C07B
|
BETA BLOCKING AGENTS AND THIAZIDES |
| 4 |
C07BA
|
Beta blocking agents, non-selective, and thiazides |
| 5 |
C07BA02
|
oxprenolol and thiazides |
| 5 |
C07BA05
|
propranolol and thiazides |
| 5 |
C07BA06
|
timolol and thiazides |
| 5 |
C07BA07
|
sotalol and thiazides |
| 5 |
C07BA12
|
nadolol and thiazides |
| 5 |
C07BA68
|
metipranolol and thiazides, combinations |
| 4 |
C07BB
|
Beta blocking agents, selective, and thiazides |
| 5 |
C07BB02
|
metoprolol and thiazides |
| 5 |
C07BB03
|
atenolol and thiazides |
| 5 |
C07BB04
|
acebutolol and thiazides |
| 5 |
C07BB06
|
bevantolol and thiazides |
| 5 |
C07BB07
|
bisoprolol and thiazides |
| 5 |
C07BB12
|
nebivolol and thiazides |
| 5 |
C07BB52
|
metoprolol and thiazides, combinations |
| 4 |
C07BG
|
Alpha and beta blocking agents and thiazides |
| 5 |
C07BG01
|
labetalol and thiazides |
| 3 |
C07C
|
BETA BLOCKING AGENTS AND OTHER DIURETICS |
| 4 |
C07CA
|
Beta blocking agents, non-selective, and other diuretics |
| 5 |
C07CA02
|
oxprenolol and other diuretics |
| 5 |
C07CA03
|
pindolol and other diuretics |
| 5 |
C07CA17
|
bopindolol and other diuretics |
| 5 |
C07CA23
|
penbutolol and other diuretics |
| 4 |
C07CB
|
Beta blocking agents, selective, and other diuretics |
| 5 |
C07CB02
|
metoprolol and other diuretics |
| 5 |
C07CB03
|
atenolol and other diuretics |
| 5 |
C07CB53
|
atenolol and other diuretics, combinations |
| 4 |
C07CG
|
Alpha and beta blocking agents and other diuretics |
| 5 |
C07CG01
|
labetalol and other diuretics |
| 3 |
C07D
|
BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS |
| 4 |
C07DA
|
Beta blocking agents, non-selective, thiazides and other diuretics |
| 5 |
C07DA06
|
timolol, thiazides and other diuretics |
| 4 |
C07DB
|
Beta blocking agents, selective, thiazides and other diuretics |
| 5 |
C07DB01
|
atenolol, thiazides and other diuretics |
| 3 |
C07E
|
BETA BLOCKING AGENTS AND VASODILATORS |
| 4 |
C07EA
|
Beta blocking agents, non-selective, and vasodilators |
| 4 |
C07EB
|
Beta blocking agents, selective, and vasodilators |
| 3 |
C07F
|
BETA BLOCKING AGENTS, OTHER COMBINATIONS |
| 4 |
C07FB
|
Beta blocking agents and calcium channel blockers |
| 5 |
C07FB02
|
metoprolol and felodipine |
| 5 |
C07FB03
|
atenolol and nifedipine |
| 5 |
C07FB07
|
bisoprolol and amlodipine |
| 5 |
C07FB12
|
nebivolol and amlodipine |
| 5 |
C07FB13
|
metoprolol and amlodipine |
| 4 |
C07FX
|
Beta blocking agents, other combinations |
| 5 |
C07FX01
|
propranolol and other combinations |
| 5 |
C07FX02
|
sotalol and acetylsalicylic acid |
| 5 |
C07FX03
|
metoprolol and acetylsalicylic acid |
| 5 |
C07FX04
|
bisoprolol and acetylsalicylic acid |
| 5 |
C07FX05
|
metoprolol and ivabradine |
| 5 |
C07FX06
|
carvedilol and ivabradine |
| 2 |
C08
|
CALCIUM CHANNEL BLOCKERS |
| 3 |
C08C
|
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS |
| 4 |
C08CA
|
Dihydropyridine derivatives |
| 5 |
C08CA01
|
amlodipine |
| 5 |
C08CA02
|
felodipine |
| 5 |
C08CA03
|
isradipine |
| 5 |
C08CA04
|
nicardipine |
| 5 |
C08CA05
|
nifedipine |
| 5 |
C08CA06
|
nimodipine |
| 5 |
C08CA07
|
nisoldipine |
| 5 |
C08CA08
|
nitrendipine |
| 5 |
C08CA09
|
lacidipine |
| 5 |
C08CA10
|
nilvadipine |
| 5 |
C08CA11
|
manidipine |
| 5 |
C08CA12
|
barnidipine |
| 5 |
C08CA13
|
lercanidipine |
| 5 |
C08CA14
|
cilnidipine |
| 5 |
C08CA15
|
benidipine |
| 5 |
C08CA16
|
clevidipine |
| 5 |
C08CA51
|
amlodipine and celecoxib |
| 5 |
C08CA55
|
nifedipine, combinations |
| 4 |
C08CX
|
Other selective calcium channel blockers with mainly vascular effects |
| 5 |
C08CX01
|
mibefradil |
| 3 |
C08D
|
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS |
| 4 |
C08DA
|
Phenylalkylamine derivatives |
| 5 |
C08DA01
|
verapamil |
| 5 |
C08DA02
|
gallopamil |
| 5 |
C08DA51
|
verapamil, combinations |
| 4 |
C08DB
|
Benzothiazepine derivatives |
| 5 |
C08DB01
|
diltiazem |
| 3 |
C08E
|
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
| 4 |
C08EA
|
Phenylalkylamine derivatives |
| 5 |
C08EA01
|
fendiline |
| 5 |
C08EA02
|
bepridil |
| 4 |
C08EX
|
Other non-selective calcium channel blockers |
| 5 |
C08EX01
|
lidoflazine |
| 5 |
C08EX02
|
perhexiline |
| 3 |
C08G
|
CALCIUM CHANNEL BLOCKERS AND DIURETICS |
| 4 |
C08GA
|
Calcium channel blockers and diuretics |
| 5 |
C08GA01
|
nifedipine and diuretics |
| 5 |
C08GA02
|
amlodipine and diuretics |
| 2 |
C09
|
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| 3 |
C09A
|
ACE INHIBITORS, PLAIN |
| 4 |
C09AA
|
ACE inhibitors, plain |
| 5 |
C09AA01
|
captopril |
| 5 |
C09AA02
|
enalapril |
| 5 |
C09AA03
|
lisinopril |
| 5 |
C09AA04
|
perindopril |
| 5 |
C09AA05
|
ramipril |
| 5 |
C09AA06
|
quinapril |
| 5 |
C09AA07
|
benazepril |
| 5 |
C09AA08
|
cilazapril |
| 5 |
C09AA09
|
fosinopril |
| 5 |
C09AA10
|
trandolapril |
| 5 |
C09AA11
|
spirapril |
| 5 |
C09AA12
|
delapril |
| 5 |
C09AA13
|
moexipril |
| 5 |
C09AA14
|
temocapril |
| 5 |
C09AA15
|
zofenopril |
| 5 |
C09AA16
|
imidapril |
| 3 |
C09B
|
ACE INHIBITORS, COMBINATIONS |
| 4 |
C09BA
|
ACE inhibitors and diuretics |
| 5 |
C09BA01
|
captopril and diuretics |
| 5 |
C09BA02
|
enalapril and diuretics |
| 5 |
C09BA03
|
lisinopril and diuretics |
| 5 |
C09BA04
|
perindopril and diuretics |
| 5 |
C09BA05
|
ramipril and diuretics |
| 5 |
C09BA06
|
quinapril and diuretics |
| 5 |
C09BA07
|
benazepril and diuretics |
| 5 |
C09BA08
|
cilazapril and diuretics |
| 5 |
C09BA09
|
fosinopril and diuretics |
| 5 |
C09BA12
|
delapril and diuretics |
| 5 |
C09BA13
|
moexipril and diuretics |
| 5 |
C09BA15
|
zofenopril and diuretics |
| 4 |
C09BB
|
ACE inhibitors and calcium channel blockers |
| 5 |
C09BB02
|
enalapril and lercanidipine |
| 5 |
C09BB03
|
lisinopril and amlodipine |
| 5 |
C09BB04
|
perindopril and amlodipine |
| 5 |
C09BB05
|
ramipril and felodipine |
| 5 |
C09BB06
|
enalapril and nitrendipine |
| 5 |
C09BB07
|
ramipril and amlodipine |
| 5 |
C09BB10
|
trandolapril and verapamil |
| 5 |
C09BB12
|
delapril and manidipine |
| 4 |
C09BX
|
ACE inhibitors, other combinations |
| 5 |
C09BX01
|
perindopril, amlodipine and indapamide |
| 5 |
C09BX02
|
perindopril and bisoprolol |
| 5 |
C09BX03
|
ramipril, amlodipine and hydrochlorothiazide |
| 5 |
C09BX04
|
perindopril, bisoprolol and amlodipine |
| 5 |
C09BX05
|
ramipril and bisoprolol |
| 3 |
C09C
|
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN |
| 4 |
C09CA
|
Angiotensin II receptor blockers (ARBs), plain |
| 5 |
C09CA01
|
losartan |
| 5 |
C09CA02
|
eprosartan |
| 5 |
C09CA03
|
valsartan |
| 5 |
C09CA04
|
irbesartan |
| 5 |
C09CA05
|
tasosartan |
| 5 |
C09CA06
|
candesartan |
| 5 |
C09CA07
|
telmisartan |
| 5 |
C09CA08
|
olmesartan medoxomil |
| 5 |
C09CA09
|
azilsartan medoxomil |
| 5 |
C09CA10
|
fimasartan |
| 3 |
C09D
|
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS |
| 4 |
C09DA
|
Angiotensin II receptor blockers (ARBs) and diuretics |
| 5 |
C09DA01
|
losartan and diuretics |
| 5 |
C09DA02
|
eprosartan and diuretics |
| 5 |
C09DA03
|
valsartan and diuretics |
| 5 |
C09DA04
|
irbesartan and diuretics |
| 5 |
C09DA06
|
candesartan and diuretics |
| 5 |
C09DA07
|
telmisartan and diuretics |
| 5 |
C09DA08
|
olmesartan medoxomil and diuretics |
| 5 |
C09DA09
|
azilsartan medoxomil and diuretics |
| 5 |
C09DA10
|
fimasartan and diuretics |
| 4 |
C09DB
|
Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
| 5 |
C09DB01
|
valsartan and amlodipine |
| 5 |
C09DB02
|
olmesartan medoxomil and amlodipine |
| 5 |
C09DB04
|
telmisartan and amlodipine |
| 5 |
C09DB05
|
irbesartan and amlodipine |
| 5 |
C09DB06
|
losartan and amlodipine |
| 5 |
C09DB07
|
candesartan and amlodipine |
| 5 |
C09DB08
|
valsartan and lercanidipine |
| 5 |
C09DB09
|
fimasartan and amlodipine |
| 4 |
C09DX
|
Angiotensin II receptor blockers (ARBs), other combinations |
| 5 |
C09DX01
|
valsartan, amlodipine and hydrochlorothiazide |
| 5 |
C09DX02
|
valsartan and aliskiren |
| 5 |
C09DX03
|
olmesartan medoxomil, amlodipine and hydrochlorothiazide |
| 5 |
C09DX04
|
valsartan and sacubitril |
| 5 |
C09DX05
|
valsartan and nebivolol |
| 5 |
C09DX06
|
candesartan, amlodipine and hydrochlorothiazide |
| 5 |
C09DX07
|
irbesartan, amlodipine and hydrochlorothiazide |
| 3 |
C09X
|
OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| 4 |
C09XA
|
Renin-inhibitors |
| 5 |
C09XA01
|
remikiren |
| 5 |
C09XA02
|
aliskiren |
| 5 |
C09XA52
|
aliskiren and hydrochlorothiazide |
| 5 |
C09XA53
|
aliskiren and amlodipine |
| 5 |
C09XA54
|
aliskiren, amlodipine and hydrochlorothiazide |
| 2 |
C10
|
LIPID MODIFYING AGENTS |
| 3 |
C10A
|
LIPID MODIFYING AGENTS, PLAIN |
| 4 |
C10AA
|
HMG CoA reductase inhibitors |
| 5 |
C10AA01
|
simvastatin |
| 5 |
C10AA02
|
lovastatin |
| 5 |
C10AA03
|
pravastatin |
| 5 |
C10AA04
|
fluvastatin |
| 5 |
C10AA05
|
atorvastatin |
| 5 |
C10AA06
|
cerivastatin |
| 5 |
C10AA07
|
rosuvastatin |
| 5 |
C10AA08
|
pitavastatin |
| 4 |
C10AB
|
Fibrates |
| 5 |
C10AB01
|
clofibrate |
| 5 |
C10AB02
|
bezafibrate |
| 5 |
C10AB03
|
aluminium clofibrate |
| 5 |
C10AB04
|
gemfibrozil |
| 5 |
C10AB05
|
fenofibrate |
| 5 |
C10AB06
|
simfibrate |
| 5 |
C10AB07
|
ronifibrate |
| 5 |
C10AB08
|
ciprofibrate |
| 5 |
C10AB09
|
etofibrate |
| 5 |
C10AB10
|
clofibride |
| 5 |
C10AB11
|
choline fenofibrate |
| 4 |
C10AC
|
Bile acid sequestrants |
| 5 |
C10AC01
|
colestyramine |
| 5 |
C10AC02
|
colestipol |
| 5 |
C10AC03
|
colextran |
| 5 |
C10AC04
|
colesevelam |
| 4 |
C10AD
|
Nicotinic acid and derivatives |
| 5 |
C10AD01
|
niceritrol |
| 5 |
C10AD02
|
nicotinic acid |
| 5 |
C10AD03
|
nicofuranose |
| 5 |
C10AD04
|
aluminium nicotinate |
| 5 |
C10AD05
|
nicotinyl alcohol (pyridylcarbinol) |
| 5 |
C10AD06
|
acipimox |
| 5 |
C10AD52
|
nicotinic acid, combinations |
| 4 |
C10AX
|
Other lipid modifying agents |
| 5 |
C10AX01
|
dextrothyroxine |
| 5 |
C10AX02
|
probucol |
| 5 |
C10AX03
|
tiadenol |
| 5 |
C10AX05
|
meglutol |
| 5 |
C10AX06
|
omega-3-triglycerides incl. other esters and acids |
| 5 |
C10AX07
|
magnesium pyridoxal 5-phosphate glutamate |
| 5 |
C10AX08
|
policosanol |
| 5 |
C10AX09
|
ezetimibe |
| 5 |
C10AX10
|
alipogene tiparvovec |
| 5 |
C10AX11
|
mipomersen |
| 5 |
C10AX12
|
lomitapide |
| 5 |
C10AX13
|
evolocumab |
| 5 |
C10AX14
|
alirocumab |
| 5 |
C10AX15
|
bempedoic acid |
| 5 |
C10AX16
|
inclisiran |
| 3 |
C10B
|
LIPID MODIFYING AGENTS, COMBINATIONS |
| 4 |
C10BA
|
Combinations of various lipid modifying agents |
| 5 |
C10BA01
|
lovastatin and nicotinic acid |
| 5 |
C10BA02
|
simvastatin and ezetimibe |
| 5 |
C10BA03
|
pravastatin and fenofibrate |
| 5 |
C10BA04
|
simvastatin and fenofibrate |
| 5 |
C10BA05
|
atorvastatin and ezetimibe |
| 5 |
C10BA06
|
rosuvastatin and ezetimibe |
| 5 |
C10BA07
|
rosuvastatin and omega-3 fatty acids |
| 5 |
C10BA08
|
atorvastatin and omega-3 fatty acids |
| 5 |
C10BA09
|
rosuvastatin and fenofibrate |
| 5 |
C10BA10
|
bempedoic acid and ezetimibe |
| 4 |
C10BX
|
Lipid modifying agents in combination with other drugs |
| 5 |
C10BX01
|
simvastatin and acetylsalicylic acid |
| 5 |
C10BX02
|
pravastatin and acetylsalicylic acid |
| 5 |
C10BX03
|
atorvastatin and amlodipine |
| 5 |
C10BX04
|
simvastatin, acetylsalicylic acid and ramipril |
| 5 |
C10BX05
|
rosuvastatin and acetylsalicylic acid |
| 5 |
C10BX06
|
atorvastatin, acetylsalicylic acid and ramipril |
| 5 |
C10BX07
|
rosuvastatin, amlodipine and lisinopril |
| 5 |
C10BX08
|
atorvastatin and acetylsalicylic acid |
| 5 |
C10BX09
|
rosuvastatin and amlodipine |
| 5 |
C10BX10
|
rosuvastatin and valsartan |
| 5 |
C10BX11
|
atorvastatin, amlodipine and perindopril |
| 5 |
C10BX12
|
atorvastatin, acetylsalicylic acid and perindopril |
| 5 |
C10BX13
|
rosuvastatin, perindopril and indapamide |
| 5 |
C10BX14
|
rosuvastatin, amlodipine and perindopril |
| 5 |
C10BX15
|
atorvastatin and perindopril |
| 5 |
C10BX16
|
rosuvastatin and fimasartan |
| 5 |
C10BX17
|
rosuvastatin and ramipril |
| 5 |
C10BX18
|
atorvastatin, amlodipine and ramipril |
| 1 |
D
|
DERMATOLOGICALS |
| 2 |
D01
|
ANTIFUNGALS FOR DERMATOLOGICAL USE |
| 3 |
D01A
|
ANTIFUNGALS FOR TOPICAL USE |
| 4 |
D01AA
|
Antibiotics |
| 5 |
D01AA01
|
nystatin |
| 5 |
D01AA02
|
natamycin |
| 5 |
D01AA03
|
hachimycin |
| 5 |
D01AA04
|
pecilocin |
| 5 |
D01AA06
|
mepartricin |
| 5 |
D01AA07
|
pyrrolnitrin |
| 5 |
D01AA08
|
griseofulvin |
| 5 |
D01AA20
|
combinations |
| 4 |
D01AC
|
Imidazole and triazole derivatives |
| 5 |
D01AC01
|
clotrimazole |
| 5 |
D01AC02
|
miconazole |
| 5 |
D01AC03
|
econazole |
| 5 |
D01AC04
|
chlormidazole |
| 5 |
D01AC05
|
isoconazole |
| 5 |
D01AC06
|
tiabendazole |
| 5 |
D01AC07
|
tioconazole |
| 5 |
D01AC08
|
ketoconazole |
| 5 |
D01AC09
|
sulconazole |
| 5 |
D01AC10
|
bifonazole |
| 5 |
D01AC11
|
oxiconazole |
| 5 |
D01AC12
|
fenticonazole |
| 5 |
D01AC13
|
omoconazole |
| 5 |
D01AC14
|
sertaconazole |
| 5 |
D01AC15
|
fluconazole |
| 5 |
D01AC16
|
flutrimazole |
| 5 |
D01AC17
|
eberconazole |
| 5 |
D01AC18
|
luliconazole |
| 5 |
D01AC19
|
efinaconazole |
| 5 |
D01AC20
|
imidazoles/triazoles in combination with corticosteroids |
| 5 |
D01AC52
|
miconazole, combinations |
| 5 |
D01AC60
|
bifonazole, combinations |
| 4 |
D01AE
|
Other antifungals for topical use |
| 5 |
D01AE01
|
bromochlorosalicylanilide |
| 5 |
D01AE02
|
methylrosaniline |
| 5 |
D01AE03
|
tribromometacresol |
| 5 |
D01AE04
|
undecylenic acid |
| 5 |
D01AE05
|
polynoxylin |
| 5 |
D01AE06
|
2-(4-chlorphenoxy)-ethanol |
| 5 |
D01AE07
|
chlorphenesin |
| 5 |
D01AE08
|
ticlatone |
| 5 |
D01AE09
|
sulbentine |
| 5 |
D01AE10
|
ethyl hydroxybenzoate |
| 5 |
D01AE11
|
haloprogin |
| 5 |
D01AE12
|
salicylic acid |
| 5 |
D01AE13
|
selenium sulfide |
| 5 |
D01AE14
|
ciclopirox |
| 5 |
D01AE15
|
terbinafine |
| 5 |
D01AE16
|
amorolfine |
| 5 |
D01AE17
|
dimazole |
| 5 |
D01AE18
|
tolnaftate |
| 5 |
D01AE19
|
tolciclate |
| 5 |
D01AE20
|
combinations |
| 5 |
D01AE21
|
flucytosine |
| 5 |
D01AE22
|
naftifine |
| 5 |
D01AE23
|
butenafine |
| 5 |
D01AE24
|
tavaborole |
| 5 |
D01AE54
|
undecylenic acid, combinations |
| 3 |
D01B
|
ANTIFUNGALS FOR SYSTEMIC USE |
| 4 |
D01BA
|
Antifungals for systemic use |
| 5 |
D01BA01
|
griseofulvin |
| 5 |
D01BA02
|
terbinafine |
| 5 |
D01BA03
|
fosravuconazole |
| 2 |
D02
|
EMOLLIENTS AND PROTECTIVES |
| 3 |
D02A
|
EMOLLIENTS AND PROTECTIVES |
| 4 |
D02AA
|
Silicone products |
| 4 |
D02AB
|
Zinc products |
| 4 |
D02AC
|
Soft paraffin and fat products |
| 4 |
D02AD
|
Liquid plasters |
| 4 |
D02AE
|
Carbamide products |
| 5 |
D02AE01
|
carbamide |
| 5 |
D02AE51
|
carbamide, combinations |
| 4 |
D02AF
|
Salicylic acid preparations |
| 4 |
D02AX
|
Other emollients and protectives |
| 3 |
D02B
|
PROTECTIVES AGAINST UV-RADIATION |
| 4 |
D02BA
|
Protectives against UV-radiation for topical use |
| 5 |
D02BA01
|
aminobenzoic acid |
| 5 |
D02BA02
|
octinoxate |
| 4 |
D02BB
|
Protectives against UV-radiation for systemic use |
| 5 |
D02BB01
|
betacarotene |
| 5 |
D02BB02
|
afamelanotide |
| 2 |
D03
|
PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS |
| 3 |
D03A
|
CICATRIZANTS |
| 4 |
D03AA
|
Cod-liver oil ointments |
| 4 |
D03AX
|
Other cicatrizants |
| 5 |
D03AX01
|
cadexomer iodine |
| 5 |
D03AX02
|
dextranomer |
| 5 |
D03AX03
|
dexpanthenol |
| 5 |
D03AX04
|
calcium pantothenate |
| 5 |
D03AX05
|
hyaluronic acid |
| 5 |
D03AX06
|
becaplermin |
| 5 |
D03AX09
|
crilanomer |
| 5 |
D03AX10
|
enoxolone |
| 5 |
D03AX11
|
sodium chlorite |
| 5 |
D03AX12
|
trolamine |
| 5 |
D03AX13
|
Betulae cortex |
| 5 |
D03AX14
|
Centella asiatica herba |
| 3 |
D03B
|
ENZYMES |
| 4 |
D03BA
|
Proteolytic enzymes |
| 5 |
D03BA01
|
trypsin |
| 5 |
D03BA02
|
collagenase |
| 5 |
D03BA03
|
bromelains |
| 5 |
D03BA52
|
collagenase, combinations |
| 2 |
D04
|
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| 3 |
D04A
|
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| 4 |
D04AA
|
Antihistamines for topical use |
| 5 |
D04AA01
|
thonzylamine |
| 5 |
D04AA02
|
mepyramine |
| 5 |
D04AA03
|
thenalidine |
| 5 |
D04AA04
|
tripelennamine |
| 5 |
D04AA09
|
chloropyramine |
| 5 |
D04AA10
|
promethazine |
| 5 |
D04AA12
|
tolpropamine |
| 5 |
D04AA13
|
dimetindene |
| 5 |
D04AA14
|
clemastine |
| 5 |
D04AA15
|
bamipine |
| 5 |
D04AA16
|
pheniramine |
| 5 |
D04AA22
|
isothipendyl |
| 5 |
D04AA32
|
diphenhydramine |
| 5 |
D04AA33
|
diphenhydramine methylbromide |
| 5 |
D04AA34
|
chlorphenoxamine |
| 4 |
D04AB
|
Anesthetics for topical use |
| 5 |
D04AB01
|
lidocaine |
| 5 |
D04AB02
|
cinchocaine |
| 5 |
D04AB03
|
oxybuprocaine |
| 5 |
D04AB04
|
benzocaine |
| 5 |
D04AB05
|
quinisocaine |
| 5 |
D04AB06
|
tetracaine |
| 5 |
D04AB07
|
pramocaine |
| 4 |
D04AX
|
Other antipruritics |
| 5 |
D04AX01
|
doxepin |
| 2 |
D05
|
ANTIPSORIATICS |
| 3 |
D05A
|
ANTIPSORIATICS FOR TOPICAL USE |
| 4 |
D05AA
|
Tars |
| 4 |
D05AC
|
Antracen derivatives |
| 5 |
D05AC01
|
dithranol |
| 5 |
D05AC51
|
dithranol, combinations |
| 4 |
D05AD
|
Psoralens for topical use |
| 5 |
D05AD01
|
trioxysalen |
| 5 |
D05AD02
|
methoxsalen |
| 4 |
D05AX
|
Other antipsoriatics for topical use |
| 5 |
D05AX01
|
fumaric acid |
| 5 |
D05AX02
|
calcipotriol |
| 5 |
D05AX03
|
calcitriol |
| 5 |
D05AX04
|
tacalcitol |
| 5 |
D05AX05
|
tazarotene |
| 5 |
D05AX52
|
calcipotriol, combinations |
| 5 |
D05AX55
|
tazarotene and ulobetasol |
| 3 |
D05B
|
ANTIPSORIATICS FOR SYSTEMIC USE |
| 4 |
D05BA
|
Psoralens for systemic use |
| 5 |
D05BA01
|
trioxysalen |
| 5 |
D05BA02
|
methoxsalen |
| 5 |
D05BA03
|
bergapten |
| 4 |
D05BB
|
Retinoids for treatment of psoriasis |
| 5 |
D05BB01
|
etretinate |
| 5 |
D05BB02
|
acitretin |
| 4 |
D05BX
|
Other antipsoriatics for systemic use |
| 5 |
D05BX51
|
fumaric acid derivatives, combinations |
| 2 |
D06
|
ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE |
| 3 |
D06A
|
ANTIBIOTICS FOR TOPICAL USE |
| 4 |
D06AA
|
Tetracycline and derivatives |
| 5 |
D06AA01
|
demeclocycline |
| 5 |
D06AA02
|
chlortetracycline |
| 5 |
D06AA03
|
oxytetracycline |
| 5 |
D06AA04
|
tetracycline |
| 4 |
D06AX
|
Other antibiotics for topical use |
| 5 |
D06AX01
|
fusidic acid |
| 5 |
D06AX02
|
chloramphenicol |
| 5 |
D06AX04
|
neomycin |
| 5 |
D06AX05
|
bacitracin |
| 5 |
D06AX07
|
gentamicin |
| 5 |
D06AX08
|
tyrothricin |
| 5 |
D06AX09
|
mupirocin |
| 5 |
D06AX10
|
virginiamycin |
| 5 |
D06AX11
|
rifaximin |
| 5 |
D06AX12
|
amikacin |
| 5 |
D06AX13
|
retapamulin |
| 5 |
D06AX14
|
ozenoxacin |
| 5 |
D06AX15
|
rifamycin |
| 3 |
D06B
|
CHEMOTHERAPEUTICS FOR TOPICAL USE |
| 4 |
D06BA
|
Sulfonamides |
| 5 |
D06BA01
|
silver sulfadiazine |
| 5 |
D06BA02
|
sulfathiazole |
| 5 |
D06BA03
|
mafenide |
| 5 |
D06BA04
|
sulfamethizole |
| 5 |
D06BA05
|
sulfanilamide |
| 5 |
D06BA06
|
sulfamerazine |
| 5 |
D06BA51
|
silver sulfadiazine, combinations |
| 4 |
D06BB
|
Antivirals |
| 5 |
D06BB01
|
idoxuridine |
| 5 |
D06BB02
|
tromantadine |
| 5 |
D06BB03
|
aciclovir |
| 5 |
D06BB04
|
podophyllotoxin |
| 5 |
D06BB05
|
inosine |
| 5 |
D06BB06
|
penciclovir |
| 5 |
D06BB07
|
lysozyme |
| 5 |
D06BB08
|
ibacitabine |
| 5 |
D06BB09
|
edoxudine |
| 5 |
D06BB10
|
imiquimod |
| 5 |
D06BB11
|
docosanol |
| 5 |
D06BB12
|
sinecatechins |
| 5 |
D06BB53
|
aciclovir, combinations |
| 4 |
D06BX
|
Other chemotherapeutics |
| 5 |
D06BX01
|
metronidazole |
| 5 |
D06BX02
|
ingenol mebutate |
| 5 |
D06BX03
|
tirbanibulin |
| 3 |
D06C
|
ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS |
| 2 |
D07
|
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS |
| 3 |
D07A
|
CORTICOSTEROIDS, PLAIN |
| 4 |
D07AA
|
Corticosteroids, weak (group I) |
| 5 |
D07AA01
|
methylprednisolone |
| 5 |
D07AA02
|
hydrocortisone |
| 5 |
D07AA03
|
prednisolone |
| 4 |
D07AB
|
Corticosteroids, moderately potent (group II) |
| 5 |
D07AB01
|
clobetasone |
| 5 |
D07AB02
|
hydrocortisone butyrate |
| 5 |
D07AB03
|
flumetasone |
| 5 |
D07AB04
|
fluocortin |
| 5 |
D07AB05
|
fluperolone |
| 5 |
D07AB06
|
fluorometholone |
| 5 |
D07AB07
|
fluprednidene |
| 5 |
D07AB08
|
desonide |
| 5 |
D07AB09
|
triamcinolone |
| 5 |
D07AB10
|
alclometasone |
| 5 |
D07AB11
|
hydrocortisone buteprate |
| 5 |
D07AB19
|
dexamethasone |
| 5 |
D07AB21
|
clocortolone |
| 5 |
D07AB30
|
combinations of corticosteroids |
| 4 |
D07AC
|
Corticosteroids, potent (group III) |
| 5 |
D07AC01
|
betamethasone |
| 5 |
D07AC02
|
fluclorolone |
| 5 |
D07AC03
|
desoximetasone |
| 5 |
D07AC04
|
fluocinolone acetonide |
| 5 |
D07AC05
|
fluocortolone |
| 5 |
D07AC06
|
diflucortolone |
| 5 |
D07AC07
|
fludroxycortide |
| 5 |
D07AC08
|
fluocinonide |
| 5 |
D07AC09
|
budesonide |
| 5 |
D07AC10
|
diflorasone |
| 5 |
D07AC11
|
amcinonide |
| 5 |
D07AC12
|
halometasone |
| 5 |
D07AC13
|
mometasone |
| 5 |
D07AC14
|
methylprednisolone aceponate |
| 5 |
D07AC15
|
beclometasone |
| 5 |
D07AC16
|
hydrocortisone aceponate |
| 5 |
D07AC17
|
fluticasone |
| 5 |
D07AC18
|
prednicarbate |
| 5 |
D07AC19
|
difluprednate |
| 5 |
D07AC21
|
ulobetasol |
| 4 |
D07AD
|
Corticosteroids, very potent (group IV) |
| 5 |
D07AD01
|
clobetasol |
| 5 |
D07AD02
|
halcinonide |
| 3 |
D07B
|
CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS |
| 4 |
D07BA
|
Corticosteroids, weak, combinations with antiseptics |
| 5 |
D07BA01
|
prednisolone and antiseptics |
| 5 |
D07BA04
|
hydrocortisone and antiseptics |
| 4 |
D07BB
|
Corticosteroids, moderately potent, combinations with antiseptics |
| 5 |
D07BB01
|
flumetasone and antiseptics |
| 5 |
D07BB02
|
desonide and antiseptics |
| 5 |
D07BB03
|
triamcinolone and antiseptics |
| 5 |
D07BB04
|
hydrocortisone butyrate and antiseptics |
| 4 |
D07BC
|
Corticosteroids, potent, combinations with antiseptics |
| 5 |
D07BC01
|
betamethasone and antiseptics |
| 5 |
D07BC02
|
fluocinolone acetonide and antiseptics |
| 5 |
D07BC03
|
fluocortolone and antiseptics |
| 5 |
D07BC04
|
diflucortolone and antiseptics |
| 4 |
D07BD
|
Corticosteroids, very potent, combinations with antiseptics |
| 3 |
D07C
|
CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS |
| 4 |
D07CA
|
Corticosteroids, weak, combinations with antibiotics |
| 5 |
D07CA01
|
hydrocortisone and antibiotics |
| 5 |
D07CA02
|
methylprednisolone and antibiotics |
| 5 |
D07CA03
|
prednisolone and antibiotics |
| 4 |
D07CB
|
Corticosteroids, moderately potent, combinations with antibiotics |
| 5 |
D07CB01
|
triamcinolone and antibiotics |
| 5 |
D07CB02
|
fluprednidene and antibiotics |
| 5 |
D07CB03
|
fluorometholone and antibiotics |
| 5 |
D07CB04
|
dexamethasone and antibiotics |
| 5 |
D07CB05
|
flumetasone and antibiotics |
| 4 |
D07CC
|
Corticosteroids, potent, combinations with antibiotics |
| 5 |
D07CC01
|
betamethasone and antibiotics |
| 5 |
D07CC02
|
fluocinolone acetonide and antibiotics |
| 5 |
D07CC03
|
fludroxycortide and antibiotics |
| 5 |
D07CC04
|
beclometasone and antibiotics |
| 5 |
D07CC05
|
fluocinonide and antibiotics |
| 5 |
D07CC06
|
fluocortolone and antibiotics |
| 4 |
D07CD
|
Corticosteroids, very potent, combinations with antibiotics |
| 5 |
D07CD01
|
clobetasol and antibiotics |
| 3 |
D07X
|
CORTICOSTEROIDS, OTHER COMBINATIONS |
| 4 |
D07XA
|
Corticosteroids, weak, other combinations |
| 5 |
D07XA01
|
hydrocortisone |
| 5 |
D07XA02
|
prednisolone |
| 4 |
D07XB
|
Corticosteroids, moderately potent, other combinations |
| 5 |
D07XB01
|
flumetasone |
| 5 |
D07XB02
|
triamcinolone |
| 5 |
D07XB03
|
fluprednidene |
| 5 |
D07XB04
|
fluorometholone |
| 5 |
D07XB05
|
dexamethasone |
| 5 |
D07XB30
|
combinations of corticosteroids |
| 4 |
D07XC
|
Corticosteroids, potent, other combinations |
| 5 |
D07XC01
|
betamethasone |
| 5 |
D07XC02
|
desoximetasone |
| 5 |
D07XC03
|
mometasone |
| 5 |
D07XC04
|
diflucortolone |
| 5 |
D07XC05
|
fluocortolone |
| 4 |
D07XD
|
Corticosteroids, very potent, other combinations |
| 2 |
D08
|
ANTISEPTICS AND DISINFECTANTS |
| 3 |
D08A
|
ANTISEPTICS AND DISINFECTANTS |
| 4 |
D08AA
|
Acridine derivatives |
| 5 |
D08AA01
|
ethacridine lactate |
| 5 |
D08AA02
|
aminoacridine |
| 5 |
D08AA03
|
euflavine |
| 4 |
D08AB
|
Aluminium agents |
| 4 |
D08AC
|
Biguanides and amidines |
| 5 |
D08AC01
|
dibrompropamidine |
| 5 |
D08AC02
|
chlorhexidine |
| 5 |
D08AC03
|
propamidine |
| 5 |
D08AC04
|
hexamidine |
| 5 |
D08AC05
|
polihexanide |
| 5 |
D08AC52
|
chlorhexidine, combinations |
| 4 |
D08AD
|
Boric acid products |
| 4 |
D08AE
|
Phenol and derivatives |
| 5 |
D08AE01
|
hexachlorophene |
| 5 |
D08AE02
|
policresulen |
| 5 |
D08AE03
|
phenol |
| 5 |
D08AE04
|
triclosan |
| 5 |
D08AE05
|
chloroxylenol |
| 5 |
D08AE06
|
biphenylol |
| 4 |
D08AF
|
Nitrofuran derivatives |
| 5 |
D08AF01
|
nitrofural |
| 4 |
D08AG
|
Iodine products |
| 5 |
D08AG01
|
iodine/octylphenoxypolyglycolether |
| 5 |
D08AG02
|
povidone-iodine |
| 5 |
D08AG03
|
iodine |
| 5 |
D08AG04
|
diiodohydroxypropane |
| 4 |
D08AH
|
Quinoline derivatives |
| 5 |
D08AH01
|
dequalinium |
| 5 |
D08AH02
|
chlorquinaldol |
| 5 |
D08AH03
|
oxyquinoline |
| 5 |
D08AH30
|
clioquinol |
| 4 |
D08AJ
|
Quaternary ammonium compounds |
| 5 |
D08AJ01
|
benzalkonium |
| 5 |
D08AJ02
|
cetrimonium |
| 5 |
D08AJ03
|
cetylpyridinium |
| 5 |
D08AJ04
|
cetrimide |
| 5 |
D08AJ05
|
benzoxonium chloride |
| 5 |
D08AJ06
|
didecyldimethylammonium chloride |
| 5 |
D08AJ08
|
benzethonium chloride |
| 5 |
D08AJ10
|
decamethoxine |
| 5 |
D08AJ57
|
octenidine, combinations |
| 5 |
D08AJ58
|
benzethonium chloride, combinations |
| 5 |
D08AJ59
|
dodeclonium bromide, combinations |
| 4 |
D08AK
|
Mercurial products |
| 5 |
D08AK01
|
mercuric amidochloride |
| 5 |
D08AK02
|
phenylmercuric borate |
| 5 |
D08AK03
|
mercuric chloride |
| 5 |
D08AK04
|
merbromin |
| 5 |
D08AK05
|
mercury, metallic |
| 5 |
D08AK06
|
thiomersal |
| 5 |
D08AK30
|
mercuric iodide |
| 4 |
D08AL
|
Silver compounds |
| 5 |
D08AL01
|
silver nitrate |
| 5 |
D08AL30
|
silver |
| 4 |
D08AX
|
Other antiseptics and disinfectants |
| 5 |
D08AX01
|
hydrogen peroxide |
| 5 |
D08AX02
|
eosin |
| 5 |
D08AX03
|
propanol |
| 5 |
D08AX04
|
tosylchloramide sodium |
| 5 |
D08AX05
|
isopropanol |
| 5 |
D08AX06
|
potassium permanganate |
| 5 |
D08AX07
|
sodium hypochlorite |
| 5 |
D08AX08
|
ethanol |
| 5 |
D08AX53
|
propanol, combinations |
| 2 |
D09
|
MEDICATED DRESSINGS |
| 3 |
D09A
|
MEDICATED DRESSINGS |
| 4 |
D09AA
|
Medicated dressings with antiinfectives |
| 5 |
D09AA01
|
framycetin |
| 5 |
D09AA02
|
fusidic acid |
| 5 |
D09AA03
|
nitrofural |
| 5 |
D09AA04
|
phenylmercuric nitrate |
| 5 |
D09AA05
|
benzododecinium |
| 5 |
D09AA06
|
triclosan |
| 5 |
D09AA07
|
cetylpyridinium |
| 5 |
D09AA08
|
aluminium chlorohydrate |
| 5 |
D09AA09
|
povidone-iodine |
| 5 |
D09AA10
|
clioquinol |
| 5 |
D09AA11
|
benzalkonium |
| 5 |
D09AA12
|
chlorhexidine |
| 5 |
D09AA13
|
iodoform |
| 4 |
D09AB
|
Zinc bandages |
| 5 |
D09AB01
|
zinc bandage without supplements |
| 5 |
D09AB02
|
zinc bandage with supplements |
| 4 |
D09AX
|
Soft paraffin dressings |
| 2 |
D10
|
ANTI-ACNE PREPARATIONS |
| 3 |
D10A
|
ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| 4 |
D10AA
|
Corticosteroids, combinations for treatment of acne |
| 5 |
D10AA01
|
fluorometholone |
| 5 |
D10AA02
|
methylprednisolone |
| 5 |
D10AA03
|
dexamethasone |
| 4 |
D10AB
|
Preparations containing sulfur |
| 5 |
D10AB01
|
bithionol |
| 5 |
D10AB02
|
sulfur |
| 5 |
D10AB03
|
tioxolone |
| 5 |
D10AB05
|
mesulfen |
| 4 |
D10AD
|
Retinoids for topical use in acne |
| 5 |
D10AD01
|
tretinoin |
| 5 |
D10AD02
|
retinol |
| 5 |
D10AD03
|
adapalene |
| 5 |
D10AD04
|
isotretinoin |
| 5 |
D10AD05
|
motretinide |
| 5 |
D10AD06
|
trifarotene |
| 5 |
D10AD51
|
tretinoin, combinations |
| 5 |
D10AD53
|
adapalene, combinations |
| 5 |
D10AD54
|
isotretinoin, combinations |
| 4 |
D10AE
|
Peroxides |
| 5 |
D10AE01
|
benzoyl peroxide |
| 5 |
D10AE51
|
benzoyl peroxide, combinations |
| 4 |
D10AF
|
Antiinfectives for treatment of acne |
| 5 |
D10AF01
|
clindamycin |
| 5 |
D10AF02
|
erythromycin |
| 5 |
D10AF03
|
chloramphenicol |
| 5 |
D10AF04
|
meclocycline |
| 5 |
D10AF05
|
nadifloxacin |
| 5 |
D10AF06
|
sulfacetamide |
| 5 |
D10AF07
|
minocycline |
| 5 |
D10AF51
|
clindamycin, combinations |
| 5 |
D10AF52
|
erythromycin, combinations |
| 4 |
D10AX
|
Other anti-acne preparations for topical use |
| 5 |
D10AX01
|
aluminium chloride |
| 5 |
D10AX02
|
resorcinol |
| 5 |
D10AX03
|
azelaic acid |
| 5 |
D10AX04
|
aluminium oxide |
| 5 |
D10AX05
|
dapsone |
| 5 |
D10AX30
|
various combinations |
| 3 |
D10B
|
ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE |
| 4 |
D10BA
|
Retinoids for treatment of acne |
| 5 |
D10BA01
|
isotretinoin |
| 4 |
D10BX
|
Other anti-acne preparations for systemic use |
| 5 |
D10BX01
|
ichtasol |
| 2 |
D11
|
OTHER DERMATOLOGICAL PREPARATIONS |
| 3 |
D11A
|
OTHER DERMATOLOGICAL PREPARATIONS |
| 4 |
D11AA
|
Antihidrotics |
| 5 |
D11AA01
|
glycopyrronium |
| 4 |
D11AC
|
Medicated shampoos |
| 5 |
D11AC01
|
cetrimide |
| 5 |
D11AC02
|
cadmium compounds |
| 5 |
D11AC03
|
selenium compounds |
| 5 |
D11AC06
|
povidone-iodine |
| 5 |
D11AC08
|
sulfur compounds |
| 5 |
D11AC09
|
xenysalate |
| 5 |
D11AC30
|
others |
| 4 |
D11AE
|
Androgens for topical use |
| 5 |
D11AE01
|
metandienone |
| 4 |
D11AF
|
Wart and anti-corn preparations |
| 4 |
D11AH
|
Agents for dermatitis, excluding corticosteroids |
| 5 |
D11AH01
|
tacrolimus |
| 5 |
D11AH02
|
pimecrolimus |
| 5 |
D11AH03
|
cromoglicic acid |
| 5 |
D11AH04
|
alitretinoin |
| 5 |
D11AH05
|
dupilumab |
| 5 |
D11AH06
|
crisaborole |
| 5 |
D11AH07
|
tralokinumab |
| 4 |
D11AX
|
Other dermatologicals |
| 5 |
D11AX01
|
minoxidil |
| 5 |
D11AX02
|
gamolenic acid |
| 5 |
D11AX03
|
calcium gluconate |
| 5 |
D11AX04
|
lithium succinate |
| 5 |
D11AX05
|
magnesium sulfate |
| 5 |
D11AX06
|
mequinol |
| 5 |
D11AX08
|
tiratricol |
| 5 |
D11AX09
|
oxaceprol |
| 5 |
D11AX10
|
finasteride |
| 5 |
D11AX11
|
hydroquinone |
| 5 |
D11AX12
|
pyrithione zinc |
| 5 |
D11AX13
|
monobenzone |
| 5 |
D11AX16
|
eflornithine |
| 5 |
D11AX18
|
diclofenac |
| 5 |
D11AX21
|
brimonidine |
| 5 |
D11AX22
|
ivermectin |
| 5 |
D11AX23
|
aminobenzoate potassium |
| 5 |
D11AX24
|
deoxycholic acid |
| 5 |
D11AX25
|
hydrogen peroxide |
| 5 |
D11AX26
|
caffeine |
| 5 |
D11AX52
|
gamolenic acid, combinations |
| 5 |
D11AX57
|
collagen, combinations |
| 1 |
G
|
GENITO URINARY SYSTEM AND SEX HORMONES |
| 2 |
G01
|
GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS |
| 3 |
G01A
|
ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS |
| 4 |
G01AA
|
Antibiotics |
| 5 |
G01AA01
|
nystatin |
| 5 |
G01AA02
|
natamycin |
| 5 |
G01AA03
|
amphotericin B |
| 5 |
G01AA04
|
candicidin |
| 5 |
G01AA05
|
chloramphenicol |
| 5 |
G01AA06
|
hachimycin |
| 5 |
G01AA07
|
oxytetracycline |
| 5 |
G01AA08
|
carfecillin |
| 5 |
G01AA09
|
mepartricin |
| 5 |
G01AA10
|
clindamycin |
| 5 |
G01AA11
|
pentamycin |
| 5 |
G01AA51
|
nystatin, combinations |
| 4 |
G01AB
|
Arsenic compounds |
| 5 |
G01AB01
|
acetarsol |
| 4 |
G01AC
|
Quinoline derivatives |
| 5 |
G01AC01
|
diiodohydroxyquinoline |
| 5 |
G01AC02
|
clioquinol |
| 5 |
G01AC03
|
chlorquinaldol |
| 5 |
G01AC05
|
dequalinium |
| 5 |
G01AC06
|
broxyquinoline |
| 5 |
G01AC30
|
oxyquinoline |
| 4 |
G01AD
|
Organic acids |
| 5 |
G01AD01
|
lactic acid |
| 5 |
G01AD02
|
acetic acid |
| 5 |
G01AD03
|
ascorbic acid |
| 4 |
G01AE
|
Sulfonamides |
| 5 |
G01AE01
|
sulfatolamide |
| 5 |
G01AE10
|
combinations of sulfonamides |
| 4 |
G01AF
|
Imidazole derivatives |
| 5 |
G01AF01
|
metronidazole |
| 5 |
G01AF02
|
clotrimazole |
| 5 |
G01AF04
|
miconazole |
| 5 |
G01AF05
|
econazole |
| 5 |
G01AF06
|
ornidazole |
| 5 |
G01AF07
|
isoconazole |
| 5 |
G01AF08
|
tioconazole |
| 5 |
G01AF11
|
ketoconazole |
| 5 |
G01AF12
|
fenticonazole |
| 5 |
G01AF13
|
azanidazole |
| 5 |
G01AF14
|
propenidazole |
| 5 |
G01AF15
|
butoconazole |
| 5 |
G01AF16
|
omoconazole |
| 5 |
G01AF17
|
oxiconazole |
| 5 |
G01AF18
|
flutrimazole |
| 5 |
G01AF19
|
sertaconazole |
| 5 |
G01AF20
|
combinations of imidazole derivatives |
| 5 |
G01AF55
|
econazole, combinations |
| 4 |
G01AG
|
Triazole derivatives |
| 5 |
G01AG02
|
terconazole |
| 4 |
G01AX
|
Other antiinfectives and antiseptics |
| 5 |
G01AX01
|
clodantoin |
| 5 |
G01AX02
|
inosine |
| 5 |
G01AX03
|
policresulen |
| 5 |
G01AX05
|
nifuratel |
| 5 |
G01AX06
|
furazolidone |
| 5 |
G01AX09
|
methylrosaniline |
| 5 |
G01AX11
|
povidone-iodine |
| 5 |
G01AX12
|
ciclopirox |
| 5 |
G01AX13
|
protiofate |
| 5 |
G01AX14
|
lactobacillus |
| 5 |
G01AX15
|
copper usnate |
| 5 |
G01AX16
|
hexetidine |
| 5 |
G01AX17
|
dapivirine |
| 5 |
G01AX66
|
octenidine, combinations |
| 3 |
G01B
|
ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS |
| 4 |
G01BA
|
Antibiotics and corticosteroids |
| 4 |
G01BC
|
Quinoline derivatives and corticosteroids |
| 4 |
G01BD
|
Antiseptics and corticosteroids |
| 4 |
G01BE
|
Sulfonamides and corticosteroids |
| 4 |
G01BF
|
Imidazole derivatives and corticosteroids |
| 2 |
G02
|
OTHER GYNECOLOGICALS |
| 3 |
G02A
|
UTEROTONICS |
| 4 |
G02AB
|
Ergot alkaloids |
| 5 |
G02AB01
|
methylergometrine |
| 5 |
G02AB02
|
ergot alkaloids |
| 5 |
G02AB03
|
ergometrine |
| 4 |
G02AC
|
Ergot alkaloids and oxytocin incl. analogues, in combination |
| 5 |
G02AC01
|
methylergometrine and oxytocin |
| 4 |
G02AD
|
Prostaglandins |
| 5 |
G02AD01
|
dinoprost |
| 5 |
G02AD02
|
dinoprostone |
| 5 |
G02AD03
|
gemeprost |
| 5 |
G02AD04
|
carboprost |
| 5 |
G02AD05
|
sulprostone |
| 5 |
G02AD06
|
misoprostol |
| 4 |
G02AX
|
Other uterotonics |
| 3 |
G02B
|
CONTRACEPTIVES FOR TOPICAL USE |
| 4 |
G02BA
|
Intrauterine contraceptives |
| 5 |
G02BA01
|
plastic IUD |
| 5 |
G02BA02
|
plastic IUD with copper |
| 5 |
G02BA03
|
plastic IUD with progestogen |
| 4 |
G02BB
|
Intravaginal contraceptives |
| 5 |
G02BB01
|
vaginal ring with progestogen and estrogen |
| 5 |
G02BB02
|
vaginal ring with progestogen |
| 3 |
G02C
|
OTHER GYNECOLOGICALS |
| 4 |
G02CA
|
Sympathomimetics, labour repressants |
| 5 |
G02CA01
|
ritodrine |
| 5 |
G02CA02
|
buphenine |
| 5 |
G02CA03
|
fenoterol |
| 4 |
G02CB
|
Prolactine inhibitors |
| 5 |
G02CB01
|
bromocriptine |
| 5 |
G02CB02
|
lisuride |
| 5 |
G02CB03
|
cabergoline |
| 5 |
G02CB04
|
quinagolide |
| 5 |
G02CB05
|
metergoline |
| 5 |
G02CB06
|
terguride |
| 4 |
G02CC
|
Antiinflammatory products for vaginal administration |
| 5 |
G02CC01
|
ibuprofen |
| 5 |
G02CC02
|
naproxen |
| 5 |
G02CC03
|
benzydamine |
| 5 |
G02CC04
|
flunoxaprofen |
| 4 |
G02CX
|
Other gynecologicals |
| 5 |
G02CX01
|
atosiban |
| 5 |
G02CX02
|
flibanserin |
| 5 |
G02CX03
|
Agni casti fructus |
| 5 |
G02CX04
|
Cimicifugae rhizoma |
| 5 |
G02CX05
|
bremelanotide |
| 2 |
G03
|
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| 3 |
G03A
|
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| 4 |
G03AA
|
Progestogens and estrogens, fixed combinations |
| 5 |
G03AA01
|
etynodiol and ethinylestradiol |
| 5 |
G03AA02
|
quingestanol and ethinylestradiol |
| 5 |
G03AA03
|
lynestrenol and ethinylestradiol |
| 5 |
G03AA04
|
megestrol and ethinylestradiol |
| 5 |
G03AA05
|
norethisterone and ethinylestradiol |
| 5 |
G03AA06
|
norgestrel and ethinylestradiol |
| 5 |
G03AA07
|
levonorgestrel and ethinylestradiol |
| 5 |
G03AA08
|
medroxyprogesterone and ethinylestradiol |
| 5 |
G03AA09
|
desogestrel and ethinylestradiol |
| 5 |
G03AA10
|
gestodene and ethinylestradiol |
| 5 |
G03AA11
|
norgestimate and ethinylestradiol |
| 5 |
G03AA12
|
drospirenone and ethinylestradiol |
| 5 |
G03AA13
|
norelgestromin and ethinylestradiol |
| 5 |
G03AA14
|
nomegestrol and estradiol |
| 5 |
G03AA15
|
chlormadinone and ethinylestradiol |
| 5 |
G03AA16
|
dienogest and ethinylestradiol |
| 5 |
G03AA17
|
medroxyprogesterone and estradiol |
| 5 |
G03AA18
|
drospirenone and estetrol |
| 4 |
G03AB
|
Progestogens and estrogens, sequential preparations |
| 5 |
G03AB01
|
megestrol and ethinylestradiol |
| 5 |
G03AB02
|
lynestrenol and ethinylestradiol |
| 5 |
G03AB03
|
levonorgestrel and ethinylestradiol |
| 5 |
G03AB04
|
norethisterone and ethinylestradiol |
| 5 |
G03AB05
|
desogestrel and ethinylestradiol |
| 5 |
G03AB06
|
gestodene and ethinylestradiol |
| 5 |
G03AB07
|
chlormadinone and ethinylestradiol |
| 5 |
G03AB08
|
dienogest and estradiol |
| 5 |
G03AB09
|
norgestimate and ethinylestradiol |
| 4 |
G03AC
|
Progestogens |
| 5 |
G03AC01
|
norethisterone |
| 5 |
G03AC02
|
lynestrenol |
| 5 |
G03AC03
|
levonorgestrel |
| 5 |
G03AC04
|
quingestanol |
| 5 |
G03AC05
|
megestrol |
| 5 |
G03AC06
|
medroxyprogesterone |
| 5 |
G03AC07
|
norgestrienone |
| 5 |
G03AC08
|
etonogestrel |
| 5 |
G03AC09
|
desogestrel |
| 5 |
G03AC10
|
drospirenone |
| 4 |
G03AD
|
Emergency contraceptives |
| 5 |
G03AD01
|
levonorgestrel |
| 5 |
G03AD02
|
ulipristal |
| 3 |
G03B
|
ANDROGENS |
| 4 |
G03BA
|
3-oxoandrosten (4) derivatives |
| 5 |
G03BA01
|
fluoxymesterone |
| 5 |
G03BA02
|
methyltestosterone |
| 5 |
G03BA03
|
testosterone |
| 4 |
G03BB
|
5-androstanon (3) derivatives |
| 5 |
G03BB01
|
mesterolone |
| 5 |
G03BB02
|
androstanolone |
| 3 |
G03C
|
ESTROGENS |
| 4 |
G03CA
|
Natural and semisynthetic estrogens, plain |
| 5 |
G03CA01
|
ethinylestradiol |
| 5 |
G03CA03
|
estradiol |
| 5 |
G03CA04
|
estriol |
| 5 |
G03CA06
|
chlorotrianisene |
| 5 |
G03CA07
|
estrone |
| 5 |
G03CA09
|
promestriene |
| 5 |
G03CA53
|
estradiol, combinations |
| 5 |
G03CA57
|
conjugated estrogens |
| 4 |
G03CB
|
Synthetic estrogens, plain |
| 5 |
G03CB01
|
dienestrol |
| 5 |
G03CB02
|
diethylstilbestrol |
| 5 |
G03CB03
|
methallenestril |
| 5 |
G03CB04
|
moxestrol |
| 4 |
G03CC
|
Estrogens, combinations with other drugs |
| 5 |
G03CC02
|
dienestrol |
| 5 |
G03CC03
|
methallenestril |
| 5 |
G03CC04
|
estrone |
| 5 |
G03CC05
|
diethylstilbestrol |
| 5 |
G03CC06
|
estriol |
| 5 |
G03CC07
|
conjugated estrogens and bazedoxifene |
| 4 |
G03CX
|
Other estrogens |
| 5 |
G03CX01
|
tibolone |
| 3 |
G03D
|
PROGESTOGENS |
| 4 |
G03DA
|
Pregnen (4) derivatives |
| 5 |
G03DA01
|
gestonorone |
| 5 |
G03DA02
|
medroxyprogesterone |
| 5 |
G03DA03
|
hydroxyprogesterone |
| 5 |
G03DA04
|
progesterone |
| 4 |
G03DB
|
Pregnadien derivatives |
| 5 |
G03DB01
|
dydrogesterone |
| 5 |
G03DB02
|
megestrol |
| 5 |
G03DB03
|
medrogestone |
| 5 |
G03DB04
|
nomegestrol |
| 5 |
G03DB05
|
demegestone |
| 5 |
G03DB06
|
chlormadinone |
| 5 |
G03DB07
|
promegestone |
| 5 |
G03DB08
|
dienogest |
| 4 |
G03DC
|
Estren derivatives |
| 5 |
G03DC01
|
allylestrenol |
| 5 |
G03DC02
|
norethisterone |
| 5 |
G03DC03
|
lynestrenol |
| 5 |
G03DC04
|
ethisterone |
| 5 |
G03DC06
|
etynodiol |
| 5 |
G03DC31
|
methylestrenolone |
| 3 |
G03E
|
ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION |
| 4 |
G03EA
|
Androgens and estrogens |
| 5 |
G03EA01
|
methyltestosterone and estrogen |
| 5 |
G03EA02
|
testosterone and estrogen |
| 5 |
G03EA03
|
prasterone and estrogen |
| 4 |
G03EB
|
Androgen, progestogen and estrogen in combination |
| 4 |
G03EK
|
Androgens and female sex hormones in combination with other drugs |
| 5 |
G03EK01
|
methyltestosterone |
| 3 |
G03F
|
PROGESTOGENS AND ESTROGENS IN COMBINATION |
| 4 |
G03FA
|
Progestogens and estrogens, fixed combinations |
| 5 |
G03FA01
|
norethisterone and estrogen |
| 5 |
G03FA02
|
hydroxyprogesterone and estrogen |
| 5 |
G03FA03
|
ethisterone and estrogen |
| 5 |
G03FA04
|
progesterone and estrogen |
| 5 |
G03FA05
|
methylnortestosterone and estrogen |
| 5 |
G03FA06
|
etynodiol and estrogen |
| 5 |
G03FA07
|
lynestrenol and estrogen |
| 5 |
G03FA08
|
megestrol and estrogen |
| 5 |
G03FA09
|
noretynodrel and estrogen |
| 5 |
G03FA10
|
norgestrel and estrogen |
| 5 |
G03FA11
|
levonorgestrel and estrogen |
| 5 |
G03FA12
|
medroxyprogesterone and estrogen |
| 5 |
G03FA13
|
norgestimate and estrogen |
| 5 |
G03FA14
|
dydrogesterone and estrogen |
| 5 |
G03FA15
|
dienogest and estrogen |
| 5 |
G03FA16
|
trimegestone and estrogen |
| 5 |
G03FA17
|
drospirenone and estrogen |
| 4 |
G03FB
|
Progestogens and estrogens, sequential preparations |
| 5 |
G03FB01
|
norgestrel and estrogen |
| 5 |
G03FB02
|
lynestrenol and estrogen |
| 5 |
G03FB03
|
chlormadinone and estrogen |
| 5 |
G03FB04
|
megestrol and estrogen |
| 5 |
G03FB05
|
norethisterone and estrogen |
| 5 |
G03FB06
|
medroxyprogesterone and estrogen |
| 5 |
G03FB07
|
medrogestone and estrogen |
| 5 |
G03FB08
|
dydrogesterone and estrogen |
| 5 |
G03FB09
|
levonorgestrel and estrogen |
| 5 |
G03FB10
|
desogestrel and estrogen |
| 5 |
G03FB11
|
trimegestone and estrogen |
| 5 |
G03FB12
|
nomegestrol and estrogen |
| 3 |
G03G
|
GONADOTROPINS AND OTHER OVULATION STIMULANTS |
| 4 |
G03GA
|
Gonadotropins |
| 5 |
G03GA01
|
chorionic gonadotrophin |
| 5 |
G03GA02
|
human menopausal gonadotrophin |
| 5 |
G03GA03
|
serum gonadotrophin |
| 5 |
G03GA04
|
urofollitropin |
| 5 |
G03GA05
|
follitropin alfa |
| 5 |
G03GA06
|
follitropin beta |
| 5 |
G03GA07
|
lutropin alfa |
| 5 |
G03GA08
|
choriogonadotropin alfa |
| 5 |
G03GA09
|
corifollitropin alfa |
| 5 |
G03GA10
|
follitropin delta |
| 5 |
G03GA30
|
combinations |
| 4 |
G03GB
|
Ovulation stimulants, synthetic |
| 5 |
G03GB01
|
cyclofenil |
| 5 |
G03GB02
|
clomifene |
| 5 |
G03GB03
|
epimestrol |
| 3 |
G03H
|
ANTIANDROGENS |
| 4 |
G03HA
|
Antiandrogens, plain |
| 5 |
G03HA01
|
cyproterone |
| 4 |
G03HB
|
Antiandrogens and estrogens |
| 5 |
G03HB01
|
cyproterone and estrogen |
| 3 |
G03X
|
OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| 4 |
G03XA
|
Antigonadotropins and similar agents |
| 5 |
G03XA01
|
danazol |
| 5 |
G03XA02
|
gestrinone |
| 4 |
G03XB
|
Progesterone receptor modulators |
| 5 |
G03XB01
|
mifepristone |
| 5 |
G03XB02
|
ulipristal |
| 5 |
G03XB51
|
mifepristone, combinations |
| 4 |
G03XC
|
Selective estrogen receptor modulators |
| 5 |
G03XC01
|
raloxifene |
| 5 |
G03XC02
|
bazedoxifene |
| 5 |
G03XC03
|
lasofoxifene |
| 5 |
G03XC04
|
ormeloxifene |
| 5 |
G03XC05
|
ospemifene |
| 4 |
G03XX
|
Other sex hormones and modulators of the genital system |
| 5 |
G03XX01
|
prasterone |
| 2 |
G04
|
UROLOGICALS |
| 3 |
G04B
|
UROLOGICALS |
| 4 |
G04BA
|
Acidifiers |
| 5 |
G04BA01
|
ammonium chloride |
| 5 |
G04BA03
|
calcium chloride |
| 4 |
G04BC
|
Urinary concrement solvents |
| 4 |
G04BD
|
Drugs for urinary frequency and incontinence |
| 5 |
G04BD01
|
emepronium |
| 5 |
G04BD02
|
flavoxate |
| 5 |
G04BD03
|
meladrazine |
| 5 |
G04BD04
|
oxybutynin |
| 5 |
G04BD05
|
terodiline |
| 5 |
G04BD06
|
propiverine |
| 5 |
G04BD07
|
tolterodine |
| 5 |
G04BD08
|
solifenacin |
| 5 |
G04BD09
|
trospium |
| 5 |
G04BD10
|
darifenacin |
| 5 |
G04BD11
|
fesoterodine |
| 5 |
G04BD12
|
mirabegron |
| 5 |
G04BD13
|
desfesoterodine |
| 4 |
G04BE
|
Drugs used in erectile dysfunction |
| 5 |
G04BE01
|
alprostadil |
| 5 |
G04BE02
|
papaverine |
| 5 |
G04BE03
|
sildenafil |
| 5 |
G04BE04
|
yohimbine |
| 5 |
G04BE06
|
moxisylyte |
| 5 |
G04BE07
|
apomorphine |
| 5 |
G04BE08
|
tadalafil |
| 5 |
G04BE09
|
vardenafil |
| 5 |
G04BE10
|
avanafil |
| 5 |
G04BE11
|
udenafil |
| 5 |
G04BE30
|
combinations |
| 5 |
G04BE52
|
papaverine, combinations |
| 4 |
G04BX
|
Other urologicals |
| 5 |
G04BX01
|
magnesium hydroxide |
| 5 |
G04BX03
|
acetohydroxamic acid |
| 5 |
G04BX06
|
phenazopyridine |
| 5 |
G04BX10
|
succinimide |
| 5 |
G04BX11
|
collagen |
| 5 |
G04BX12
|
phenyl salicylate |
| 5 |
G04BX13
|
dimethyl sulfoxide |
| 5 |
G04BX14
|
dapoxetine |
| 5 |
G04BX15
|
pentosan polysulfate sodium |
| 5 |
G04BX16
|
tiopronin |
| 3 |
G04C
|
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| 4 |
G04CA
|
Alpha-adrenoreceptor antagonists |
| 5 |
G04CA01
|
alfuzosin |
| 5 |
G04CA02
|
tamsulosin |
| 5 |
G04CA03
|
terazosin |
| 5 |
G04CA04
|
silodosin |
| 5 |
G04CA51
|
alfuzosin and finasteride |
| 5 |
G04CA52
|
tamsulosin and dutasteride |
| 5 |
G04CA53
|
tamsulosin and solifenacin |
| 5 |
G04CA54
|
tamsulosin and tadalafil |
| 4 |
G04CB
|
Testosterone-5-alpha reductase inhibitors |
| 5 |
G04CB01
|
finasteride |
| 5 |
G04CB02
|
dutasteride |
| 4 |
G04CX
|
Other drugs used in benign prostatic hypertrophy |
| 5 |
G04CX01
|
Prunus africanae cortex |
| 5 |
G04CX02
|
Sabalis serrulatae fructus |
| 5 |
G04CX03
|
mepartricin |
| 5 |
G04CX04
|
fexapotide |
| 1 |
H
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS |
| 2 |
H01
|
PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES |
| 3 |
H01A
|
ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| 4 |
H01AA
|
ACTH |
| 5 |
H01AA01
|
corticotropin |
| 5 |
H01AA02
|
tetracosactide |
| 4 |
H01AB
|
Thyrotropin |
| 5 |
H01AB01
|
thyrotropin alfa |
| 4 |
H01AC
|
Somatropin and somatropin agonists |
| 5 |
H01AC01
|
somatropin |
| 5 |
H01AC02
|
somatrem |
| 5 |
H01AC03
|
mecasermin |
| 5 |
H01AC04
|
sermorelin |
| 5 |
H01AC05
|
mecasermin rinfabate |
| 5 |
H01AC06
|
tesamorelin |
| 5 |
H01AC07
|
somapacitan |
| 4 |
H01AX
|
Other anterior pituitary lobe hormones and analogues |
| 5 |
H01AX01
|
pegvisomant |
| 3 |
H01B
|
POSTERIOR PITUITARY LOBE HORMONES |
| 4 |
H01BA
|
Vasopressin and analogues |
| 5 |
H01BA01
|
vasopressin (argipressin) |
| 5 |
H01BA02
|
desmopressin |
| 5 |
H01BA03
|
lypressin |
| 5 |
H01BA04
|
terlipressin |
| 5 |
H01BA05
|
ornipressin |
| 4 |
H01BB
|
Oxytocin and analogues |
| 5 |
H01BB01
|
demoxytocin |
| 5 |
H01BB02
|
oxytocin |
| 5 |
H01BB03
|
carbetocin |
| 3 |
H01C
|
HYPOTHALAMIC HORMONES |
| 4 |
H01CA
|
Gonadotropin-releasing hormones |
| 5 |
H01CA01
|
gonadorelin |
| 5 |
H01CA02
|
nafarelin |
| 4 |
H01CB
|
Somatostatin and analogues |
| 5 |
H01CB01
|
somatostatin |
| 5 |
H01CB02
|
octreotide |
| 5 |
H01CB03
|
lanreotide |
| 5 |
H01CB04
|
vapreotide |
| 5 |
H01CB05
|
pasireotide |
| 4 |
H01CC
|
Anti-gonadotropin-releasing hormones |
| 5 |
H01CC01
|
ganirelix |
| 5 |
H01CC02
|
cetrorelix |
| 5 |
H01CC03
|
elagolix |
| 5 |
H01CC54
|
relugolix, estradiol and norethisterone |
| 2 |
H02
|
CORTICOSTEROIDS FOR SYSTEMIC USE |
| 3 |
H02A
|
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| 4 |
H02AA
|
Mineralocorticoids |
| 5 |
H02AA01
|
aldosterone |
| 5 |
H02AA02
|
fludrocortisone |
| 5 |
H02AA03
|
desoxycortone |
| 4 |
H02AB
|
Glucocorticoids |
| 5 |
H02AB01
|
betamethasone |
| 5 |
H02AB02
|
dexamethasone |
| 5 |
H02AB03
|
fluocortolone |
| 5 |
H02AB04
|
methylprednisolone |
| 5 |
H02AB05
|
paramethasone |
| 5 |
H02AB06
|
prednisolone |
| 5 |
H02AB07
|
prednisone |
| 5 |
H02AB08
|
triamcinolone |
| 5 |
H02AB09
|
hydrocortisone |
| 5 |
H02AB10
|
cortisone |
| 5 |
H02AB11
|
prednylidene |
| 5 |
H02AB12
|
rimexolone |
| 5 |
H02AB13
|
deflazacort |
| 5 |
H02AB14
|
cloprednol |
| 5 |
H02AB15
|
meprednisone |
| 5 |
H02AB17
|
cortivazol |
| 3 |
H02B
|
CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS |
| 4 |
H02BX
|
Corticosteroids for systemic use, combinations |
| 5 |
H02BX01
|
methylprednisolone, combinations |
| 3 |
H02C
|
ANTIADRENAL PREPARATIONS |
| 4 |
H02CA
|
Anticorticosteroids |
| 5 |
H02CA01
|
trilostane |
| 5 |
H02CA02
|
osilodrostat |
| 5 |
H02CA03
|
ketoconazole |
| 2 |
H03
|
THYROID THERAPY |
| 3 |
H03A
|
THYROID PREPARATIONS |
| 4 |
H03AA
|
Thyroid hormones |
| 5 |
H03AA01
|
levothyroxine sodium |
| 5 |
H03AA02
|
liothyronine sodium |
| 5 |
H03AA03
|
combinations of levothyroxine and liothyronine |
| 5 |
H03AA04
|
tiratricol |
| 5 |
H03AA05
|
thyroid gland preparations |
| 3 |
H03B
|
ANTITHYROID PREPARATIONS |
| 4 |
H03BA
|
Thiouracils |
| 5 |
H03BA01
|
methylthiouracil |
| 5 |
H03BA02
|
propylthiouracil |
| 5 |
H03BA03
|
benzylthiouracil |
| 4 |
H03BB
|
Sulfur-containing imidazole derivatives |
| 5 |
H03BB01
|
carbimazole |
| 5 |
H03BB02
|
thiamazole |
| 5 |
H03BB52
|
thiamazole, combinations |
| 4 |
H03BC
|
Perchlorates |
| 5 |
H03BC01
|
potassium perchlorate |
| 4 |
H03BX
|
Other antithyroid preparations |
| 5 |
H03BX01
|
diiodotyrosine |
| 5 |
H03BX02
|
dibromotyrosine |
| 3 |
H03C
|
IODINE THERAPY |
| 4 |
H03CA
|
Iodine therapy |
| 2 |
H04
|
PANCREATIC HORMONES |
| 3 |
H04A
|
GLYCOGENOLYTIC HORMONES |
| 4 |
H04AA
|
Glycogenolytic hormones |
| 5 |
H04AA01
|
glucagon |
| 2 |
H05
|
CALCIUM HOMEOSTASIS |
| 3 |
H05A
|
PARATHYROID HORMONES AND ANALOGUES |
| 4 |
H05AA
|
Parathyroid hormones and analogues |
| 5 |
H05AA01
|
parathyroid gland extract |
| 5 |
H05AA02
|
teriparatide |
| 5 |
H05AA03
|
parathyroid hormone |
| 5 |
H05AA04
|
abaloparatide |
| 3 |
H05B
|
ANTI-PARATHYROID AGENTS |
| 4 |
H05BA
|
Calcitonin preparations |
| 5 |
H05BA01
|
calcitonin (salmon synthetic) |
| 5 |
H05BA02
|
calcitonin (pork natural) |
| 5 |
H05BA03
|
calcitonin (human synthetic) |
| 5 |
H05BA04
|
elcatonin |
| 4 |
H05BX
|
Other anti-parathyroid agents |
| 5 |
H05BX01
|
cinacalcet |
| 5 |
H05BX02
|
paricalcitol |
| 5 |
H05BX03
|
doxercalciferol |
| 5 |
H05BX04
|
etelcalcetide |
| 5 |
H05BX05
|
calcifediol |
| 1 |
J
|
ANTIINFECTIVES FOR SYSTEMIC USE |
| 2 |
J01
|
ANTIBACTERIALS FOR SYSTEMIC USE |
| 3 |
J01A
|
TETRACYCLINES |
| 4 |
J01AA
|
Tetracyclines |
| 5 |
J01AA01
|
demeclocycline |
| 5 |
J01AA02
|
doxycycline |
| 5 |
J01AA03
|
chlortetracycline |
| 5 |
J01AA04
|
lymecycline |
| 5 |
J01AA05
|
metacycline |
| 5 |
J01AA06
|
oxytetracycline |
| 5 |
J01AA07
|
tetracycline |
| 5 |
J01AA08
|
minocycline |
| 5 |
J01AA09
|
rolitetracycline |
| 5 |
J01AA10
|
penimepicycline |
| 5 |
J01AA11
|
clomocycline |
| 5 |
J01AA12
|
tigecycline |
| 5 |
J01AA13
|
eravacycline |
| 5 |
J01AA14
|
sarecycline |
| 5 |
J01AA15
|
omadacycline |
| 5 |
J01AA20
|
combinations of tetracyclines |
| 5 |
J01AA56
|
oxytetracycline, combinations |
| 3 |
J01B
|
AMPHENICOLS |
| 4 |
J01BA
|
Amphenicols |
| 5 |
J01BA01
|
chloramphenicol |
| 5 |
J01BA02
|
thiamphenicol |
| 5 |
J01BA52
|
thiamphenicol, combinations |
| 3 |
J01C
|
BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| 4 |
J01CA
|
Penicillins with extended spectrum |
| 5 |
J01CA01
|
ampicillin |
| 5 |
J01CA02
|
pivampicillin |
| 5 |
J01CA03
|
carbenicillin |
| 5 |
J01CA04
|
amoxicillin |
| 5 |
J01CA05
|
carindacillin |
| 5 |
J01CA06
|
bacampicillin |
| 5 |
J01CA07
|
epicillin |
| 5 |
J01CA08
|
pivmecillinam |
| 5 |
J01CA09
|
azlocillin |
| 5 |
J01CA10
|
mezlocillin |
| 5 |
J01CA11
|
mecillinam |
| 5 |
J01CA12
|
piperacillin |
| 5 |
J01CA13
|
ticarcillin |
| 5 |
J01CA14
|
metampicillin |
| 5 |
J01CA15
|
talampicillin |
| 5 |
J01CA16
|
sulbenicillin |
| 5 |
J01CA17
|
temocillin |
| 5 |
J01CA18
|
hetacillin |
| 5 |
J01CA19
|
aspoxicillin |
| 5 |
J01CA20
|
combinations |
| 5 |
J01CA51
|
ampicillin, combinations |
| 4 |
J01CE
|
Beta-lactamase sensitive penicillins |
| 5 |
J01CE01
|
benzylpenicillin |
| 5 |
J01CE02
|
phenoxymethylpenicillin |
| 5 |
J01CE03
|
propicillin |
| 5 |
J01CE04
|
azidocillin |
| 5 |
J01CE05
|
pheneticillin |
| 5 |
J01CE06
|
penamecillin |
| 5 |
J01CE07
|
clometocillin |
| 5 |
J01CE08
|
benzathine benzylpenicillin |
| 5 |
J01CE09
|
procaine benzylpenicillin |
| 5 |
J01CE10
|
benzathine phenoxymethylpenicillin |
| 5 |
J01CE30
|
combinations |
| 4 |
J01CF
|
Beta-lactamase resistant penicillins |
| 5 |
J01CF01
|
dicloxacillin |
| 5 |
J01CF02
|
cloxacillin |
| 5 |
J01CF03
|
meticillin |
| 5 |
J01CF04
|
oxacillin |
| 5 |
J01CF05
|
flucloxacillin |
| 5 |
J01CF06
|
nafcillin |
| 4 |
J01CG
|
Beta-lactamase inhibitors |
| 5 |
J01CG01
|
sulbactam |
| 5 |
J01CG02
|
tazobactam |
| 4 |
J01CR
|
Combinations of penicillins, incl. beta-lactamase inhibitors |
| 5 |
J01CR01
|
ampicillin and beta-lactamase inhibitor |
| 5 |
J01CR02
|
amoxicillin and beta-lactamase inhibitor |
| 5 |
J01CR03
|
ticarcillin and beta-lactamase inhibitor |
| 5 |
J01CR04
|
sultamicillin |
| 5 |
J01CR05
|
piperacillin and beta-lactamase inhibitor |
| 5 |
J01CR50
|
combinations of penicillins |
| 3 |
J01D
|
OTHER BETA-LACTAM ANTIBACTERIALS |
| 4 |
J01DB
|
First-generation cephalosporins |
| 5 |
J01DB01
|
cefalexin |
| 5 |
J01DB02
|
cefaloridine |
| 5 |
J01DB03
|
cefalotin |
| 5 |
J01DB04
|
cefazolin |
| 5 |
J01DB05
|
cefadroxil |
| 5 |
J01DB06
|
cefazedone |
| 5 |
J01DB07
|
cefatrizine |
| 5 |
J01DB08
|
cefapirin |
| 5 |
J01DB09
|
cefradine |
| 5 |
J01DB10
|
cefacetrile |
| 5 |
J01DB11
|
cefroxadine |
| 5 |
J01DB12
|
ceftezole |
| 4 |
J01DC
|
Second-generation cephalosporins |
| 5 |
J01DC01
|
cefoxitin |
| 5 |
J01DC02
|
cefuroxime |
| 5 |
J01DC03
|
cefamandole |
| 5 |
J01DC04
|
cefaclor |
| 5 |
J01DC05
|
cefotetan |
| 5 |
J01DC06
|
cefonicid |
| 5 |
J01DC07
|
cefotiam |
| 5 |
J01DC08
|
loracarbef |
| 5 |
J01DC09
|
cefmetazole |
| 5 |
J01DC10
|
cefprozil |
| 5 |
J01DC11
|
ceforanide |
| 5 |
J01DC12
|
cefminox |
| 5 |
J01DC13
|
cefbuperazone |
| 5 |
J01DC14
|
flomoxef |
| 4 |
J01DD
|
Third-generation cephalosporins |
| 5 |
J01DD01
|
cefotaxime |
| 5 |
J01DD02
|
ceftazidime |
| 5 |
J01DD03
|
cefsulodin |
| 5 |
J01DD04
|
ceftriaxone |
| 5 |
J01DD05
|
cefmenoxime |
| 5 |
J01DD06
|
latamoxef |
| 5 |
J01DD07
|
ceftizoxime |
| 5 |
J01DD08
|
cefixime |
| 5 |
J01DD09
|
cefodizime |
| 5 |
J01DD10
|
cefetamet |
| 5 |
J01DD11
|
cefpiramide |
| 5 |
J01DD12
|
cefoperazone |
| 5 |
J01DD13
|
cefpodoxime |
| 5 |
J01DD14
|
ceftibuten |
| 5 |
J01DD15
|
cefdinir |
| 5 |
J01DD16
|
cefditoren |
| 5 |
J01DD17
|
cefcapene |
| 5 |
J01DD18
|
cefteram |
| 5 |
J01DD51
|
cefotaxime and beta-lactamase inhibitor |
| 5 |
J01DD52
|
ceftazidime and beta-lactamase inhibitor |
| 5 |
J01DD54
|
ceftriaxone, combinations |
| 5 |
J01DD62
|
cefoperazone and beta-lactamase inhibitor |
| 5 |
J01DD63
|
ceftriaxone and beta-lactamase inhibitor |
| 5 |
J01DD64
|
cefpodoxime and beta-lactamase inhibitor |
| 4 |
J01DE
|
Fourth-generation cephalosporins |
| 5 |
J01DE01
|
cefepime |
| 5 |
J01DE02
|
cefpirome |
| 5 |
J01DE03
|
cefozopran |
| 4 |
J01DF
|
Monobactams |
| 5 |
J01DF01
|
aztreonam |
| 5 |
J01DF02
|
carumonam |
| 4 |
J01DH
|
Carbapenems |
| 5 |
J01DH02
|
meropenem |
| 5 |
J01DH03
|
ertapenem |
| 5 |
J01DH04
|
doripenem |
| 5 |
J01DH05
|
biapenem |
| 5 |
J01DH06
|
tebipenem pivoxil |
| 5 |
J01DH51
|
imipenem and cilastatin |
| 5 |
J01DH52
|
meropenem and vaborbactam |
| 5 |
J01DH55
|
panipenem and betamipron |
| 5 |
J01DH56
|
imipenem, cilastatin and relebactam |
| 4 |
J01DI
|
Other cephalosporins and penems |
| 5 |
J01DI01
|
ceftobiprole medocaril |
| 5 |
J01DI02
|
ceftaroline fosamil |
| 5 |
J01DI03
|
faropenem |
| 5 |
J01DI04
|
cefiderocol |
| 5 |
J01DI54
|
ceftolozane and beta-lactamase inhibitor |
| 3 |
J01E
|
SULFONAMIDES AND TRIMETHOPRIM |
| 4 |
J01EA
|
Trimethoprim and derivatives |
| 5 |
J01EA01
|
trimethoprim |
| 5 |
J01EA02
|
brodimoprim |
| 5 |
J01EA03
|
iclaprim |
| 4 |
J01EB
|
Short-acting sulfonamides |
| 5 |
J01EB01
|
sulfaisodimidine |
| 5 |
J01EB02
|
sulfamethizole |
| 5 |
J01EB03
|
sulfadimidine |
| 5 |
J01EB04
|
sulfapyridine |
| 5 |
J01EB05
|
sulfafurazole |
| 5 |
J01EB06
|
sulfanilamide |
| 5 |
J01EB07
|
sulfathiazole |
| 5 |
J01EB08
|
sulfathiourea |
| 5 |
J01EB20
|
combinations |
| 4 |
J01EC
|
Intermediate-acting sulfonamides |
| 5 |
J01EC01
|
sulfamethoxazole |
| 5 |
J01EC02
|
sulfadiazine |
| 5 |
J01EC03
|
sulfamoxole |
| 5 |
J01EC20
|
combinations |
| 4 |
J01ED
|
Long-acting sulfonamides |
| 5 |
J01ED01
|
sulfadimethoxine |
| 5 |
J01ED02
|
sulfalene |
| 5 |
J01ED03
|
sulfametomidine |
| 5 |
J01ED04
|
sulfametoxydiazine |
| 5 |
J01ED05
|
sulfamethoxypyridazine |
| 5 |
J01ED06
|
sulfaperin |
| 5 |
J01ED07
|
sulfamerazine |
| 5 |
J01ED08
|
sulfaphenazole |
| 5 |
J01ED09
|
sulfamazone |
| 5 |
J01ED20
|
combinations |
| 4 |
J01EE
|
Combinations of sulfonamides and trimethoprim, incl. derivatives |
| 5 |
J01EE01
|
sulfamethoxazole and trimethoprim |
| 5 |
J01EE02
|
sulfadiazine and trimethoprim |
| 5 |
J01EE03
|
sulfametrole and trimethoprim |
| 5 |
J01EE04
|
sulfamoxole and trimethoprim |
| 5 |
J01EE05
|
sulfadimidine and trimethoprim |
| 5 |
J01EE06
|
sulfadiazine and tetroxoprim |
| 5 |
J01EE07
|
sulfamerazine and trimethoprim |
| 3 |
J01F
|
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| 4 |
J01FA
|
Macrolides |
| 5 |
J01FA01
|
erythromycin |
| 5 |
J01FA02
|
spiramycin |
| 5 |
J01FA03
|
midecamycin |
| 5 |
J01FA05
|
oleandomycin |
| 5 |
J01FA06
|
roxithromycin |
| 5 |
J01FA07
|
josamycin |
| 5 |
J01FA08
|
troleandomycin |
| 5 |
J01FA09
|
clarithromycin |
| 5 |
J01FA10
|
azithromycin |
| 5 |
J01FA11
|
miocamycin |
| 5 |
J01FA12
|
rokitamycin |
| 5 |
J01FA13
|
dirithromycin |
| 5 |
J01FA14
|
flurithromycin |
| 5 |
J01FA15
|
telithromycin |
| 5 |
J01FA16
|
solithromycin |
| 4 |
J01FF
|
Lincosamides |
| 5 |
J01FF01
|
clindamycin |
| 5 |
J01FF02
|
lincomycin |
| 4 |
J01FG
|
Streptogramins |
| 5 |
J01FG01
|
pristinamycin |
| 5 |
J01FG02
|
quinupristin/dalfopristin |
| 3 |
J01G
|
AMINOGLYCOSIDE ANTIBACTERIALS |
| 4 |
J01GA
|
Streptomycins |
| 5 |
J01GA01
|
streptomycin |
| 5 |
J01GA02
|
streptoduocin |
| 4 |
J01GB
|
Other aminoglycosides |
| 5 |
J01GB01
|
tobramycin |
| 5 |
J01GB03
|
gentamicin |
| 5 |
J01GB04
|
kanamycin |
| 5 |
J01GB05
|
neomycin |
| 5 |
J01GB06
|
amikacin |
| 5 |
J01GB07
|
netilmicin |
| 5 |
J01GB08
|
sisomicin |
| 5 |
J01GB09
|
dibekacin |
| 5 |
J01GB10
|
ribostamycin |
| 5 |
J01GB11
|
isepamicin |
| 5 |
J01GB12
|
arbekacin |
| 5 |
J01GB13
|
bekanamycin |
| 5 |
J01GB14
|
plazomicin |
| 3 |
J01M
|
QUINOLONE ANTIBACTERIALS |
| 4 |
J01MA
|
Fluoroquinolones |
| 5 |
J01MA01
|
ofloxacin |
| 5 |
J01MA02
|
ciprofloxacin |
| 5 |
J01MA03
|
pefloxacin |
| 5 |
J01MA04
|
enoxacin |
| 5 |
J01MA05
|
temafloxacin |
| 5 |
J01MA06
|
norfloxacin |
| 5 |
J01MA07
|
lomefloxacin |
| 5 |
J01MA08
|
fleroxacin |
| 5 |
J01MA09
|
sparfloxacin |
| 5 |
J01MA10
|
rufloxacin |
| 5 |
J01MA11
|
grepafloxacin |
| 5 |
J01MA12
|
levofloxacin |
| 5 |
J01MA13
|
trovafloxacin |
| 5 |
J01MA14
|
moxifloxacin |
| 5 |
J01MA15
|
gemifloxacin |
| 5 |
J01MA16
|
gatifloxacin |
| 5 |
J01MA17
|
prulifloxacin |
| 5 |
J01MA18
|
pazufloxacin |
| 5 |
J01MA19
|
garenoxacin |
| 5 |
J01MA21
|
sitafloxacin |
| 5 |
J01MA22
|
tosufloxacin |
| 5 |
J01MA23
|
delafloxacin |
| 5 |
J01MA24
|
levonadifloxacin |
| 5 |
J01MA25
|
lascufloxacin |
| 4 |
J01MB
|
Other quinolones |
| 5 |
J01MB01
|
rosoxacin |
| 5 |
J01MB02
|
nalidixic acid |
| 5 |
J01MB03
|
piromidic acid |
| 5 |
J01MB04
|
pipemidic acid |
| 5 |
J01MB05
|
oxolinic acid |
| 5 |
J01MB06
|
cinoxacin |
| 5 |
J01MB07
|
flumequine |
| 5 |
J01MB08
|
nemonoxacin |
| 3 |
J01R
|
COMBINATIONS OF ANTIBACTERIALS |
| 4 |
J01RA
|
Combinations of antibacterials |
| 5 |
J01RA01
|
penicillins, combinations with other antibacterials |
| 5 |
J01RA02
|
sulfonamides, combinations with other antibacterials (excl. trimethoprim) |
| 5 |
J01RA03
|
cefuroxime and metronidazole |
| 5 |
J01RA04
|
spiramycin and metronidazole |
| 5 |
J01RA05
|
levofloxacin and ornidazole |
| 5 |
J01RA06
|
cefepime and amikacin |
| 5 |
J01RA07
|
azithromycin, fluconazole and secnidazole |
| 5 |
J01RA08
|
tetracycline and oleandomycin |
| 5 |
J01RA09
|
ofloxacin and ornidazole |
| 5 |
J01RA10
|
ciprofloxacin and metronidazole |
| 5 |
J01RA11
|
ciprofloxacin and tinidazole |
| 5 |
J01RA12
|
ciprofloxacin and ornidazole |
| 5 |
J01RA13
|
norfloxacin and tinidazole |
| 3 |
J01X
|
OTHER ANTIBACTERIALS |
| 4 |
J01XA
|
Glycopeptide antibacterials |
| 5 |
J01XA01
|
vancomycin |
| 5 |
J01XA02
|
teicoplanin |
| 5 |
J01XA03
|
telavancin |
| 5 |
J01XA04
|
dalbavancin |
| 5 |
J01XA05
|
oritavancin |
| 4 |
J01XB
|
Polymyxins |
| 5 |
J01XB01
|
colistin |
| 5 |
J01XB02
|
polymyxin B |
| 4 |
J01XC
|
Steroid antibacterials |
| 5 |
J01XC01
|
fusidic acid |
| 4 |
J01XD
|
Imidazole derivatives |
| 5 |
J01XD01
|
metronidazole |
| 5 |
J01XD02
|
tinidazole |
| 5 |
J01XD03
|
ornidazole |
| 4 |
J01XE
|
Nitrofuran derivatives |
| 5 |
J01XE01
|
nitrofurantoin |
| 5 |
J01XE02
|
nifurtoinol |
| 5 |
J01XE03
|
furazidin |
| 5 |
J01XE51
|
nitrofurantoin, combinations |
| 4 |
J01XX
|
Other antibacterials |
| 5 |
J01XX01
|
fosfomycin |
| 5 |
J01XX02
|
xibornol |
| 5 |
J01XX03
|
clofoctol |
| 5 |
J01XX04
|
spectinomycin |
| 5 |
J01XX05
|
methenamine |
| 5 |
J01XX06
|
mandelic acid |
| 5 |
J01XX07
|
nitroxoline |
| 5 |
J01XX08
|
linezolid |
| 5 |
J01XX09
|
daptomycin |
| 5 |
J01XX10
|
bacitracin |
| 5 |
J01XX11
|
tedizolid |
| 5 |
J01XX12
|
lefamulin |
| 2 |
J02
|
ANTIMYCOTICS FOR SYSTEMIC USE |
| 3 |
J02A
|
ANTIMYCOTICS FOR SYSTEMIC USE |
| 4 |
J02AA
|
Antibiotics |
| 5 |
J02AA01
|
amphotericin B |
| 5 |
J02AA02
|
hachimycin |
| 4 |
J02AB
|
Imidazole derivatives |
| 5 |
J02AB01
|
miconazole |
| 5 |
J02AB02
|
ketoconazole |
| 4 |
J02AC
|
Triazole derivatives |
| 5 |
J02AC01
|
fluconazole |
| 5 |
J02AC02
|
itraconazole |
| 5 |
J02AC03
|
voriconazole |
| 5 |
J02AC04
|
posaconazole |
| 5 |
J02AC05
|
isavuconazole |
| 4 |
J02AX
|
Other antimycotics for systemic use |
| 5 |
J02AX01
|
flucytosine |
| 5 |
J02AX04
|
caspofungin |
| 5 |
J02AX05
|
micafungin |
| 5 |
J02AX06
|
anidulafungin |
| 2 |
J04
|
ANTIMYCOBACTERIALS |
| 3 |
J04A
|
DRUGS FOR TREATMENT OF TUBERCULOSIS |
| 4 |
J04AA
|
Aminosalicylic acid and derivatives |
| 5 |
J04AA01
|
4-aminosalicylic acid |
| 5 |
J04AA02
|
sodium aminosalicylate |
| 5 |
J04AA03
|
calcium aminosalicylate |
| 4 |
J04AB
|
Antibiotics |
| 5 |
J04AB01
|
cycloserine |
| 5 |
J04AB02
|
rifampicin |
| 5 |
J04AB03
|
rifamycin |
| 5 |
J04AB04
|
rifabutin |
| 5 |
J04AB05
|
rifapentine |
| 5 |
J04AB06
|
enviomycin |
| 5 |
J04AB30
|
capreomycin |
| 4 |
J04AC
|
Hydrazides |
| 5 |
J04AC01
|
isoniazid |
| 5 |
J04AC51
|
isoniazid, combinations |
| 4 |
J04AD
|
Thiocarbamide derivatives |
| 5 |
J04AD01
|
protionamide |
| 5 |
J04AD02
|
tiocarlide |
| 5 |
J04AD03
|
ethionamide |
| 4 |
J04AK
|
Other drugs for treatment of tuberculosis |
| 5 |
J04AK01
|
pyrazinamide |
| 5 |
J04AK02
|
ethambutol |
| 5 |
J04AK03
|
terizidone |
| 5 |
J04AK04
|
morinamide |
| 5 |
J04AK05
|
bedaquiline |
| 5 |
J04AK06
|
delamanid |
| 5 |
J04AK07
|
thioacetazone |
| 5 |
J04AK08
|
pretomanid |
| 4 |
J04AM
|
Combinations of drugs for treatment of tuberculosis |
| 5 |
J04AM01
|
streptomycin and isoniazid |
| 5 |
J04AM02
|
rifampicin and isoniazid |
| 5 |
J04AM03
|
ethambutol and isoniazid |
| 5 |
J04AM04
|
thioacetazone and isoniazid |
| 5 |
J04AM05
|
rifampicin, pyrazinamide and isoniazid |
| 5 |
J04AM06
|
rifampicin, pyrazinamide, ethambutol and isoniazid |
| 5 |
J04AM07
|
rifampicin, ethambutol and isoniazid |
| 5 |
J04AM08
|
isoniazid, sulfamethoxazole, trimethoprim and pyridoxine |
| 3 |
J04B
|
DRUGS FOR TREATMENT OF LEPRA |
| 4 |
J04BA
|
Drugs for treatment of lepra |
| 5 |
J04BA01
|
clofazimine |
| 5 |
J04BA02
|
dapsone |
| 5 |
J04BA03
|
aldesulfone sodium |
| 2 |
J05
|
ANTIVIRALS FOR SYSTEMIC USE |
| 3 |
J05A
|
DIRECT ACTING ANTIVIRALS |
| 4 |
J05AA
|
Thiosemicarbazones |
| 5 |
J05AA01
|
metisazone |
| 4 |
J05AB
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
| 5 |
J05AB01
|
aciclovir |
| 5 |
J05AB02
|
idoxuridine |
| 5 |
J05AB03
|
vidarabine |
| 5 |
J05AB06
|
ganciclovir |
| 5 |
J05AB09
|
famciclovir |
| 5 |
J05AB11
|
valaciclovir |
| 5 |
J05AB12
|
cidofovir |
| 5 |
J05AB13
|
penciclovir |
| 5 |
J05AB14
|
valganciclovir |
| 5 |
J05AB15
|
brivudine |
| 4 |
J05AC
|
Cyclic amines |
| 5 |
J05AC02
|
rimantadine |
| 5 |
J05AC03
|
tromantadine |
| 4 |
J05AD
|
Phosphonic acid derivatives |
| 5 |
J05AD01
|
foscarnet |
| 5 |
J05AD02
|
fosfonet |
| 4 |
J05AE
|
Protease inhibitors |
| 5 |
J05AE01
|
saquinavir |
| 5 |
J05AE02
|
indinavir |
| 5 |
J05AE03
|
ritonavir |
| 5 |
J05AE04
|
nelfinavir |
| 5 |
J05AE05
|
amprenavir |
| 5 |
J05AE07
|
fosamprenavir |
| 5 |
J05AE08
|
atazanavir |
| 5 |
J05AE09
|
tipranavir |
| 5 |
J05AE10
|
darunavir |
| 4 |
J05AF
|
Nucleoside and nucleotide reverse transcriptase inhibitors |
| 5 |
J05AF01
|
zidovudine |
| 5 |
J05AF02
|
didanosine |
| 5 |
J05AF03
|
zalcitabine |
| 5 |
J05AF04
|
stavudine |
| 5 |
J05AF05
|
lamivudine |
| 5 |
J05AF06
|
abacavir |
| 5 |
J05AF07
|
tenofovir disoproxil |
| 5 |
J05AF08
|
adefovir dipivoxil |
| 5 |
J05AF09
|
emtricitabine |
| 5 |
J05AF10
|
entecavir |
| 5 |
J05AF11
|
telbivudine |
| 5 |
J05AF12
|
clevudine |
| 5 |
J05AF13
|
tenofovir alafenamide |
| 4 |
J05AG
|
Non-nucleoside reverse transcriptase inhibitors |
| 5 |
J05AG01
|
nevirapine |
| 5 |
J05AG02
|
delavirdine |
| 5 |
J05AG03
|
efavirenz |
| 5 |
J05AG04
|
etravirine |
| 5 |
J05AG05
|
rilpivirine |
| 5 |
J05AG06
|
doravirine |
| 4 |
J05AH
|
Neuraminidase inhibitors |
| 5 |
J05AH01
|
zanamivir |
| 5 |
J05AH02
|
oseltamivir |
| 5 |
J05AH03
|
peramivir |
| 5 |
J05AH04
|
laninamivir |
| 4 |
J05AJ
|
Integrase inhibitors |
| 5 |
J05AJ01
|
raltegravir |
| 5 |
J05AJ02
|
elvitegravir |
| 5 |
J05AJ03
|
dolutegravir |
| 5 |
J05AJ04
|
cabotegravir |
| 4 |
J05AP
|
Antivirals for treatment of HCV infections |
| 5 |
J05AP01
|
ribavirin |
| 5 |
J05AP02
|
telaprevir |
| 5 |
J05AP03
|
boceprevir |
| 5 |
J05AP04
|
faldaprevir |
| 5 |
J05AP05
|
simeprevir |
| 5 |
J05AP06
|
asunaprevir |
| 5 |
J05AP07
|
daclatasvir |
| 5 |
J05AP08
|
sofosbuvir |
| 5 |
J05AP09
|
dasabuvir |
| 5 |
J05AP10
|
elbasvir |
| 5 |
J05AP11
|
grazoprevir |
| 5 |
J05AP51
|
sofosbuvir and ledipasvir |
| 5 |
J05AP52
|
dasabuvir, ombitasvir, paritaprevir and ritonavir |
| 5 |
J05AP53
|
ombitasvir, paritaprevir and ritonavir |
| 5 |
J05AP54
|
elbasvir and grazoprevir |
| 5 |
J05AP55
|
sofosbuvir and velpatasvir |
| 5 |
J05AP56
|
sofosbuvir, velpatasvir and voxilaprevir |
| 5 |
J05AP57
|
glecaprevir and pibrentasvir |
| 5 |
J05AP58
|
daclatasvir, asunaprevir and beclabuvir |
| 4 |
J05AR
|
Antivirals for treatment of HIV infections, combinations |
| 5 |
J05AR01
|
zidovudine and lamivudine |
| 5 |
J05AR02
|
lamivudine and abacavir |
| 5 |
J05AR03
|
tenofovir disoproxil and emtricitabine |
| 5 |
J05AR04
|
zidovudine, lamivudine and abacavir |
| 5 |
J05AR05
|
zidovudine, lamivudine and nevirapine |
| 5 |
J05AR06
|
emtricitabine, tenofovir disoproxil and efavirenz |
| 5 |
J05AR07
|
stavudine, lamivudine and nevirapine |
| 5 |
J05AR08
|
emtricitabine, tenofovir disoproxil and rilpivirine |
| 5 |
J05AR09
|
emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat |
| 5 |
J05AR10
|
lopinavir and ritonavir |
| 5 |
J05AR11
|
lamivudine, tenofovir disoproxil and efavirenz |
| 5 |
J05AR12
|
lamivudine and tenofovir disoproxil |
| 5 |
J05AR13
|
lamivudine, abacavir and dolutegravir |
| 5 |
J05AR14
|
darunavir and cobicistat |
| 5 |
J05AR15
|
atazanavir and cobicistat |
| 5 |
J05AR16
|
lamivudine and raltegravir |
| 5 |
J05AR17
|
emtricitabine and tenofovir alafenamide |
| 5 |
J05AR18
|
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat |
| 5 |
J05AR19
|
emtricitabine, tenofovir alafenamide and rilpivirine |
| 5 |
J05AR20
|
emtricitabine, tenofovir alafenamide and bictegravir |
| 5 |
J05AR21
|
dolutegravir and rilpivirine |
| 5 |
J05AR22
|
emtricitabine, tenofovir alafenamide, darunavir and cobicistat |
| 5 |
J05AR23
|
atazanavir and ritonavir |
| 5 |
J05AR24
|
lamivudine, tenofovir disoproxil and doravirine |
| 5 |
J05AR25
|
lamivudine and dolutegravir |
| 5 |
J05AR26
|
darunavir and ritonavir |
| 5 |
J05AR27
|
lamivudine, tenofovir disoproxil and dolutegravir |
| 4 |
J05AX
|
Other antivirals |
| 5 |
J05AX01
|
moroxydine |
| 5 |
J05AX02
|
lysozyme |
| 5 |
J05AX05
|
inosine pranobex |
| 5 |
J05AX06
|
pleconaril |
| 5 |
J05AX07
|
enfuvirtide |
| 5 |
J05AX09
|
maraviroc |
| 5 |
J05AX10
|
maribavir |
| 5 |
J05AX13
|
umifenovir |
| 5 |
J05AX17
|
enisamium iodide |
| 5 |
J05AX18
|
letermovir |
| 5 |
J05AX19
|
tilorone |
| 5 |
J05AX21
|
pentanedioic acid imidazolyl ethanamide |
| 5 |
J05AX23
|
ibalizumab |
| 5 |
J05AX24
|
tecovirimat |
| 5 |
J05AX25
|
baloxavir marboxil |
| 5 |
J05AX26
|
amenamevir |
| 5 |
J05AX27
|
favipiravir |
| 5 |
J05AX28
|
bulevirtide |
| 5 |
J05AX29
|
fostemsavir |
| 2 |
J06
|
IMMUNE SERA AND IMMUNOGLOBULINS |
| 3 |
J06A
|
IMMUNE SERA |
| 4 |
J06AA
|
Immune sera |
| 5 |
J06AA01
|
diphtheria antitoxin |
| 5 |
J06AA02
|
tetanus antitoxin |
| 5 |
J06AA03
|
snake venom antiserum |
| 5 |
J06AA04
|
botulinum antitoxin |
| 5 |
J06AA05
|
gas-gangrene sera |
| 5 |
J06AA06
|
rabies serum |
| 3 |
J06B
|
IMMUNOGLOBULINS |
| 4 |
J06BA
|
Immunoglobulins, normal human |
| 5 |
J06BA01
|
immunoglobulins, normal human, for extravascular adm. |
| 5 |
J06BA02
|
immunoglobulins, normal human, for intravascular adm. |
| 4 |
J06BB
|
Specific immunoglobulins |
| 5 |
J06BB01
|
anti-D (rh) immunoglobulin |
| 5 |
J06BB02
|
tetanus immunoglobulin |
| 5 |
J06BB03
|
varicella/zoster immunoglobulin |
| 5 |
J06BB04
|
hepatitis B immunoglobulin |
| 5 |
J06BB05
|
rabies immunoglobulin |
| 5 |
J06BB06
|
rubella immunoglobulin |
| 5 |
J06BB07
|
vaccinia immunoglobulin |
| 5 |
J06BB08
|
staphylococcus immunoglobulin |
| 5 |
J06BB09
|
cytomegalovirus immunoglobulin |
| 5 |
J06BB10
|
diphtheria immunoglobulin |
| 5 |
J06BB11
|
hepatitis A immunoglobulin |
| 5 |
J06BB12
|
encephalitis, tick borne immunoglobulin |
| 5 |
J06BB13
|
pertussis immunoglobulin |
| 5 |
J06BB14
|
measles immunoglobulin |
| 5 |
J06BB15
|
mumps immunoglobulin |
| 5 |
J06BB16
|
palivizumab |
| 5 |
J06BB17
|
motavizumab |
| 5 |
J06BB18
|
raxibacumab |
| 5 |
J06BB19
|
anthrax immunoglobulin |
| 5 |
J06BB21
|
bezlotoxumab |
| 5 |
J06BB22
|
obiltoxaximab |
| 5 |
J06BB30
|
combinations |
| 4 |
J06BC
|
Other immunoglobulins |
| 5 |
J06BC01
|
nebacumab |
| 2 |
J07
|
VACCINES |
| 3 |
J07A
|
BACTERIAL VACCINES |
| 4 |
J07AC
|
Anthrax vaccines |
| 5 |
J07AC01
|
anthrax antigen |
| 4 |
J07AD
|
Brucellosis vaccines |
| 5 |
J07AD01
|
brucella antigen |
| 4 |
J07AE
|
Cholera vaccines |
| 5 |
J07AE01
|
cholera, inactivated, whole cell |
| 5 |
J07AE02
|
cholera, live attenuated |
| 5 |
J07AE51
|
cholera, combinations with typhoid vaccine, inactivated, whole cell |
| 4 |
J07AF
|
Diphtheria vaccines |
| 5 |
J07AF01
|
diphtheria toxoid |
| 4 |
J07AG
|
Haemophilus influenzae B vaccines |
| 5 |
J07AG01
|
haemophilus influenzae B, purified antigen conjugated |
| 5 |
J07AG51
|
haemophilus influenzae B, combinations with toxoids |
| 5 |
J07AG52
|
haemophilus influenzae B, combinations with pertussis and toxoids |
| 5 |
J07AG53
|
haemophilus influenzae B, combinations with meningococcus C, conjugated |
| 4 |
J07AH
|
Meningococcal vaccines |
| 5 |
J07AH01
|
meningococcus A, purified polysaccharides antigen |
| 5 |
J07AH02
|
other meningococcal monovalent purified polysaccharides antigen |
| 5 |
J07AH03
|
meningococcus A,C, bivalent purified polysaccharides antigen |
| 5 |
J07AH04
|
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen |
| 5 |
J07AH05
|
other meningococcal polyvalent purified polysaccharides antigen |
| 5 |
J07AH06
|
meningococcus B, outer membrane vesicle vaccine |
| 5 |
J07AH07
|
meningococcus C, purified polysaccharides antigen conjugated |
| 5 |
J07AH08
|
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated |
| 5 |
J07AH09
|
meningococcus B, multicomponent vaccine |
| 5 |
J07AH10
|
meningococcus A, purified polysaccharides antigen conjugated |
| 4 |
J07AJ
|
Pertussis vaccines |
| 5 |
J07AJ01
|
pertussis, inactivated, whole cell |
| 5 |
J07AJ02
|
pertussis, purified antigen |
| 5 |
J07AJ51
|
pertussis, inactivated, whole cell, combinations with toxoids |
| 5 |
J07AJ52
|
pertussis, purified antigen, combinations with toxoids |
| 4 |
J07AK
|
Plague vaccines |
| 5 |
J07AK01
|
plague, inactivated, whole cell |
| 4 |
J07AL
|
Pneumococcal vaccines |
| 5 |
J07AL01
|
pneumococcus, purified polysaccharides antigen |
| 5 |
J07AL02
|
pneumococcus, purified polysaccharides antigen conjugated |
| 5 |
J07AL52
|
pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
| 4 |
J07AM
|
Tetanus vaccines |
| 5 |
J07AM01
|
tetanus toxoid |
| 5 |
J07AM51
|
tetanus toxoid, combinations with diphtheria toxoid |
| 5 |
J07AM52
|
tetanus toxoid, combinations with tetanus immunoglobulin |
| 4 |
J07AN
|
Tuberculosis vaccines |
| 5 |
J07AN01
|
tuberculosis, live attenuated |
| 4 |
J07AP
|
Typhoid vaccines |
| 5 |
J07AP01
|
typhoid, oral, live attenuated |
| 5 |
J07AP02
|
typhoid, inactivated, whole cell |
| 5 |
J07AP03
|
typhoid, purified polysaccharide antigen |
| 5 |
J07AP10
|
typhoid, combinations with paratyphi types |
| 4 |
J07AR
|
Typhus (exanthematicus) vaccines |
| 5 |
J07AR01
|
typhus exanthematicus, inactivated, whole cell |
| 4 |
J07AX
|
Other bacterial vaccines |
| 3 |
J07B
|
VIRAL VACCINES |
| 4 |
J07BA
|
Encephalitis vaccines |
| 5 |
J07BA01
|
encephalitis, tick borne, inactivated, whole virus |
| 5 |
J07BA02
|
encephalitis, Japanese, inactivated, whole virus |
| 5 |
J07BA03
|
encephalitis, Japanese, live attenuated |
| 4 |
J07BB
|
Influenza vaccines |
| 5 |
J07BB01
|
influenza, inactivated, whole virus |
| 5 |
J07BB02
|
influenza, inactivated, split virus or surface antigen |
| 5 |
J07BB03
|
influenza, live attenuated |
| 5 |
J07BB04
|
influenza, virus like particles |
| 4 |
J07BC
|
Hepatitis vaccines |
| 5 |
J07BC01
|
hepatitis B, purified antigen |
| 5 |
J07BC02
|
hepatitis A, inactivated, whole virus |
| 5 |
J07BC20
|
combinations |
| 4 |
J07BD
|
Measles vaccines |
| 5 |
J07BD01
|
measles, live attenuated |
| 5 |
J07BD51
|
measles, combinations with mumps, live attenuated |
| 5 |
J07BD52
|
measles, combinations with mumps and rubella, live attenuated |
| 5 |
J07BD53
|
measles, combinations with rubella, live attenuated |
| 5 |
J07BD54
|
measles, combinations with mumps, rubella and varicella, live attenuated |
| 4 |
J07BE
|
Mumps vaccines |
| 5 |
J07BE01
|
mumps, live attenuated |
| 4 |
J07BF
|
Poliomyelitis vaccines |
| 5 |
J07BF01
|
poliomyelitis oral, monovalent, live attenuated |
| 5 |
J07BF02
|
poliomyelitis oral, trivalent, live attenuated |
| 5 |
J07BF03
|
poliomyelitis, trivalent, inactivated, whole virus |
| 5 |
J07BF04
|
poliomyelitis oral, bivalent, live attenuated |
| 4 |
J07BG
|
Rabies vaccines |
| 5 |
J07BG01
|
rabies, inactivated, whole virus |
| 4 |
J07BH
|
Rota virus diarrhea vaccines |
| 5 |
J07BH01
|
rota virus, live attenuated |
| 5 |
J07BH02
|
rota virus, pentavalent, live, reassorted |
| 4 |
J07BJ
|
Rubella vaccines |
| 5 |
J07BJ01
|
rubella, live attenuated |
| 5 |
J07BJ51
|
rubella, combinations with mumps, live attenuated |
| 4 |
J07BK
|
Varicella zoster vaccines |
| 5 |
J07BK01
|
varicella, live attenuated |
| 5 |
J07BK02
|
zoster, live attenuated |
| 5 |
J07BK03
|
zoster, purified antigen |
| 4 |
J07BL
|
Yellow fever vaccines |
| 5 |
J07BL01
|
yellow fever, live attenuated |
| 4 |
J07BM
|
Papillomavirus vaccines |
| 5 |
J07BM01
|
papillomavirus (human types 6, 11, 16, 18) |
| 5 |
J07BM02
|
papillomavirus (human types 16, 18) |
| 5 |
J07BM03
|
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) |
| 4 |
J07BX
|
Other viral vaccines |
| 5 |
J07BX01
|
smallpox vaccines |
| 5 |
J07BX02
|
ebola vaccines |
| 3 |
J07C
|
BACTERIAL AND VIRAL VACCINES, COMBINED |
| 4 |
J07CA
|
Bacterial and viral vaccines, combined |
| 5 |
J07CA01
|
diphtheria-poliomyelitis-tetanus |
| 5 |
J07CA02
|
diphtheria-pertussis-poliomyelitis-tetanus |
| 5 |
J07CA03
|
diphtheria-rubella-tetanus |
| 5 |
J07CA04
|
haemophilus influenzae B and poliomyelitis |
| 5 |
J07CA05
|
diphtheria-hepatitis B-pertussis-tetanus |
| 5 |
J07CA06
|
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus |
| 5 |
J07CA07
|
diphtheria-hepatitis B-tetanus |
| 5 |
J07CA08
|
haemophilus influenzae B and hepatitis B |
| 5 |
J07CA09
|
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |
| 5 |
J07CA10
|
typhoid-hepatitis A |
| 5 |
J07CA11
|
diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B |
| 5 |
J07CA12
|
diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B |
| 5 |
J07CA13
|
diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C |
| 3 |
J07X
|
OTHER VACCINES |
| 1 |
L
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| 2 |
L01
|
ANTINEOPLASTIC AGENTS |
| 3 |
L01A
|
ALKYLATING AGENTS |
| 4 |
L01AA
|
Nitrogen mustard analogues |
| 5 |
L01AA01
|
cyclophosphamide |
| 5 |
L01AA02
|
chlorambucil |
| 5 |
L01AA03
|
melphalan |
| 5 |
L01AA05
|
chlormethine |
| 5 |
L01AA06
|
ifosfamide |
| 5 |
L01AA07
|
trofosfamide |
| 5 |
L01AA08
|
prednimustine |
| 5 |
L01AA09
|
bendamustine |
| 4 |
L01AB
|
Alkyl sulfonates |
| 5 |
L01AB01
|
busulfan |
| 5 |
L01AB02
|
treosulfan |
| 5 |
L01AB03
|
mannosulfan |
| 4 |
L01AC
|
Ethylene imines |
| 5 |
L01AC01
|
thiotepa |
| 5 |
L01AC02
|
triaziquone |
| 5 |
L01AC03
|
carboquone |
| 4 |
L01AD
|
Nitrosoureas |
| 5 |
L01AD01
|
carmustine |
| 5 |
L01AD02
|
lomustine |
| 5 |
L01AD03
|
semustine |
| 5 |
L01AD04
|
streptozocin |
| 5 |
L01AD05
|
fotemustine |
| 5 |
L01AD06
|
nimustine |
| 5 |
L01AD07
|
ranimustine |
| 5 |
L01AD08
|
uramustine |
| 4 |
L01AG
|
Epoxides |
| 5 |
L01AG01
|
etoglucid |
| 4 |
L01AX
|
Other alkylating agents |
| 5 |
L01AX01
|
mitobronitol |
| 5 |
L01AX02
|
pipobroman |
| 5 |
L01AX03
|
temozolomide |
| 5 |
L01AX04
|
dacarbazine |
| 3 |
L01B
|
ANTIMETABOLITES |
| 4 |
L01BA
|
Folic acid analogues |
| 5 |
L01BA01
|
methotrexate |
| 5 |
L01BA03
|
raltitrexed |
| 5 |
L01BA04
|
pemetrexed |
| 5 |
L01BA05
|
pralatrexate |
| 4 |
L01BB
|
Purine analogues |
| 5 |
L01BB02
|
mercaptopurine |
| 5 |
L01BB03
|
tioguanine |
| 5 |
L01BB04
|
cladribine |
| 5 |
L01BB05
|
fludarabine |
| 5 |
L01BB06
|
clofarabine |
| 5 |
L01BB07
|
nelarabine |
| 4 |
L01BC
|
Pyrimidine analogues |
| 5 |
L01BC01
|
cytarabine |
| 5 |
L01BC02
|
fluorouracil |
| 5 |
L01BC03
|
tegafur |
| 5 |
L01BC04
|
carmofur |
| 5 |
L01BC05
|
gemcitabine |
| 5 |
L01BC06
|
capecitabine |
| 5 |
L01BC07
|
azacitidine |
| 5 |
L01BC08
|
decitabine |
| 5 |
L01BC09
|
floxuridine |
| 5 |
L01BC52
|
fluorouracil, combinations |
| 5 |
L01BC53
|
tegafur, combinations |
| 5 |
L01BC59
|
trifluridine, combinations |
| 3 |
L01C
|
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| 4 |
L01CA
|
Vinca alkaloids and analogues |
| 5 |
L01CA01
|
vinblastine |
| 5 |
L01CA02
|
vincristine |
| 5 |
L01CA03
|
vindesine |
| 5 |
L01CA04
|
vinorelbine |
| 5 |
L01CA05
|
vinflunine |
| 5 |
L01CA06
|
vintafolide |
| 4 |
L01CB
|
Podophyllotoxin derivatives |
| 5 |
L01CB01
|
etoposide |
| 5 |
L01CB02
|
teniposide |
| 4 |
L01CC
|
Colchicine derivatives |
| 5 |
L01CC01
|
demecolcine |
| 4 |
L01CD
|
Taxanes |
| 5 |
L01CD01
|
paclitaxel |
| 5 |
L01CD02
|
docetaxel |
| 5 |
L01CD03
|
paclitaxel poliglumex |
| 5 |
L01CD04
|
cabazitaxel |
| 4 |
L01CE
|
Topoisomerase 1 (TOP1) inhibitors |
| 5 |
L01CE01
|
topotecan |
| 5 |
L01CE02
|
irinotecan |
| 5 |
L01CE03
|
etirinotecan pegol |
| 5 |
L01CE04
|
belotecan |
| 4 |
L01CX
|
Other plant alkaloids and natural products |
| 5 |
L01CX01
|
trabectedin |
| 3 |
L01D
|
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| 4 |
L01DA
|
Actinomycines |
| 5 |
L01DA01
|
dactinomycin |
| 4 |
L01DB
|
Anthracyclines and related substances |
| 5 |
L01DB01
|
doxorubicin |
| 5 |
L01DB02
|
daunorubicin |
| 5 |
L01DB03
|
epirubicin |
| 5 |
L01DB04
|
aclarubicin |
| 5 |
L01DB05
|
zorubicin |
| 5 |
L01DB06
|
idarubicin |
| 5 |
L01DB07
|
mitoxantrone |
| 5 |
L01DB08
|
pirarubicin |
| 5 |
L01DB09
|
valrubicin |
| 5 |
L01DB10
|
amrubicin |
| 5 |
L01DB11
|
pixantrone |
| 4 |
L01DC
|
Other cytotoxic antibiotics |
| 5 |
L01DC01
|
bleomycin |
| 5 |
L01DC02
|
plicamycin |
| 5 |
L01DC03
|
mitomycin |
| 5 |
L01DC04
|
ixabepilone |
| 3 |
L01E
|
PROTEIN KINASE INHIBITORS |
| 4 |
L01EA
|
BCR-ABL tyrosine kinase inhibitors |
| 5 |
L01EA01
|
imatinib |
| 5 |
L01EA02
|
dasatinib |
| 5 |
L01EA03
|
nilotinib |
| 5 |
L01EA04
|
bosutinib |
| 5 |
L01EA05
|
ponatinib |
| 4 |
L01EB
|
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors |
| 5 |
L01EB01
|
gefitinib |
| 5 |
L01EB02
|
erlotinib |
| 5 |
L01EB03
|
afatinib |
| 5 |
L01EB04
|
osimertinib |
| 5 |
L01EB05
|
rociletinib |
| 5 |
L01EB06
|
olmutinib |
| 5 |
L01EB07
|
dacomitinib |
| 5 |
L01EB08
|
icotinib |
| 4 |
L01EC
|
B-Raf serine-threonine kinase (BRAF) inhibitors |
| 5 |
L01EC01
|
vemurafenib |
| 5 |
L01EC02
|
dabrafenib |
| 5 |
L01EC03
|
encorafenib |
| 4 |
L01ED
|
Anaplastic lymphoma kinase (ALK) inhibitors |
| 5 |
L01ED01
|
crizotinib |
| 5 |
L01ED02
|
ceritinib |
| 5 |
L01ED03
|
alectinib |
| 5 |
L01ED04
|
brigatinib |
| 5 |
L01ED05
|
lorlatinib |
| 4 |
L01EE
|
Mitogen-activated protein kinase (MEK) inhibitors |
| 5 |
L01EE01
|
trametinib |
| 5 |
L01EE02
|
cobimetinib |
| 5 |
L01EE03
|
binimetinib |
| 5 |
L01EE04
|
selumetinib |
| 4 |
L01EF
|
Cyclin-dependent kinase (CDK) inhibitors |
| 5 |
L01EF01
|
palbociclib |
| 5 |
L01EF02
|
ribociclib |
| 5 |
L01EF03
|
abemaciclib |
| 4 |
L01EG
|
Mammalian target of rapamycin (mTOR) kinase inhibitors |
| 5 |
L01EG01
|
temsirolimus |
| 5 |
L01EG02
|
everolimus |
| 5 |
L01EG03
|
ridaforolimus |
| 4 |
L01EH
|
Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors |
| 5 |
L01EH01
|
lapatinib |
| 5 |
L01EH02
|
neratinib |
| 5 |
L01EH03
|
tucatinib |
| 4 |
L01EJ
|
Janus-associated kinase (JAK) inhibitors |
| 5 |
L01EJ01
|
ruxolitinib |
| 5 |
L01EJ02
|
fedratinib |
| 4 |
L01EK
|
Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| 5 |
L01EK01
|
axitinib |
| 5 |
L01EK02
|
cediranib |
| 5 |
L01EK03
|
tivozanib |
| 4 |
L01EL
|
Bruton's tyrosine kinase (BTK) inhibitors |
| 5 |
L01EL01
|
ibrutinib |
| 5 |
L01EL02
|
acalabrutinib |
| 5 |
L01EL03
|
zanubrutinib |
| 4 |
L01EM
|
Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| 5 |
L01EM01
|
idelalisib |
| 5 |
L01EM02
|
copanlisib |
| 5 |
L01EM03
|
alpelisib |
| 5 |
L01EM04
|
duvelisib |
| 4 |
L01EX
|
Other protein kinase inhibitors |
| 5 |
L01EX01
|
sunitinib |
| 5 |
L01EX02
|
sorafenib |
| 5 |
L01EX03
|
pazopanib |
| 5 |
L01EX04
|
vandetanib |
| 5 |
L01EX05
|
regorafenib |
| 5 |
L01EX06
|
masitinib |
| 5 |
L01EX07
|
cabozantinib |
| 5 |
L01EX08
|
lenvatinib |
| 5 |
L01EX09
|
nintedanib |
| 5 |
L01EX10
|
midostaurin |
| 5 |
L01EX11
|
quizartinib |
| 5 |
L01EX12
|
larotrectinib |
| 5 |
L01EX13
|
gilteritinib |
| 5 |
L01EX14
|
entrectinib |
| 5 |
L01EX15
|
pexidartinib |
| 5 |
L01EX16
|
erdafitinib |
| 5 |
L01EX17
|
capmatinib |
| 5 |
L01EX18
|
avapritinib |
| 5 |
L01EX19
|
ripretinib |
| 5 |
L01EX20
|
pemigatinib |
| 5 |
L01EX21
|
tepotinib |
| 3 |
L01X
|
OTHER ANTINEOPLASTIC AGENTS |
| 4 |
L01XA
|
Platinum compounds |
| 5 |
L01XA01
|
cisplatin |
| 5 |
L01XA02
|
carboplatin |
| 5 |
L01XA03
|
oxaliplatin |
| 5 |
L01XA04
|
satraplatin |
| 5 |
L01XA05
|
polyplatillen |
| 4 |
L01XB
|
Methylhydrazines |
| 5 |
L01XB01
|
procarbazine |
| 4 |
L01XC
|
Monoclonal antibodies |
| 5 |
L01XC01
|
edrecolomab |
| 5 |
L01XC02
|
rituximab |
| 5 |
L01XC03
|
trastuzumab |
| 5 |
L01XC05
|
gemtuzumab ozogamicin |
| 5 |
L01XC06
|
cetuximab |
| 5 |
L01XC07
|
bevacizumab |
| 5 |
L01XC08
|
panitumumab |
| 5 |
L01XC09
|
catumaxomab |
| 5 |
L01XC10
|
ofatumumab |
| 5 |
L01XC11
|
ipilimumab |
| 5 |
L01XC12
|
brentuximab vedotin |
| 5 |
L01XC13
|
pertuzumab |
| 5 |
L01XC14
|
trastuzumab emtansine |
| 5 |
L01XC15
|
obinutuzumab |
| 5 |
L01XC16
|
dinutuximab beta |
| 5 |
L01XC17
|
nivolumab |
| 5 |
L01XC18
|
pembrolizumab |
| 5 |
L01XC19
|
blinatumomab |
| 5 |
L01XC21
|
ramucirumab |
| 5 |
L01XC22
|
necitumumab |
| 5 |
L01XC23
|
elotuzumab |
| 5 |
L01XC24
|
daratumumab |
| 5 |
L01XC25
|
mogamulizumab |
| 5 |
L01XC26
|
inotuzumab ozogamicin |
| 5 |
L01XC27
|
olaratumab |
| 5 |
L01XC28
|
durvalumab |
| 5 |
L01XC29
|
bermekimab |
| 5 |
L01XC31
|
avelumab |
| 5 |
L01XC32
|
atezolizumab |
| 5 |
L01XC33
|
cemiplimab |
| 5 |
L01XC34
|
moxetumomab pasudotox |
| 5 |
L01XC35
|
tafasitamab |
| 5 |
L01XC36
|
enfortumab vedotin |
| 5 |
L01XC37
|
polatuzumab vedotin |
| 5 |
L01XC38
|
isatuximab |
| 5 |
L01XC39
|
belantamab mafodotin |
| 5 |
L01XC40
|
dostarlimab |
| 5 |
L01XC41
|
trastuzumab deruxtecan |
| 4 |
L01XD
|
Sensitizers used in photodynamic/radiation therapy |
| 5 |
L01XD01
|
porfimer sodium |
| 5 |
L01XD03
|
methyl aminolevulinate |
| 5 |
L01XD04
|
aminolevulinic acid |
| 5 |
L01XD05
|
temoporfin |
| 5 |
L01XD06
|
efaproxiral |
| 5 |
L01XD07
|
padeliporfin |
| 4 |
L01XF
|
Retinoids for cancer treatment |
| 5 |
L01XF01
|
tretinoin |
| 5 |
L01XF02
|
alitretinoin |
| 5 |
L01XF03
|
bexarotene |
| 4 |
L01XG
|
Proteasome inhibitors |
| 5 |
L01XG01
|
bortezomib |
| 5 |
L01XG02
|
carfilzomib |
| 5 |
L01XG03
|
ixazomib |
| 4 |
L01XH
|
Histone deacetylase (HDAC) inhibitors |
| 5 |
L01XH01
|
vorinostat |
| 5 |
L01XH02
|
romidepsin |
| 5 |
L01XH03
|
panobinostat |
| 5 |
L01XH04
|
belinostat |
| 5 |
L01XH05
|
entinostat |
| 4 |
L01XJ
|
Hedgehog pathway inhibitors |
| 5 |
L01XJ01
|
vismodegib |
| 5 |
L01XJ02
|
sonidegib |
| 5 |
L01XJ03
|
glasdegib |
| 4 |
L01XK
|
Poly (ADP-ribose) polymerase (PARP) inhibitors |
| 5 |
L01XK01
|
olaparib |
| 5 |
L01XK02
|
niraparib |
| 5 |
L01XK03
|
rucaparib |
| 5 |
L01XK04
|
talazoparib |
| 5 |
L01XK05
|
veliparib |
| 4 |
L01XX
|
Other antineoplastic agents |
| 5 |
L01XX01
|
amsacrine |
| 5 |
L01XX02
|
asparaginase |
| 5 |
L01XX03
|
altretamine |
| 5 |
L01XX05
|
hydroxycarbamide |
| 5 |
L01XX07
|
lonidamine |
| 5 |
L01XX08
|
pentostatin |
| 5 |
L01XX10
|
masoprocol |
| 5 |
L01XX11
|
estramustine |
| 5 |
L01XX16
|
mitoguazone |
| 5 |
L01XX18
|
tiazofurine |
| 5 |
L01XX23
|
mitotane |
| 5 |
L01XX24
|
pegaspargase |
| 5 |
L01XX27
|
arsenic trioxide |
| 5 |
L01XX29
|
denileukin diftitox |
| 5 |
L01XX33
|
celecoxib |
| 5 |
L01XX35
|
anagrelide |
| 5 |
L01XX36
|
oblimersen |
| 5 |
L01XX37
|
sitimagene ceradenovec |
| 5 |
L01XX40
|
omacetaxine mepesuccinate |
| 5 |
L01XX41
|
eribulin |
| 5 |
L01XX44
|
aflibercept |
| 5 |
L01XX51
|
talimogene laherparepvec |
| 5 |
L01XX52
|
venetoclax |
| 5 |
L01XX53
|
vosaroxin |
| 5 |
L01XX57
|
plitidepsin |
| 5 |
L01XX58
|
epacadostat |
| 5 |
L01XX59
|
enasidenib |
| 5 |
L01XX62
|
ivosidenib |
| 5 |
L01XX66
|
selinexor |
| 5 |
L01XX67
|
tagraxofusp |
| 5 |
L01XX69
|
lurbinectedin |
| 5 |
L01XX70
|
axicabtagene ciloleucel |
| 5 |
L01XX71
|
tisagenlecleucel |
| 4 |
L01XY
|
Combinations of antineoplastic agents |
| 5 |
L01XY01
|
cytarabine and daunorubicin |
| 5 |
L01XY02
|
pertuzumab and trastuzumab |
| 2 |
L02
|
ENDOCRINE THERAPY |
| 3 |
L02A
|
HORMONES AND RELATED AGENTS |
| 4 |
L02AA
|
Estrogens |
| 5 |
L02AA01
|
diethylstilbestrol |
| 5 |
L02AA02
|
polyestradiol phosphate |
| 5 |
L02AA03
|
ethinylestradiol |
| 5 |
L02AA04
|
fosfestrol |
| 4 |
L02AB
|
Progestogens |
| 5 |
L02AB01
|
megestrol |
| 5 |
L02AB02
|
medroxyprogesterone |
| 5 |
L02AB03
|
gestonorone |
| 4 |
L02AE
|
Gonadotropin releasing hormone analogues |
| 5 |
L02AE01
|
buserelin |
| 5 |
L02AE02
|
leuprorelin |
| 5 |
L02AE03
|
goserelin |
| 5 |
L02AE04
|
triptorelin |
| 5 |
L02AE05
|
histrelin |
| 5 |
L02AE51
|
leuprorelin and bicalutamide |
| 4 |
L02AX
|
Other hormones |
| 3 |
L02B
|
HORMONE ANTAGONISTS AND RELATED AGENTS |
| 4 |
L02BA
|
Anti-estrogens |
| 5 |
L02BA01
|
tamoxifen |
| 5 |
L02BA02
|
toremifene |
| 5 |
L02BA03
|
fulvestrant |
| 4 |
L02BB
|
Anti-androgens |
| 5 |
L02BB01
|
flutamide |
| 5 |
L02BB02
|
nilutamide |
| 5 |
L02BB03
|
bicalutamide |
| 5 |
L02BB04
|
enzalutamide |
| 5 |
L02BB05
|
apalutamide |
| 5 |
L02BB06
|
darolutamide |
| 4 |
L02BG
|
Aromatase inhibitors |
| 5 |
L02BG01
|
aminoglutethimide |
| 5 |
L02BG02
|
formestane |
| 5 |
L02BG03
|
anastrozole |
| 5 |
L02BG04
|
letrozole |
| 5 |
L02BG05
|
vorozole |
| 5 |
L02BG06
|
exemestane |
| 4 |
L02BX
|
Other hormone antagonists and related agents |
| 5 |
L02BX01
|
abarelix |
| 5 |
L02BX02
|
degarelix |
| 5 |
L02BX03
|
abiraterone |
| 2 |
L03
|
IMMUNOSTIMULANTS |
| 3 |
L03A
|
IMMUNOSTIMULANTS |
| 4 |
L03AA
|
Colony stimulating factors |
| 5 |
L03AA02
|
filgrastim |
| 5 |
L03AA03
|
molgramostim |
| 5 |
L03AA09
|
sargramostim |
| 5 |
L03AA10
|
lenograstim |
| 5 |
L03AA12
|
ancestim |
| 5 |
L03AA13
|
pegfilgrastim |
| 5 |
L03AA14
|
lipegfilgrastim |
| 5 |
L03AA15
|
balugrastim |
| 5 |
L03AA16
|
empegfilgrastim |
| 5 |
L03AA17
|
pegteograstim |
| 4 |
L03AB
|
Interferons |
| 5 |
L03AB01
|
interferon alfa natural |
| 5 |
L03AB02
|
interferon beta natural |
| 5 |
L03AB03
|
interferon gamma |
| 5 |
L03AB04
|
interferon alfa-2a |
| 5 |
L03AB05
|
interferon alfa-2b |
| 5 |
L03AB06
|
interferon alfa-n1 |
| 5 |
L03AB07
|
interferon beta-1a |
| 5 |
L03AB08
|
interferon beta-1b |
| 5 |
L03AB09
|
interferon alfacon-1 |
| 5 |
L03AB10
|
peginterferon alfa-2b |
| 5 |
L03AB11
|
peginterferon alfa-2a |
| 5 |
L03AB12
|
albinterferon alfa-2b |
| 5 |
L03AB13
|
peginterferon beta-1a |
| 5 |
L03AB14
|
cepeginterferon alfa-2b |
| 5 |
L03AB15
|
ropeginterferon alfa-2b |
| 5 |
L03AB60
|
peginterferon alfa-2b, combinations |
| 5 |
L03AB61
|
peginterferon alfa-2a, combinations |
| 4 |
L03AC
|
Interleukins |
| 5 |
L03AC01
|
aldesleukin |
| 5 |
L03AC02
|
oprelvekin |
| 4 |
L03AX
|
Other immunostimulants |
| 5 |
L03AX01
|
lentinan |
| 5 |
L03AX02
|
roquinimex |
| 5 |
L03AX03
|
BCG vaccine |
| 5 |
L03AX04
|
pegademase |
| 5 |
L03AX05
|
pidotimod |
| 5 |
L03AX07
|
poly I:C |
| 5 |
L03AX08
|
poly ICLC |
| 5 |
L03AX09
|
thymopentin |
| 5 |
L03AX10
|
immunocyanin |
| 5 |
L03AX11
|
tasonermin |
| 5 |
L03AX12
|
melanoma vaccine |
| 5 |
L03AX13
|
glatiramer acetate |
| 5 |
L03AX14
|
histamine dihydrochloride |
| 5 |
L03AX15
|
mifamurtide |
| 5 |
L03AX16
|
plerixafor |
| 5 |
L03AX17
|
sipuleucel-T |
| 5 |
L03AX18
|
cridanimod |
| 5 |
L03AX19
|
dasiprotimut-T |
| 5 |
L03AX21
|
elapegademase |
| 2 |
L04
|
IMMUNOSUPPRESSANTS |
| 3 |
L04A
|
IMMUNOSUPPRESSANTS |
| 4 |
L04AA
|
Selective immunosuppressants |
| 5 |
L04AA02
|
muromonab-CD3 |
| 5 |
L04AA03
|
antilymphocyte immunoglobulin (horse) |
| 5 |
L04AA04
|
antithymocyte immunoglobulin (rabbit) |
| 5 |
L04AA06
|
mycophenolic acid |
| 5 |
L04AA10
|
sirolimus |
| 5 |
L04AA13
|
leflunomide |
| 5 |
L04AA15
|
alefacept |
| 5 |
L04AA18
|
everolimus |
| 5 |
L04AA19
|
gusperimus |
| 5 |
L04AA21
|
efalizumab |
| 5 |
L04AA22
|
abetimus |
| 5 |
L04AA23
|
natalizumab |
| 5 |
L04AA24
|
abatacept |
| 5 |
L04AA25
|
eculizumab |
| 5 |
L04AA26
|
belimumab |
| 5 |
L04AA27
|
fingolimod |
| 5 |
L04AA28
|
belatacept |
| 5 |
L04AA29
|
tofacitinib |
| 5 |
L04AA31
|
teriflunomide |
| 5 |
L04AA32
|
apremilast |
| 5 |
L04AA33
|
vedolizumab |
| 5 |
L04AA34
|
alemtuzumab |
| 5 |
L04AA35
|
begelomab |
| 5 |
L04AA36
|
ocrelizumab |
| 5 |
L04AA37
|
baricitinib |
| 5 |
L04AA38
|
ozanimod |
| 5 |
L04AA39
|
emapalumab |
| 5 |
L04AA40
|
cladribine |
| 5 |
L04AA41
|
imlifidase |
| 5 |
L04AA42
|
siponimod |
| 5 |
L04AA43
|
ravulizumab |
| 5 |
L04AA44
|
upadacitinib |
| 5 |
L04AA45
|
filgotinib |
| 5 |
L04AA46
|
itacitinib |
| 5 |
L04AA47
|
inebilizumab |
| 4 |
L04AB
|
Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| 5 |
L04AB01
|
etanercept |
| 5 |
L04AB02
|
infliximab |
| 5 |
L04AB03
|
afelimomab |
| 5 |
L04AB04
|
adalimumab |
| 5 |
L04AB05
|
certolizumab pegol |
| 5 |
L04AB06
|
golimumab |
| 5 |
L04AB07
|
opinercept |
| 4 |
L04AC
|
Interleukin inhibitors |
| 5 |
L04AC01
|
daclizumab |
| 5 |
L04AC02
|
basiliximab |
| 5 |
L04AC03
|
anakinra |
| 5 |
L04AC04
|
rilonacept |
| 5 |
L04AC05
|
ustekinumab |
| 5 |
L04AC07
|
tocilizumab |
| 5 |
L04AC08
|
canakinumab |
| 5 |
L04AC09
|
briakinumab |
| 5 |
L04AC10
|
secukinumab |
| 5 |
L04AC11
|
siltuximab |
| 5 |
L04AC12
|
brodalumab |
| 5 |
L04AC13
|
ixekizumab |
| 5 |
L04AC14
|
sarilumab |
| 5 |
L04AC15
|
sirukumab |
| 5 |
L04AC16
|
guselkumab |
| 5 |
L04AC17
|
tildrakizumab |
| 5 |
L04AC18
|
risankizumab |
| 5 |
L04AC19
|
satralizumab |
| 4 |
L04AD
|
Calcineurin inhibitors |
| 5 |
L04AD01
|
ciclosporin |
| 5 |
L04AD02
|
tacrolimus |
| 5 |
L04AD03
|
voclosporin |
| 4 |
L04AX
|
Other immunosuppressants |
| 5 |
L04AX01
|
azathioprine |
| 5 |
L04AX02
|
thalidomide |
| 5 |
L04AX03
|
methotrexate |
| 5 |
L04AX04
|
lenalidomide |
| 5 |
L04AX05
|
pirfenidone |
| 5 |
L04AX06
|
pomalidomide |
| 5 |
L04AX07
|
dimethyl fumarate |
| 5 |
L04AX08
|
darvadstrocel |
| 1 |
M
|
MUSCULO-SKELETAL SYSTEM |
| 2 |
M01
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS |
| 3 |
M01A
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS |
| 4 |
M01AA
|
Butylpyrazolidines |
| 5 |
M01AA01
|
phenylbutazone |
| 5 |
M01AA02
|
mofebutazone |
| 5 |
M01AA03
|
oxyphenbutazone |
| 5 |
M01AA05
|
clofezone |
| 5 |
M01AA06
|
kebuzone |
| 4 |
M01AB
|
Acetic acid derivatives and related substances |
| 5 |
M01AB01
|
indometacin |
| 5 |
M01AB02
|
sulindac |
| 5 |
M01AB03
|
tolmetin |
| 5 |
M01AB04
|
zomepirac |
| 5 |
M01AB05
|
diclofenac |
| 5 |
M01AB06
|
alclofenac |
| 5 |
M01AB07
|
bumadizone |
| 5 |
M01AB08
|
etodolac |
| 5 |
M01AB09
|
lonazolac |
| 5 |
M01AB10
|
fentiazac |
| 5 |
M01AB11
|
acemetacin |
| 5 |
M01AB12
|
difenpiramide |
| 5 |
M01AB13
|
oxametacin |
| 5 |
M01AB14
|
proglumetacin |
| 5 |
M01AB15
|
ketorolac |
| 5 |
M01AB16
|
aceclofenac |
| 5 |
M01AB17
|
bufexamac |
| 5 |
M01AB51
|
indometacin, combinations |
| 5 |
M01AB55
|
diclofenac, combinations |
| 4 |
M01AC
|
Oxicams |
| 5 |
M01AC01
|
piroxicam |
| 5 |
M01AC02
|
tenoxicam |
| 5 |
M01AC04
|
droxicam |
| 5 |
M01AC05
|
lornoxicam |
| 5 |
M01AC06
|
meloxicam |
| 5 |
M01AC56
|
meloxicam, combinations |
| 4 |
M01AE
|
Propionic acid derivatives |
| 5 |
M01AE01
|
ibuprofen |
| 5 |
M01AE02
|
naproxen |
| 5 |
M01AE03
|
ketoprofen |
| 5 |
M01AE04
|
fenoprofen |
| 5 |
M01AE05
|
fenbufen |
| 5 |
M01AE06
|
benoxaprofen |
| 5 |
M01AE07
|
suprofen |
| 5 |
M01AE08
|
pirprofen |
| 5 |
M01AE09
|
flurbiprofen |
| 5 |
M01AE10
|
indoprofen |
| 5 |
M01AE11
|
tiaprofenic acid |
| 5 |
M01AE12
|
oxaprozin |
| 5 |
M01AE13
|
ibuproxam |
| 5 |
M01AE14
|
dexibuprofen |
| 5 |
M01AE15
|
flunoxaprofen |
| 5 |
M01AE16
|
alminoprofen |
| 5 |
M01AE17
|
dexketoprofen |
| 5 |
M01AE18
|
naproxcinod |
| 5 |
M01AE51
|
ibuprofen, combinations |
| 5 |
M01AE52
|
naproxen and esomeprazole |
| 5 |
M01AE53
|
ketoprofen, combinations |
| 5 |
M01AE56
|
naproxen and misoprostol |
| 4 |
M01AG
|
Fenamates |
| 5 |
M01AG01
|
mefenamic acid |
| 5 |
M01AG02
|
tolfenamic acid |
| 5 |
M01AG03
|
flufenamic acid |
| 5 |
M01AG04
|
meclofenamic acid |
| 4 |
M01AH
|
Coxibs |
| 5 |
M01AH01
|
celecoxib |
| 5 |
M01AH02
|
rofecoxib |
| 5 |
M01AH03
|
valdecoxib |
| 5 |
M01AH04
|
parecoxib |
| 5 |
M01AH05
|
etoricoxib |
| 5 |
M01AH06
|
lumiracoxib |
| 5 |
M01AH07
|
polmacoxib |
| 4 |
M01AX
|
Other antiinflammatory and antirheumatic agents, non-steroids |
| 5 |
M01AX01
|
nabumetone |
| 5 |
M01AX02
|
niflumic acid |
| 5 |
M01AX04
|
azapropazone |
| 5 |
M01AX05
|
glucosamine |
| 5 |
M01AX07
|
benzydamine |
| 5 |
M01AX12
|
glucosaminoglycan polysulfate |
| 5 |
M01AX13
|
proquazone |
| 5 |
M01AX14
|
orgotein |
| 5 |
M01AX17
|
nimesulide |
| 5 |
M01AX18
|
feprazone |
| 5 |
M01AX21
|
diacerein |
| 5 |
M01AX22
|
morniflumate |
| 5 |
M01AX23
|
tenidap |
| 5 |
M01AX24
|
oxaceprol |
| 5 |
M01AX25
|
chondroitin sulfate |
| 5 |
M01AX26
|
avocado and soyabean oil, unsaponifiables |
| 5 |
M01AX68
|
feprazone, combinations |
| 3 |
M01B
|
ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION |
| 4 |
M01BA
|
Antiinflammatory/antirheumatic agents in combination with corticosteroids |
| 5 |
M01BA01
|
phenylbutazone and corticosteroids |
| 5 |
M01BA02
|
dipyrocetyl and corticosteroids |
| 5 |
M01BA03
|
acetylsalicylic acid and corticosteroids |
| 4 |
M01BX
|
Other antiinflammatory/antirheumatic agents in combination with other drugs |
| 3 |
M01C
|
SPECIFIC ANTIRHEUMATIC AGENTS |
| 4 |
M01CA
|
Quinolines |
| 5 |
M01CA03
|
oxycinchophen |
| 4 |
M01CB
|
Gold preparations |
| 5 |
M01CB01
|
sodium aurothiomalate |
| 5 |
M01CB02
|
sodium aurotiosulfate |
| 5 |
M01CB03
|
auranofin |
| 5 |
M01CB04
|
aurothioglucose |
| 5 |
M01CB05
|
aurotioprol |
| 4 |
M01CC
|
Penicillamine and similar agents |
| 5 |
M01CC01
|
penicillamine |
| 5 |
M01CC02
|
bucillamine |
| 4 |
M01CX
|
Other specific antirheumatic agents |
| 2 |
M02
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| 3 |
M02A
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| 4 |
M02AA
|
Antiinflammatory preparations, non-steroids for topical use |
| 5 |
M02AA01
|
phenylbutazone |
| 5 |
M02AA02
|
mofebutazone |
| 5 |
M02AA03
|
clofezone |
| 5 |
M02AA04
|
oxyphenbutazone |
| 5 |
M02AA05
|
benzydamine |
| 5 |
M02AA06
|
etofenamate |
| 5 |
M02AA07
|
piroxicam |
| 5 |
M02AA08
|
felbinac |
| 5 |
M02AA09
|
bufexamac |
| 5 |
M02AA10
|
ketoprofen |
| 5 |
M02AA11
|
bendazac |
| 5 |
M02AA12
|
naproxen |
| 5 |
M02AA13
|
ibuprofen |
| 5 |
M02AA14
|
fentiazac |
| 5 |
M02AA15
|
diclofenac |
| 5 |
M02AA16
|
feprazone |
| 5 |
M02AA17
|
niflumic acid |
| 5 |
M02AA18
|
meclofenamic acid |
| 5 |
M02AA19
|
flurbiprofen |
| 5 |
M02AA21
|
tolmetin |
| 5 |
M02AA22
|
suxibuzone |
| 5 |
M02AA23
|
indometacin |
| 5 |
M02AA24
|
nifenazone |
| 5 |
M02AA25
|
aceclofenac |
| 5 |
M02AA26
|
nimesulide |
| 5 |
M02AA27
|
dexketoprofen |
| 5 |
M02AA28
|
piketoprofen |
| 5 |
M02AA29
|
esflurbiprofen |
| 4 |
M02AB
|
Capsaicin and similar agents |
| 5 |
M02AB01
|
capsaicin |
| 5 |
M02AB02
|
zucapsaicin |
| 4 |
M02AC
|
Preparations with salicylic acid derivatives |
| 4 |
M02AX
|
Other topical products for joint and muscular pain |
| 5 |
M02AX02
|
tolazoline |
| 5 |
M02AX03
|
dimethyl sulfoxide |
| 5 |
M02AX05
|
idrocilamide |
| 5 |
M02AX06
|
tolperisone |
| 5 |
M02AX10
|
various |
| 2 |
M03
|
MUSCLE RELAXANTS |
| 3 |
M03A
|
MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| 4 |
M03AA
|
Curare alkaloids |
| 5 |
M03AA01
|
alcuronium |
| 5 |
M03AA02
|
tubocurarine |
| 5 |
M03AA04
|
dimethyltubocurarine |
| 4 |
M03AB
|
Choline derivatives |
| 5 |
M03AB01
|
suxamethonium |
| 4 |
M03AC
|
Other quaternary ammonium compounds |
| 5 |
M03AC01
|
pancuronium |
| 5 |
M03AC02
|
gallamine |
| 5 |
M03AC03
|
vecuronium |
| 5 |
M03AC04
|
atracurium |
| 5 |
M03AC05
|
hexafluronium |
| 5 |
M03AC06
|
pipecuronium bromide |
| 5 |
M03AC07
|
doxacurium chloride |
| 5 |
M03AC08
|
fazadinium bromide |
| 5 |
M03AC09
|
rocuronium bromide |
| 5 |
M03AC10
|
mivacurium chloride |
| 5 |
M03AC11
|
cisatracurium |
| 4 |
M03AX
|
Other muscle relaxants, peripherally acting agents |
| 5 |
M03AX01
|
botulinum toxin |
| 3 |
M03B
|
MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| 4 |
M03BA
|
Carbamic acid esters |
| 5 |
M03BA01
|
phenprobamate |
| 5 |
M03BA02
|
carisoprodol |
| 5 |
M03BA03
|
methocarbamol |
| 5 |
M03BA04
|
styramate |
| 5 |
M03BA05
|
febarbamate |
| 5 |
M03BA51
|
phenprobamate, combinations excl. psycholeptics |
| 5 |
M03BA52
|
carisoprodol, combinations excl. psycholeptics |
| 5 |
M03BA53
|
methocarbamol, combinations excl. psycholeptics |
| 5 |
M03BA71
|
phenprobamate, combinations with psycholeptics |
| 5 |
M03BA72
|
carisoprodol, combinations with psycholeptics |
| 5 |
M03BA73
|
methocarbamol, combinations with psycholeptics |
| 4 |
M03BB
|
Oxazol, thiazine, and triazine derivatives |
| 5 |
M03BB02
|
chlormezanone |
| 5 |
M03BB03
|
chlorzoxazone |
| 5 |
M03BB52
|
chlormezanone, combinations excl. psycholeptics |
| 5 |
M03BB53
|
chlorzoxazone, combinations excl. psycholeptics |
| 5 |
M03BB72
|
chlormezanone, combinations with psycholeptics |
| 5 |
M03BB73
|
chlorzoxazone, combinations with psycholeptics |
| 4 |
M03BC
|
Ethers, chemically close to antihistamines |
| 5 |
M03BC01
|
orphenadrine (citrate) |
| 5 |
M03BC51
|
orphenadrine, combinations |
| 4 |
M03BX
|
Other centrally acting agents |
| 5 |
M03BX01
|
baclofen |
| 5 |
M03BX02
|
tizanidine |
| 5 |
M03BX03
|
pridinol |
| 5 |
M03BX04
|
tolperisone |
| 5 |
M03BX05
|
thiocolchicoside |
| 5 |
M03BX06
|
mephenesin |
| 5 |
M03BX07
|
tetrazepam |
| 5 |
M03BX08
|
cyclobenzaprine |
| 5 |
M03BX09
|
eperisone |
| 5 |
M03BX30
|
fenyramidol |
| 5 |
M03BX55
|
thiocolchicoside, combinations |
| 3 |
M03C
|
MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| 4 |
M03CA
|
Dantrolene and derivatives |
| 5 |
M03CA01
|
dantrolene |
| 2 |
M04
|
ANTIGOUT PREPARATIONS |
| 3 |
M04A
|
ANTIGOUT PREPARATIONS |
| 4 |
M04AA
|
Preparations inhibiting uric acid production |
| 5 |
M04AA01
|
allopurinol |
| 5 |
M04AA02
|
tisopurine |
| 5 |
M04AA03
|
febuxostat |
| 5 |
M04AA51
|
allopurinol, combinations |
| 4 |
M04AB
|
Preparations increasing uric acid excretion |
| 5 |
M04AB01
|
probenecid |
| 5 |
M04AB02
|
sulfinpyrazone |
| 5 |
M04AB03
|
benzbromarone |
| 5 |
M04AB04
|
isobromindione |
| 5 |
M04AB05
|
lesinurad |
| 4 |
M04AC
|
Preparations with no effect on uric acid metabolism |
| 5 |
M04AC01
|
colchicine |
| 5 |
M04AC02
|
cinchophen |
| 4 |
M04AX
|
Other antigout preparations |
| 5 |
M04AX01
|
urate oxidase |
| 5 |
M04AX02
|
pegloticase |
| 2 |
M05
|
DRUGS FOR TREATMENT OF BONE DISEASES |
| 3 |
M05B
|
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| 4 |
M05BA
|
Bisphosphonates |
| 5 |
M05BA01
|
etidronic acid |
| 5 |
M05BA02
|
clodronic acid |
| 5 |
M05BA03
|
pamidronic acid |
| 5 |
M05BA04
|
alendronic acid |
| 5 |
M05BA05
|
tiludronic acid |
| 5 |
M05BA06
|
ibandronic acid |
| 5 |
M05BA07
|
risedronic acid |
| 5 |
M05BA08
|
zoledronic acid |
| 4 |
M05BB
|
Bisphosphonates, combinations |
| 5 |
M05BB01
|
etidronic acid and calcium, sequential |
| 5 |
M05BB02
|
risedronic acid and calcium, sequential |
| 5 |
M05BB03
|
alendronic acid and colecalciferol |
| 5 |
M05BB04
|
risedronic acid, calcium and colecalciferol, sequential |
| 5 |
M05BB05
|
alendronic acid, calcium and colecalciferol, sequential |
| 5 |
M05BB06
|
alendronic acid and alfacalcidol, sequential |
| 5 |
M05BB07
|
risedronic acid and colecalciferol |
| 5 |
M05BB08
|
zoledronic acid, calcium and colecalciferol, sequential |
| 5 |
M05BB09
|
ibandronic acid and colecalciferol |
| 4 |
M05BC
|
Bone morphogenetic proteins |
| 5 |
M05BC01
|
dibotermin alfa |
| 5 |
M05BC02
|
eptotermin alfa |
| 4 |
M05BX
|
Other drugs affecting bone structure and mineralization |
| 5 |
M05BX01
|
ipriflavone |
| 5 |
M05BX02
|
aluminium chlorohydrate |
| 5 |
M05BX03
|
strontium ranelate |
| 5 |
M05BX04
|
denosumab |
| 5 |
M05BX05
|
burosumab |
| 5 |
M05BX06
|
romosozumab |
| 5 |
M05BX53
|
strontium ranelate and colecalciferol |
| 2 |
M09
|
OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| 3 |
M09A
|
OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| 4 |
M09AA
|
Quinine and derivatives |
| 5 |
M09AA01
|
hydroquinine |
| 5 |
M09AA72
|
quinine, combinations with psycholeptics |
| 4 |
M09AB
|
Enzymes |
| 5 |
M09AB01
|
chymopapain |
| 5 |
M09AB02
|
collagenase clostridium histolyticum |
| 5 |
M09AB03
|
bromelains |
| 5 |
M09AB52
|
trypsin, combinations |
| 4 |
M09AX
|
Other drugs for disorders of the musculo-skeletal system |
| 5 |
M09AX01
|
hyaluronic acid |
| 5 |
M09AX02
|
chondrocytes, autologous |
| 5 |
M09AX03
|
ataluren |
| 5 |
M09AX04
|
drisapersen |
| 5 |
M09AX05
|
aceneuramic acid |
| 5 |
M09AX06
|
eteplirsen |
| 5 |
M09AX07
|
nusinersen |
| 5 |
M09AX08
|
golodirsen |
| 5 |
M09AX09
|
onasemnogene abeparvovec |
| 5 |
M09AX10
|
risdiplam |
| 5 |
M09AX11
|
palovarotene |
| 1 |
N
|
NERVOUS SYSTEM |
| 2 |
N01
|
ANESTHETICS |
| 3 |
N01A
|
ANESTHETICS, GENERAL |
| 4 |
N01AA
|
Ethers |
| 5 |
N01AA01
|
diethyl ether |
| 5 |
N01AA02
|
vinyl ether |
| 4 |
N01AB
|
Halogenated hydrocarbons |
| 5 |
N01AB01
|
halothane |
| 5 |
N01AB02
|
chloroform |
| 5 |
N01AB04
|
enflurane |
| 5 |
N01AB05
|
trichloroethylene |
| 5 |
N01AB06
|
isoflurane |
| 5 |
N01AB07
|
desflurane |
| 5 |
N01AB08
|
sevoflurane |
| 4 |
N01AF
|
Barbiturates, plain |
| 5 |
N01AF01
|
methohexital |
| 5 |
N01AF02
|
hexobarbital |
| 5 |
N01AF03
|
thiopental |
| 4 |
N01AG
|
Barbiturates in combination with other drugs |
| 5 |
N01AG01
|
narcobarbital |
| 4 |
N01AH
|
Opioid anesthetics |
| 5 |
N01AH01
|
fentanyl |
| 5 |
N01AH02
|
alfentanil |
| 5 |
N01AH03
|
sufentanil |
| 5 |
N01AH04
|
phenoperidine |
| 5 |
N01AH05
|
anileridine |
| 5 |
N01AH06
|
remifentanil |
| 5 |
N01AH51
|
fentanyl, combinations |
| 4 |
N01AX
|
Other general anesthetics |
| 5 |
N01AX03
|
ketamine |
| 5 |
N01AX04
|
propanidid |
| 5 |
N01AX05
|
alfaxalone |
| 5 |
N01AX07
|
etomidate |
| 5 |
N01AX10
|
propofol |
| 5 |
N01AX11
|
sodium oxybate |
| 5 |
N01AX13
|
nitrous oxide |
| 5 |
N01AX14
|
esketamine |
| 5 |
N01AX15
|
xenon |
| 5 |
N01AX63
|
nitrous oxide, combinations |
| 3 |
N01B
|
ANESTHETICS, LOCAL |
| 4 |
N01BA
|
Esters of aminobenzoic acid |
| 5 |
N01BA01
|
metabutethamine |
| 5 |
N01BA02
|
procaine |
| 5 |
N01BA03
|
tetracaine |
| 5 |
N01BA04
|
chloroprocaine |
| 5 |
N01BA05
|
benzocaine |
| 5 |
N01BA52
|
procaine, combinations |
| 5 |
N01BA53
|
tetracaine, combinations |
| 4 |
N01BB
|
Amides |
| 5 |
N01BB01
|
bupivacaine |
| 5 |
N01BB02
|
lidocaine |
| 5 |
N01BB03
|
mepivacaine |
| 5 |
N01BB04
|
prilocaine |
| 5 |
N01BB05
|
butanilicaine |
| 5 |
N01BB06
|
cinchocaine |
| 5 |
N01BB07
|
etidocaine |
| 5 |
N01BB08
|
articaine |
| 5 |
N01BB09
|
ropivacaine |
| 5 |
N01BB10
|
levobupivacaine |
| 5 |
N01BB20
|
combinations |
| 5 |
N01BB51
|
bupivacaine, combinations |
| 5 |
N01BB52
|
lidocaine, combinations |
| 5 |
N01BB53
|
mepivacaine, combinations |
| 5 |
N01BB54
|
prilocaine, combinations |
| 5 |
N01BB57
|
etidocaine, combinations |
| 5 |
N01BB58
|
articaine, combinations |
| 5 |
N01BB59
|
bupivacaine and meloxicam |
| 4 |
N01BC
|
Esters of benzoic acid |
| 5 |
N01BC01
|
cocaine |
| 4 |
N01BX
|
Other local anesthetics |
| 5 |
N01BX01
|
ethyl chloride |
| 5 |
N01BX02
|
dyclonine |
| 5 |
N01BX03
|
phenol |
| 5 |
N01BX04
|
capsaicin |
| 2 |
N02
|
ANALGESICS |
| 3 |
N02A
|
OPIOIDS |
| 4 |
N02AA
|
Natural opium alkaloids |
| 5 |
N02AA01
|
morphine |
| 5 |
N02AA02
|
opium |
| 5 |
N02AA03
|
hydromorphone |
| 5 |
N02AA04
|
nicomorphine |
| 5 |
N02AA05
|
oxycodone |
| 5 |
N02AA08
|
dihydrocodeine |
| 5 |
N02AA10
|
papaveretum |
| 5 |
N02AA11
|
oxymorphone |
| 5 |
N02AA51
|
morphine, combinations |
| 5 |
N02AA53
|
hydromorphone and naloxone |
| 5 |
N02AA55
|
oxycodone and naloxone |
| 5 |
N02AA56
|
oxycodone and naltrexone |
| 5 |
N02AA58
|
dihydrocodeine, combinations |
| 5 |
N02AA59
|
codeine, combinations excl. psycholeptics |
| 5 |
N02AA79
|
codeine, combinations with psycholeptics |
| 4 |
N02AB
|
Phenylpiperidine derivatives |
| 5 |
N02AB01
|
ketobemidone |
| 5 |
N02AB02
|
pethidine |
| 5 |
N02AB03
|
fentanyl |
| 5 |
N02AB52
|
pethidine, combinations excl. psycholeptics |
| 5 |
N02AB72
|
pethidine, combinations with psycholeptics |
| 4 |
N02AC
|
Diphenylpropylamine derivatives |
| 5 |
N02AC01
|
dextromoramide |
| 5 |
N02AC03
|
piritramide |
| 5 |
N02AC04
|
dextropropoxyphene |
| 5 |
N02AC05
|
bezitramide |
| 5 |
N02AC52
|
methadone, combinations excl. psycholeptics |
| 5 |
N02AC54
|
dextropropoxyphene, combinations excl. psycholeptics |
| 5 |
N02AC74
|
dextropropoxyphene, combinations with psycholeptics |
| 4 |
N02AD
|
Benzomorphan derivatives |
| 5 |
N02AD01
|
pentazocine |
| 5 |
N02AD02
|
phenazocine |
| 4 |
N02AE
|
Oripavine derivatives |
| 5 |
N02AE01
|
buprenorphine |
| 4 |
N02AF
|
Morphinan derivatives |
| 5 |
N02AF01
|
butorphanol |
| 5 |
N02AF02
|
nalbuphine |
| 4 |
N02AG
|
Opioids in combination with antispasmodics |
| 5 |
N02AG01
|
morphine and antispasmodics |
| 5 |
N02AG02
|
ketobemidone and antispasmodics |
| 5 |
N02AG03
|
pethidine and antispasmodics |
| 5 |
N02AG04
|
hydromorphone and antispasmodics |
| 4 |
N02AJ
|
Opioids in combination with non-opioid analgesics |
| 5 |
N02AJ01
|
dihydrocodeine and paracetamol |
| 5 |
N02AJ02
|
dihydrocodeine and acetylsalicylic acid |
| 5 |
N02AJ03
|
dihydrocodeine and other non-opioid analgesics |
| 5 |
N02AJ06
|
codeine and paracetamol |
| 5 |
N02AJ07
|
codeine and acetylsalicylic acid |
| 5 |
N02AJ08
|
codeine and ibuprofen |
| 5 |
N02AJ09
|
codeine and other non-opioid analgesics |
| 5 |
N02AJ13
|
tramadol and paracetamol |
| 5 |
N02AJ14
|
tramadol and dexketoprofen |
| 5 |
N02AJ15
|
tramadol and other non-opioid analgesics |
| 5 |
N02AJ17
|
oxycodone and paracetamol |
| 5 |
N02AJ18
|
oxycodone and acetylsalicylic acid |
| 5 |
N02AJ19
|
oxycodone and ibuprofen |
| 4 |
N02AX
|
Other opioids |
| 5 |
N02AX01
|
tilidine |
| 5 |
N02AX02
|
tramadol |
| 5 |
N02AX03
|
dezocine |
| 5 |
N02AX05
|
meptazinol |
| 5 |
N02AX06
|
tapentadol |
| 3 |
N02B
|
OTHER ANALGESICS AND ANTIPYRETICS |
| 4 |
N02BA
|
Salicylic acid and derivatives |
| 5 |
N02BA01
|
acetylsalicylic acid |
| 5 |
N02BA02
|
aloxiprin |
| 5 |
N02BA03
|
choline salicylate |
| 5 |
N02BA04
|
sodium salicylate |
| 5 |
N02BA05
|
salicylamide |
| 5 |
N02BA06
|
salsalate |
| 5 |
N02BA07
|
ethenzamide |
| 5 |
N02BA08
|
morpholine salicylate |
| 5 |
N02BA09
|
dipyrocetyl |
| 5 |
N02BA10
|
benorilate |
| 5 |
N02BA11
|
diflunisal |
| 5 |
N02BA12
|
potassium salicylate |
| 5 |
N02BA14
|
guacetisal |
| 5 |
N02BA15
|
carbasalate calcium |
| 5 |
N02BA16
|
imidazole salicylate |
| 5 |
N02BA51
|
acetylsalicylic acid, combinations excl. psycholeptics |
| 5 |
N02BA55
|
salicylamide, combinations excl. psycholeptics |
| 5 |
N02BA57
|
ethenzamide, combinations excl. psycholeptics |
| 5 |
N02BA59
|
dipyrocetyl, combinations excl. psycholeptics |
| 5 |
N02BA65
|
carbasalate calcium combinations excl. psycholeptics |
| 5 |
N02BA71
|
acetylsalicylic acid, combinations with psycholeptics |
| 5 |
N02BA75
|
salicylamide, combinations with psycholeptics |
| 5 |
N02BA77
|
ethenzamide, combinations with psycholeptics |
| 5 |
N02BA79
|
dipyrocetyl, combinations with psycholeptics |
| 4 |
N02BB
|
Pyrazolones |
| 5 |
N02BB01
|
phenazone |
| 5 |
N02BB02
|
metamizole sodium |
| 5 |
N02BB03
|
aminophenazone |
| 5 |
N02BB04
|
propyphenazone |
| 5 |
N02BB05
|
nifenazone |
| 5 |
N02BB51
|
phenazone, combinations excl. psycholeptics |
| 5 |
N02BB52
|
metamizole sodium, combinations excl. psycholeptics |
| 5 |
N02BB53
|
aminophenazone, combinations excl. psycholeptics |
| 5 |
N02BB54
|
propyphenazone, combinations excl. psycholeptics |
| 5 |
N02BB71
|
phenazone, combinations with psycholeptics |
| 5 |
N02BB72
|
metamizole sodium, combinations with psycholeptics |
| 5 |
N02BB73
|
aminophenazone, combinations with psycholeptics |
| 5 |
N02BB74
|
propyphenazone, combinations with psycholeptics |
| 4 |
N02BE
|
Anilides |
| 5 |
N02BE01
|
paracetamol |
| 5 |
N02BE03
|
phenacetin |
| 5 |
N02BE04
|
bucetin |
| 5 |
N02BE05
|
propacetamol |
| 5 |
N02BE51
|
paracetamol, combinations excl. psycholeptics |
| 5 |
N02BE53
|
phenacetin, combinations excl. psycholeptics |
| 5 |
N02BE54
|
bucetin, combinations excl. psycholeptics |
| 5 |
N02BE71
|
paracetamol, combinations with psycholeptics |
| 5 |
N02BE73
|
phenacetin, combinations with psycholeptics |
| 5 |
N02BE74
|
bucetin, combinations with psycholeptics |
| 4 |
N02BG
|
Other analgesics and antipyretics |
| 5 |
N02BG02
|
rimazolium |
| 5 |
N02BG03
|
glafenine |
| 5 |
N02BG04
|
floctafenine |
| 5 |
N02BG05
|
viminol |
| 5 |
N02BG06
|
nefopam |
| 5 |
N02BG07
|
flupirtine |
| 5 |
N02BG08
|
ziconotide |
| 5 |
N02BG09
|
methoxyflurane |
| 5 |
N02BG10
|
cannabinoids |
| 5 |
N02BG11
|
mirogabalin |
| 3 |
N02C
|
ANTIMIGRAINE PREPARATIONS |
| 4 |
N02CA
|
Ergot alkaloids |
| 5 |
N02CA01
|
dihydroergotamine |
| 5 |
N02CA02
|
ergotamine |
| 5 |
N02CA04
|
methysergide |
| 5 |
N02CA07
|
lisuride |
| 5 |
N02CA51
|
dihydroergotamine, combinations |
| 5 |
N02CA52
|
ergotamine, combinations excl. psycholeptics |
| 5 |
N02CA72
|
ergotamine, combinations with psycholeptics |
| 4 |
N02CB
|
Corticosteroid derivatives |
| 5 |
N02CB01
|
flumedroxone |
| 4 |
N02CC
|
Selective serotonin (5HT1) agonists |
| 5 |
N02CC01
|
sumatriptan |
| 5 |
N02CC02
|
naratriptan |
| 5 |
N02CC03
|
zolmitriptan |
| 5 |
N02CC04
|
rizatriptan |
| 5 |
N02CC05
|
almotriptan |
| 5 |
N02CC06
|
eletriptan |
| 5 |
N02CC07
|
frovatriptan |
| 4 |
N02CD
|
Calcitonin gene-related peptide (CGRP) antagonists |
| 5 |
N02CD01
|
erenumab |
| 5 |
N02CD02
|
galcanezumab |
| 5 |
N02CD03
|
fremanezumab |
| 4 |
N02CX
|
Other antimigraine preparations |
| 5 |
N02CX01
|
pizotifen |
| 5 |
N02CX02
|
clonidine |
| 5 |
N02CX03
|
iprazochrome |
| 5 |
N02CX05
|
dimetotiazine |
| 5 |
N02CX06
|
oxetorone |
| 2 |
N03
|
ANTIEPILEPTICS |
| 3 |
N03A
|
ANTIEPILEPTICS |
| 4 |
N03AA
|
Barbiturates and derivatives |
| 5 |
N03AA01
|
methylphenobarbital |
| 5 |
N03AA02
|
phenobarbital |
| 5 |
N03AA03
|
primidone |
| 5 |
N03AA04
|
barbexaclone |
| 5 |
N03AA30
|
metharbital |
| 4 |
N03AB
|
Hydantoin derivatives |
| 5 |
N03AB01
|
ethotoin |
| 5 |
N03AB02
|
phenytoin |
| 5 |
N03AB03
|
amino(diphenylhydantoin) valeric acid |
| 5 |
N03AB04
|
mephenytoin |
| 5 |
N03AB05
|
fosphenytoin |
| 5 |
N03AB52
|
phenytoin, combinations |
| 5 |
N03AB54
|
mephenytoin, combinations |
| 4 |
N03AC
|
Oxazolidine derivatives |
| 5 |
N03AC01
|
paramethadione |
| 5 |
N03AC02
|
trimethadione |
| 5 |
N03AC03
|
ethadione |
| 4 |
N03AD
|
Succinimide derivatives |
| 5 |
N03AD01
|
ethosuximide |
| 5 |
N03AD02
|
phensuximide |
| 5 |
N03AD03
|
mesuximide |
| 5 |
N03AD51
|
ethosuximide, combinations |
| 4 |
N03AE
|
Benzodiazepine derivatives |
| 5 |
N03AE01
|
clonazepam |
| 4 |
N03AF
|
Carboxamide derivatives |
| 5 |
N03AF01
|
carbamazepine |
| 5 |
N03AF02
|
oxcarbazepine |
| 5 |
N03AF03
|
rufinamide |
| 5 |
N03AF04
|
eslicarbazepine |
| 4 |
N03AG
|
Fatty acid derivatives |
| 5 |
N03AG01
|
valproic acid |
| 5 |
N03AG02
|
valpromide |
| 5 |
N03AG03
|
aminobutyric acid |
| 5 |
N03AG04
|
vigabatrin |
| 5 |
N03AG05
|
progabide |
| 5 |
N03AG06
|
tiagabine |
| 4 |
N03AX
|
Other antiepileptics |
| 5 |
N03AX03
|
sultiame |
| 5 |
N03AX07
|
phenacemide |
| 5 |
N03AX09
|
lamotrigine |
| 5 |
N03AX10
|
felbamate |
| 5 |
N03AX11
|
topiramate |
| 5 |
N03AX12
|
gabapentin |
| 5 |
N03AX13
|
pheneturide |
| 5 |
N03AX14
|
levetiracetam |
| 5 |
N03AX15
|
zonisamide |
| 5 |
N03AX16
|
pregabalin |
| 5 |
N03AX17
|
stiripentol |
| 5 |
N03AX18
|
lacosamide |
| 5 |
N03AX19
|
carisbamate |
| 5 |
N03AX21
|
retigabine |
| 5 |
N03AX22
|
perampanel |
| 5 |
N03AX23
|
brivaracetam |
| 5 |
N03AX24
|
cannabidiol |
| 5 |
N03AX25
|
cenobamate |
| 5 |
N03AX26
|
fenfluramine |
| 5 |
N03AX30
|
beclamide |
| 2 |
N04
|
ANTI-PARKINSON DRUGS |
| 3 |
N04A
|
ANTICHOLINERGIC AGENTS |
| 4 |
N04AA
|
Tertiary amines |
| 5 |
N04AA01
|
trihexyphenidyl |
| 5 |
N04AA02
|
biperiden |
| 5 |
N04AA03
|
metixene |
| 5 |
N04AA04
|
procyclidine |
| 5 |
N04AA05
|
profenamine |
| 5 |
N04AA08
|
dexetimide |
| 5 |
N04AA09
|
phenglutarimide |
| 5 |
N04AA10
|
mazaticol |
| 5 |
N04AA11
|
bornaprine |
| 5 |
N04AA12
|
tropatepine |
| 4 |
N04AB
|
Ethers chemically close to antihistamines |
| 5 |
N04AB01
|
etanautine |
| 5 |
N04AB02
|
orphenadrine (chloride) |
| 4 |
N04AC
|
Ethers of tropine or tropine derivatives |
| 5 |
N04AC01
|
benzatropine |
| 5 |
N04AC30
|
etybenzatropine |
| 3 |
N04B
|
DOPAMINERGIC AGENTS |
| 4 |
N04BA
|
Dopa and dopa derivatives |
| 5 |
N04BA01
|
levodopa |
| 5 |
N04BA02
|
levodopa and decarboxylase inhibitor |
| 5 |
N04BA03
|
levodopa, decarboxylase inhibitor and COMT inhibitor |
| 5 |
N04BA04
|
melevodopa |
| 5 |
N04BA05
|
melevodopa and decarboxylase inhibitor |
| 5 |
N04BA06
|
etilevodopa and decarboxylase inhibitor |
| 4 |
N04BB
|
Adamantane derivatives |
| 5 |
N04BB01
|
amantadine |
| 4 |
N04BC
|
Dopamine agonists |
| 5 |
N04BC01
|
bromocriptine |
| 5 |
N04BC02
|
pergolide |
| 5 |
N04BC03
|
dihydroergocryptine mesylate |
| 5 |
N04BC04
|
ropinirole |
| 5 |
N04BC05
|
pramipexole |
| 5 |
N04BC06
|
cabergoline |
| 5 |
N04BC07
|
apomorphine |
| 5 |
N04BC08
|
piribedil |
| 5 |
N04BC09
|
rotigotine |
| 4 |
N04BD
|
Monoamine oxidase B inhibitors |
| 5 |
N04BD01
|
selegiline |
| 5 |
N04BD02
|
rasagiline |
| 5 |
N04BD03
|
safinamide |
| 4 |
N04BX
|
Other dopaminergic agents |
| 5 |
N04BX01
|
tolcapone |
| 5 |
N04BX02
|
entacapone |
| 5 |
N04BX03
|
budipine |
| 5 |
N04BX04
|
opicapone |
| 3 |
N04C
|
OTHER ANTIPARKINSON DRUGS |
| 4 |
N04CX
|
Other antiparkinson drugs |
| 5 |
N04CX01
|
istradefyllin |
| 2 |
N05
|
PSYCHOLEPTICS |
| 3 |
N05A
|
ANTIPSYCHOTICS |
| 4 |
N05AA
|
Phenothiazines with aliphatic side-chain |
| 5 |
N05AA01
|
chlorpromazine |
| 5 |
N05AA02
|
levomepromazine |
| 5 |
N05AA03
|
promazine |
| 5 |
N05AA04
|
acepromazine |
| 5 |
N05AA05
|
triflupromazine |
| 5 |
N05AA06
|
cyamemazine |
| 5 |
N05AA07
|
chlorproethazine |
| 4 |
N05AB
|
Phenothiazines with piperazine structure |
| 5 |
N05AB01
|
dixyrazine |
| 5 |
N05AB02
|
fluphenazine |
| 5 |
N05AB03
|
perphenazine |
| 5 |
N05AB04
|
prochlorperazine |
| 5 |
N05AB05
|
thiopropazate |
| 5 |
N05AB06
|
trifluoperazine |
| 5 |
N05AB07
|
acetophenazine |
| 5 |
N05AB08
|
thioproperazine |
| 5 |
N05AB09
|
butaperazine |
| 5 |
N05AB10
|
perazine |
| 4 |
N05AC
|
Phenothiazines with piperidine structure |
| 5 |
N05AC01
|
periciazine |
| 5 |
N05AC02
|
thioridazine |
| 5 |
N05AC03
|
mesoridazine |
| 5 |
N05AC04
|
pipotiazine |
| 4 |
N05AD
|
Butyrophenone derivatives |
| 5 |
N05AD01
|
haloperidol |
| 5 |
N05AD02
|
trifluperidol |
| 5 |
N05AD03
|
melperone |
| 5 |
N05AD04
|
moperone |
| 5 |
N05AD05
|
pipamperone |
| 5 |
N05AD06
|
bromperidol |
| 5 |
N05AD07
|
benperidol |
| 5 |
N05AD08
|
droperidol |
| 5 |
N05AD09
|
fluanisone |
| 4 |
N05AE
|
Indole derivatives |
| 5 |
N05AE01
|
oxypertine |
| 5 |
N05AE02
|
molindone |
| 5 |
N05AE03
|
sertindole |
| 5 |
N05AE04
|
ziprasidone |
| 5 |
N05AE05
|
lurasidone |
| 4 |
N05AF
|
Thioxanthene derivatives |
| 5 |
N05AF01
|
flupentixol |
| 5 |
N05AF02
|
clopenthixol |
| 5 |
N05AF03
|
chlorprothixene |
| 5 |
N05AF04
|
tiotixene |
| 5 |
N05AF05
|
zuclopenthixol |
| 4 |
N05AG
|
Diphenylbutylpiperidine derivatives |
| 5 |
N05AG01
|
fluspirilene |
| 5 |
N05AG02
|
pimozide |
| 5 |
N05AG03
|
penfluridol |
| 4 |
N05AH
|
Diazepines, oxazepines, thiazepines and oxepines |
| 5 |
N05AH01
|
loxapine |
| 5 |
N05AH02
|
clozapine |
| 5 |
N05AH03
|
olanzapine |
| 5 |
N05AH04
|
quetiapine |
| 5 |
N05AH05
|
asenapine |
| 5 |
N05AH06
|
clotiapine |
| 4 |
N05AL
|
Benzamides |
| 5 |
N05AL01
|
sulpiride |
| 5 |
N05AL02
|
sultopride |
| 5 |
N05AL03
|
tiapride |
| 5 |
N05AL04
|
remoxipride |
| 5 |
N05AL05
|
amisulpride |
| 5 |
N05AL06
|
veralipride |
| 5 |
N05AL07
|
levosulpiride |
| 4 |
N05AN
|
Lithium |
| 5 |
N05AN01
|
lithium |
| 4 |
N05AX
|
Other antipsychotics |
| 5 |
N05AX07
|
prothipendyl |
| 5 |
N05AX08
|
risperidone |
| 5 |
N05AX10
|
mosapramine |
| 5 |
N05AX11
|
zotepine |
| 5 |
N05AX12
|
aripiprazole |
| 5 |
N05AX13
|
paliperidone |
| 5 |
N05AX14
|
iloperidone |
| 5 |
N05AX15
|
cariprazine |
| 5 |
N05AX16
|
brexpiprazole |
| 5 |
N05AX17
|
pimavanserin |
| 3 |
N05B
|
ANXIOLYTICS |
| 4 |
N05BA
|
Benzodiazepine derivatives |
| 5 |
N05BA01
|
diazepam |
| 5 |
N05BA02
|
chlordiazepoxide |
| 5 |
N05BA03
|
medazepam |
| 5 |
N05BA04
|
oxazepam |
| 5 |
N05BA05
|
potassium clorazepate |
| 5 |
N05BA06
|
lorazepam |
| 5 |
N05BA07
|
adinazolam |
| 5 |
N05BA08
|
bromazepam |
| 5 |
N05BA09
|
clobazam |
| 5 |
N05BA10
|
ketazolam |
| 5 |
N05BA11
|
prazepam |
| 5 |
N05BA12
|
alprazolam |
| 5 |
N05BA13
|
halazepam |
| 5 |
N05BA14
|
pinazepam |
| 5 |
N05BA15
|
camazepam |
| 5 |
N05BA16
|
nordazepam |
| 5 |
N05BA17
|
fludiazepam |
| 5 |
N05BA18
|
ethyl loflazepate |
| 5 |
N05BA19
|
etizolam |
| 5 |
N05BA21
|
clotiazepam |
| 5 |
N05BA22
|
cloxazolam |
| 5 |
N05BA23
|
tofisopam |
| 5 |
N05BA24
|
bentazepam |
| 5 |
N05BA56
|
lorazepam, combinations |
| 4 |
N05BB
|
Diphenylmethane derivatives |
| 5 |
N05BB01
|
hydroxyzine |
| 5 |
N05BB02
|
captodiame |
| 5 |
N05BB51
|
hydroxyzine, combinations |
| 4 |
N05BC
|
Carbamates |
| 5 |
N05BC01
|
meprobamate |
| 5 |
N05BC03
|
emylcamate |
| 5 |
N05BC04
|
mebutamate |
| 5 |
N05BC51
|
meprobamate, combinations |
| 4 |
N05BD
|
Dibenzo-bicyclo-octadiene derivatives |
| 5 |
N05BD01
|
benzoctamine |
| 4 |
N05BE
|
Azaspirodecanedione derivatives |
| 5 |
N05BE01
|
buspirone |
| 4 |
N05BX
|
Other anxiolytics |
| 5 |
N05BX01
|
mephenoxalone |
| 5 |
N05BX02
|
gedocarnil |
| 5 |
N05BX03
|
etifoxine |
| 5 |
N05BX04
|
fabomotizole |
| 5 |
N05BX05
|
Lavandulae aetheroleum |
| 3 |
N05C
|
HYPNOTICS AND SEDATIVES |
| 4 |
N05CA
|
Barbiturates, plain |
| 5 |
N05CA01
|
pentobarbital |
| 5 |
N05CA02
|
amobarbital |
| 5 |
N05CA03
|
butobarbital |
| 5 |
N05CA04
|
barbital |
| 5 |
N05CA05
|
aprobarbital |
| 5 |
N05CA06
|
secobarbital |
| 5 |
N05CA07
|
talbutal |
| 5 |
N05CA08
|
vinylbital |
| 5 |
N05CA09
|
vinbarbital |
| 5 |
N05CA10
|
cyclobarbital |
| 5 |
N05CA11
|
heptabarbital |
| 5 |
N05CA12
|
reposal |
| 5 |
N05CA15
|
methohexital |
| 5 |
N05CA16
|
hexobarbital |
| 5 |
N05CA19
|
thiopental |
| 5 |
N05CA20
|
etallobarbital |
| 5 |
N05CA21
|
allobarbital |
| 5 |
N05CA22
|
proxibarbal |
| 4 |
N05CB
|
Barbiturates, combinations |
| 5 |
N05CB01
|
combinations of barbiturates |
| 5 |
N05CB02
|
barbiturates in combination with other drugs |
| 4 |
N05CC
|
Aldehydes and derivatives |
| 5 |
N05CC01
|
chloral hydrate |
| 5 |
N05CC02
|
chloralodol |
| 5 |
N05CC03
|
acetylglycinamide chloral hydrate |
| 5 |
N05CC04
|
dichloralphenazone |
| 5 |
N05CC05
|
paraldehyde |
| 4 |
N05CD
|
Benzodiazepine derivatives |
| 5 |
N05CD01
|
flurazepam |
| 5 |
N05CD02
|
nitrazepam |
| 5 |
N05CD03
|
flunitrazepam |
| 5 |
N05CD04
|
estazolam |
| 5 |
N05CD05
|
triazolam |
| 5 |
N05CD06
|
lormetazepam |
| 5 |
N05CD07
|
temazepam |
| 5 |
N05CD08
|
midazolam |
| 5 |
N05CD09
|
brotizolam |
| 5 |
N05CD10
|
quazepam |
| 5 |
N05CD11
|
loprazolam |
| 5 |
N05CD12
|
doxefazepam |
| 5 |
N05CD13
|
cinolazepam |
| 5 |
N05CD14
|
remimazolam |
| 5 |
N05CD15
|
nimetazepam |
| 4 |
N05CE
|
Piperidinedione derivatives |
| 5 |
N05CE01
|
glutethimide |
| 5 |
N05CE02
|
methyprylon |
| 5 |
N05CE03
|
pyrithyldione |
| 4 |
N05CF
|
Benzodiazepine related drugs |
| 5 |
N05CF01
|
zopiclone |
| 5 |
N05CF02
|
zolpidem |
| 5 |
N05CF03
|
zaleplon |
| 5 |
N05CF04
|
eszopiclone |
| 4 |
N05CH
|
Melatonin receptor agonists |
| 5 |
N05CH01
|
melatonin |
| 5 |
N05CH02
|
ramelteon |
| 5 |
N05CH03
|
tasimelteon |
| 4 |
N05CM
|
Other hypnotics and sedatives |
| 5 |
N05CM01
|
methaqualone |
| 5 |
N05CM02
|
clomethiazole |
| 5 |
N05CM03
|
bromisoval |
| 5 |
N05CM04
|
carbromal |
| 5 |
N05CM05
|
scopolamine |
| 5 |
N05CM06
|
propiomazine |
| 5 |
N05CM07
|
triclofos |
| 5 |
N05CM08
|
ethchlorvynol |
| 5 |
N05CM09
|
Valerianae radix |
| 5 |
N05CM10
|
hexapropymate |
| 5 |
N05CM11
|
bromides |
| 5 |
N05CM12
|
apronal |
| 5 |
N05CM13
|
valnoctamide |
| 5 |
N05CM15
|
methylpentynol |
| 5 |
N05CM16
|
niaprazine |
| 5 |
N05CM18
|
dexmedetomidine |
| 5 |
N05CM19
|
suvorexant |
| 4 |
N05CX
|
Hypnotics and sedatives in combination, excl. barbiturates |
| 5 |
N05CX01
|
meprobamate, combinations |
| 5 |
N05CX02
|
methaqualone, combinations |
| 5 |
N05CX03
|
methylpentynol, combinations |
| 5 |
N05CX04
|
clomethiazole, combinations |
| 5 |
N05CX05
|
emepronium, combinations |
| 5 |
N05CX06
|
dipiperonylaminoethanol, combinations |
| 2 |
N06
|
PSYCHOANALEPTICS |
| 3 |
N06A
|
ANTIDEPRESSANTS |
| 4 |
N06AA
|
Non-selective monoamine reuptake inhibitors |
| 5 |
N06AA01
|
desipramine |
| 5 |
N06AA02
|
imipramine |
| 5 |
N06AA03
|
imipramine oxide |
| 5 |
N06AA04
|
clomipramine |
| 5 |
N06AA05
|
opipramol |
| 5 |
N06AA06
|
trimipramine |
| 5 |
N06AA07
|
lofepramine |
| 5 |
N06AA08
|
dibenzepin |
| 5 |
N06AA09
|
amitriptyline |
| 5 |
N06AA10
|
nortriptyline |
| 5 |
N06AA11
|
protriptyline |
| 5 |
N06AA12
|
doxepin |
| 5 |
N06AA13
|
iprindole |
| 5 |
N06AA14
|
melitracen |
| 5 |
N06AA15
|
butriptyline |
| 5 |
N06AA16
|
dosulepin |
| 5 |
N06AA17
|
amoxapine |
| 5 |
N06AA18
|
dimetacrine |
| 5 |
N06AA19
|
amineptine |
| 5 |
N06AA21
|
maprotiline |
| 5 |
N06AA23
|
quinupramine |
| 4 |
N06AB
|
Selective serotonin reuptake inhibitors |
| 5 |
N06AB02
|
zimeldine |
| 5 |
N06AB03
|
fluoxetine |
| 5 |
N06AB04
|
citalopram |
| 5 |
N06AB05
|
paroxetine |
| 5 |
N06AB06
|
sertraline |
| 5 |
N06AB07
|
alaproclate |
| 5 |
N06AB08
|
fluvoxamine |
| 5 |
N06AB09
|
etoperidone |
| 5 |
N06AB10
|
escitalopram |
| 4 |
N06AF
|
Monoamine oxidase inhibitors, non-selective |
| 5 |
N06AF01
|
isocarboxazid |
| 5 |
N06AF02
|
nialamide |
| 5 |
N06AF03
|
phenelzine |
| 5 |
N06AF04
|
tranylcypromine |
| 5 |
N06AF05
|
iproniazide |
| 5 |
N06AF06
|
iproclozide |
| 4 |
N06AG
|
Monoamine oxidase A inhibitors |
| 5 |
N06AG02
|
moclobemide |
| 5 |
N06AG03
|
toloxatone |
| 4 |
N06AX
|
Other antidepressants |
| 5 |
N06AX01
|
oxitriptan |
| 5 |
N06AX02
|
tryptophan |
| 5 |
N06AX03
|
mianserin |
| 5 |
N06AX04
|
nomifensine |
| 5 |
N06AX05
|
trazodone |
| 5 |
N06AX06
|
nefazodone |
| 5 |
N06AX07
|
minaprine |
| 5 |
N06AX08
|
bifemelane |
| 5 |
N06AX09
|
viloxazine |
| 5 |
N06AX10
|
oxaflozane |
| 5 |
N06AX11
|
mirtazapine |
| 5 |
N06AX12
|
bupropion |
| 5 |
N06AX13
|
medifoxamine |
| 5 |
N06AX14
|
tianeptine |
| 5 |
N06AX15
|
pivagabine |
| 5 |
N06AX16
|
venlafaxine |
| 5 |
N06AX17
|
milnacipran |
| 5 |
N06AX18
|
reboxetine |
| 5 |
N06AX19
|
gepirone |
| 5 |
N06AX21
|
duloxetine |
| 5 |
N06AX22
|
agomelatine |
| 5 |
N06AX23
|
desvenlafaxine |
| 5 |
N06AX24
|
vilazodone |
| 5 |
N06AX25
|
Hyperici herba |
| 5 |
N06AX26
|
vortioxetine |
| 5 |
N06AX27
|
esketamine |
| 3 |
N06B
|
PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS |
| 4 |
N06BA
|
Centrally acting sympathomimetics |
| 5 |
N06BA01
|
amfetamine |
| 5 |
N06BA02
|
dexamfetamine |
| 5 |
N06BA03
|
metamfetamine |
| 5 |
N06BA04
|
methylphenidate |
| 5 |
N06BA05
|
pemoline |
| 5 |
N06BA06
|
fencamfamin |
| 5 |
N06BA07
|
modafinil |
| 5 |
N06BA08
|
fenozolone |
| 5 |
N06BA09
|
atomoxetine |
| 5 |
N06BA10
|
fenetylline |
| 5 |
N06BA11
|
dexmethylphenidate |
| 5 |
N06BA12
|
lisdexamfetamine |
| 5 |
N06BA13
|
armodafinil |
| 5 |
N06BA14
|
solriamfetol |
| 4 |
N06BC
|
Xanthine derivatives |
| 5 |
N06BC01
|
caffeine |
| 5 |
N06BC02
|
propentofylline |
| 4 |
N06BX
|
Other psychostimulants and nootropics |
| 5 |
N06BX01
|
meclofenoxate |
| 5 |
N06BX02
|
pyritinol |
| 5 |
N06BX03
|
piracetam |
| 5 |
N06BX04
|
deanol |
| 5 |
N06BX05
|
fipexide |
| 5 |
N06BX06
|
citicoline |
| 5 |
N06BX07
|
oxiracetam |
| 5 |
N06BX08
|
pirisudanol |
| 5 |
N06BX09
|
linopirdine |
| 5 |
N06BX10
|
nizofenone |
| 5 |
N06BX11
|
aniracetam |
| 5 |
N06BX12
|
acetylcarnitine |
| 5 |
N06BX13
|
idebenone |
| 5 |
N06BX14
|
prolintane |
| 5 |
N06BX15
|
pipradrol |
| 5 |
N06BX16
|
pramiracetam |
| 5 |
N06BX17
|
adrafinil |
| 5 |
N06BX18
|
vinpocetine |
| 5 |
N06BX21
|
tetramethylglycoluril |
| 5 |
N06BX22
|
phenibut |
| 3 |
N06C
|
PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
| 4 |
N06CA
|
Antidepressants in combination with psycholeptics |
| 5 |
N06CA01
|
amitriptyline and psycholeptics |
| 5 |
N06CA02
|
melitracen and psycholeptics |
| 5 |
N06CA03
|
fluoxetine and psycholeptics |
| 4 |
N06CB
|
Psychostimulants in combination with psycholeptics |
| 3 |
N06D
|
ANTI-DEMENTIA DRUGS |
| 4 |
N06DA
|
Anticholinesterases |
| 5 |
N06DA01
|
tacrine |
| 5 |
N06DA02
|
donepezil |
| 5 |
N06DA03
|
rivastigmine |
| 5 |
N06DA04
|
galantamine |
| 5 |
N06DA05
|
ipidacrine |
| 5 |
N06DA52
|
donepezil and memantine |
| 5 |
N06DA53
|
donepezil, memantine and Ginkgo folium |
| 4 |
N06DX
|
Other anti-dementia drugs |
| 5 |
N06DX01
|
memantine |
| 5 |
N06DX02
|
Ginkgo folium |
| 5 |
N06DX30
|
combinations |
| 2 |
N07
|
OTHER NERVOUS SYSTEM DRUGS |
| 3 |
N07A
|
PARASYMPATHOMIMETICS |
| 4 |
N07AA
|
Anticholinesterases |
| 5 |
N07AA01
|
neostigmine |
| 5 |
N07AA02
|
pyridostigmine |
| 5 |
N07AA03
|
distigmine |
| 5 |
N07AA30
|
ambenonium |
| 5 |
N07AA51
|
neostigmine, combinations |
| 4 |
N07AB
|
Choline esters |
| 5 |
N07AB01
|
carbachol |
| 5 |
N07AB02
|
bethanechol |
| 4 |
N07AX
|
Other parasympathomimetics |
| 5 |
N07AX01
|
pilocarpine |
| 5 |
N07AX02
|
choline alfoscerate |
| 5 |
N07AX03
|
cevimeline |
| 3 |
N07B
|
DRUGS USED IN ADDICTIVE DISORDERS |
| 4 |
N07BA
|
Drugs used in nicotine dependence |
| 5 |
N07BA01
|
nicotine |
| 5 |
N07BA03
|
varenicline |
| 5 |
N07BA04
|
cytisine |
| 4 |
N07BB
|
Drugs used in alcohol dependence |
| 5 |
N07BB01
|
disulfiram |
| 5 |
N07BB02
|
calcium carbimide |
| 5 |
N07BB03
|
acamprosate |
| 5 |
N07BB04
|
naltrexone |
| 5 |
N07BB05
|
nalmefene |
| 4 |
N07BC
|
Drugs used in opioid dependence |
| 5 |
N07BC01
|
buprenorphine |
| 5 |
N07BC02
|
methadone |
| 5 |
N07BC03
|
levacetylmethadol |
| 5 |
N07BC04
|
lofexidine |
| 5 |
N07BC05
|
levomethadone |
| 5 |
N07BC06
|
diamorphine |
| 5 |
N07BC51
|
buprenorphine, combinations |
| 3 |
N07C
|
ANTIVERTIGO PREPARATIONS |
| 4 |
N07CA
|
Antivertigo preparations |
| 5 |
N07CA01
|
betahistine |
| 5 |
N07CA02
|
cinnarizine |
| 5 |
N07CA03
|
flunarizine |
| 5 |
N07CA04
|
acetylleucine |
| 5 |
N07CA52
|
cinnarizine, combinations |
| 3 |
N07X
|
OTHER NERVOUS SYSTEM DRUGS |
| 4 |
N07XA
|
Gangliosides and ganglioside derivatives |
| 4 |
N07XX
|
Other nervous system drugs |
| 5 |
N07XX01
|
tirilazad |
| 5 |
N07XX02
|
riluzole |
| 5 |
N07XX03
|
xaliproden |
| 5 |
N07XX04
|
sodium oxybate |
| 5 |
N07XX05
|
amifampridine |
| 5 |
N07XX06
|
tetrabenazine |
| 5 |
N07XX07
|
fampridine |
| 5 |
N07XX08
|
tafamidis |
| 5 |
N07XX10
|
laquinimod |
| 5 |
N07XX11
|
pitolisant |
| 5 |
N07XX12
|
patisiran |
| 5 |
N07XX13
|
valbenazine |
| 5 |
N07XX14
|
edaravone |
| 5 |
N07XX15
|
inotersen |
| 5 |
N07XX59
|
dextromethorphan, combinations |
| 1 |
P
|
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
| 2 |
P01
|
ANTIPROTOZOALS |
| 3 |
P01A
|
AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES |
| 4 |
P01AA
|
Hydroxyquinoline derivatives |
| 5 |
P01AA01
|
broxyquinoline |
| 5 |
P01AA02
|
clioquinol |
| 5 |
P01AA04
|
chlorquinaldol |
| 5 |
P01AA05
|
tilbroquinol |
| 5 |
P01AA52
|
clioquinol, combinations |
| 4 |
P01AB
|
Nitroimidazole derivatives |
| 5 |
P01AB01
|
metronidazole |
| 5 |
P01AB02
|
tinidazole |
| 5 |
P01AB03
|
ornidazole |
| 5 |
P01AB04
|
azanidazole |
| 5 |
P01AB05
|
propenidazole |
| 5 |
P01AB06
|
nimorazole |
| 5 |
P01AB07
|
secnidazole |
| 5 |
P01AB51
|
metronidazole, combinations |
| 4 |
P01AC
|
Dichloroacetamide derivatives |
| 5 |
P01AC01
|
diloxanide |
| 5 |
P01AC02
|
clefamide |
| 5 |
P01AC03
|
etofamide |
| 5 |
P01AC04
|
teclozan |
| 4 |
P01AR
|
Arsenic compounds |
| 5 |
P01AR01
|
arsthinol |
| 5 |
P01AR02
|
difetarsone |
| 5 |
P01AR03
|
glycobiarsol |
| 5 |
P01AR53
|
glycobiarsol, combinations |
| 4 |
P01AX
|
Other agents against amoebiasis and other protozoal diseases |
| 5 |
P01AX01
|
chiniofon |
| 5 |
P01AX02
|
emetine |
| 5 |
P01AX04
|
phanquinone |
| 5 |
P01AX05
|
mepacrine |
| 5 |
P01AX06
|
atovaquone |
| 5 |
P01AX07
|
trimetrexate |
| 5 |
P01AX08
|
tenonitrozole |
| 5 |
P01AX09
|
dehydroemetine |
| 5 |
P01AX10
|
fumagillin |
| 5 |
P01AX11
|
nitazoxanide |
| 5 |
P01AX52
|
emetine, combinations |
| 3 |
P01B
|
ANTIMALARIALS |
| 4 |
P01BA
|
Aminoquinolines |
| 5 |
P01BA01
|
chloroquine |
| 5 |
P01BA02
|
hydroxychloroquine |
| 5 |
P01BA03
|
primaquine |
| 5 |
P01BA06
|
amodiaquine |
| 5 |
P01BA07
|
tafenoquine |
| 4 |
P01BB
|
Biguanides |
| 5 |
P01BB01
|
proguanil |
| 5 |
P01BB02
|
cycloguanil embonate |
| 5 |
P01BB51
|
proguanil, combinations |
| 4 |
P01BC
|
Methanolquinolines |
| 5 |
P01BC01
|
quinine |
| 5 |
P01BC02
|
mefloquine |
| 4 |
P01BD
|
Diaminopyrimidines |
| 5 |
P01BD01
|
pyrimethamine |
| 5 |
P01BD51
|
pyrimethamine, combinations |
| 4 |
P01BE
|
Artemisinin and derivatives, plain |
| 5 |
P01BE01
|
artemisinin |
| 5 |
P01BE02
|
artemether |
| 5 |
P01BE03
|
artesunate |
| 5 |
P01BE04
|
artemotil |
| 5 |
P01BE05
|
artenimol |
| 4 |
P01BF
|
Artemisinin and derivatives, combinations |
| 5 |
P01BF01
|
artemether and lumefantrine |
| 5 |
P01BF02
|
artesunate and mefloquine |
| 5 |
P01BF03
|
artesunate and amodiaquine |
| 5 |
P01BF04
|
artesunate, sulfalene and pyrimethamine |
| 5 |
P01BF05
|
artenimol and piperaquine |
| 5 |
P01BF06
|
artesunate and pyronaridine |
| 4 |
P01BX
|
Other antimalarials |
| 5 |
P01BX01
|
halofantrine |
| 5 |
P01BX02
|
arterolane and piperaquine |
| 3 |
P01C
|
AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS |
| 4 |
P01CA
|
Nitroimidazole derivatives |
| 5 |
P01CA02
|
benznidazole |
| 5 |
P01CA03
|
fexinidazole |
| 4 |
P01CB
|
Antimony compounds |
| 5 |
P01CB01
|
meglumine antimonate |
| 5 |
P01CB02
|
sodium stibogluconate |
| 4 |
P01CC
|
Nitrofuran derivatives |
| 5 |
P01CC01
|
nifurtimox |
| 5 |
P01CC02
|
nitrofural |
| 4 |
P01CD
|
Arsenic compounds |
| 5 |
P01CD01
|
melarsoprol |
| 5 |
P01CD02
|
acetarsol |
| 4 |
P01CX
|
Other agents against leishmaniasis and trypanosomiasis |
| 5 |
P01CX01
|
pentamidine isethionate |
| 5 |
P01CX02
|
suramin sodium |
| 5 |
P01CX03
|
eflornithine |
| 5 |
P01CX04
|
miltefosine |
| 2 |
P02
|
ANTHELMINTICS |
| 3 |
P02B
|
ANTITREMATODALS |
| 4 |
P02BA
|
Quinoline derivatives and related substances |
| 5 |
P02BA01
|
praziquantel |
| 5 |
P02BA02
|
oxamniquine |
| 4 |
P02BB
|
Organophosphorous compounds |
| 5 |
P02BB01
|
metrifonate |
| 4 |
P02BX
|
Other antitrematodal agents |
| 5 |
P02BX01
|
bithionol |
| 5 |
P02BX02
|
niridazole |
| 5 |
P02BX03
|
stibophen |
| 5 |
P02BX04
|
triclabendazole |
| 3 |
P02C
|
ANTINEMATODAL AGENTS |
| 4 |
P02CA
|
Benzimidazole derivatives |
| 5 |
P02CA01
|
mebendazole |
| 5 |
P02CA02
|
tiabendazole |
| 5 |
P02CA03
|
albendazole |
| 5 |
P02CA04
|
ciclobendazole |
| 5 |
P02CA05
|
flubendazole |
| 5 |
P02CA06
|
fenbendazole |
| 5 |
P02CA51
|
mebendazole, combinations |
| 4 |
P02CB
|
Piperazine and derivatives |
| 5 |
P02CB01
|
piperazine |
| 5 |
P02CB02
|
diethylcarbamazine |
| 4 |
P02CC
|
Tetrahydropyrimidine derivatives |
| 5 |
P02CC01
|
pyrantel |
| 5 |
P02CC02
|
oxantel |
| 4 |
P02CE
|
Imidazothiazole derivatives |
| 5 |
P02CE01
|
levamisole |
| 4 |
P02CF
|
Avermectines |
| 5 |
P02CF01
|
ivermectin |
| 4 |
P02CX
|
Other antinematodals |
| 5 |
P02CX01
|
pyrvinium |
| 5 |
P02CX02
|
bephenium |
| 5 |
P02CX03
|
moxidectin |
| 3 |
P02D
|
ANTICESTODALS |
| 4 |
P02DA
|
Salicylic acid derivatives |
| 5 |
P02DA01
|
niclosamide |
| 4 |
P02DX
|
Other anticestodals |
| 5 |
P02DX01
|
desaspidin |
| 5 |
P02DX02
|
dichlorophen |
| 2 |
P03
|
ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS |
| 3 |
P03A
|
ECTOPARASITICIDES, INCL. SCABICIDES |
| 4 |
P03AA
|
Sulfur containing products |
| 5 |
P03AA01
|
dixanthogen |
| 5 |
P03AA02
|
potassium polysulfide |
| 5 |
P03AA03
|
mesulfen |
| 5 |
P03AA04
|
disulfiram |
| 5 |
P03AA05
|
thiram |
| 5 |
P03AA54
|
disulfiram, combinations |
| 4 |
P03AB
|
Chlorine containing products |
| 5 |
P03AB01
|
clofenotane |
| 5 |
P03AB02
|
lindane |
| 5 |
P03AB51
|
clofenotane, combinations |
| 4 |
P03AC
|
Pyrethrines, incl. synthetic compounds |
| 5 |
P03AC01
|
pyrethrum |
| 5 |
P03AC02
|
bioallethrin |
| 5 |
P03AC03
|
phenothrin |
| 5 |
P03AC04
|
permethrin |
| 5 |
P03AC51
|
pyrethrum, combinations |
| 5 |
P03AC52
|
bioallethrin, combinations |
| 5 |
P03AC53
|
phenothrin, combinations |
| 5 |
P03AC54
|
permethrin, combinations |
| 4 |
P03AX
|
Other ectoparasiticides, incl. scabicides |
| 5 |
P03AX01
|
benzyl benzoate |
| 5 |
P03AX02
|
copper oleinate |
| 5 |
P03AX03
|
malathion |
| 5 |
P03AX04
|
quassia |
| 5 |
P03AX05
|
dimeticone |
| 5 |
P03AX06
|
benzyl alcohol |
| 3 |
P03B
|
INSECTICIDES AND REPELLENTS |
| 4 |
P03BA
|
Pyrethrines |
| 5 |
P03BA01
|
cyfluthrin |
| 5 |
P03BA02
|
cypermethrin |
| 5 |
P03BA03
|
decamethrin |
| 5 |
P03BA04
|
tetramethrin |
| 4 |
P03BX
|
Other insecticides and repellents |
| 5 |
P03BX01
|
diethyltoluamide |
| 5 |
P03BX02
|
dimethylphthalate |
| 5 |
P03BX03
|
dibutylphthalate |
| 5 |
P03BX04
|
dibutylsuccinate |
| 5 |
P03BX05
|
dimethylcarbate |
| 5 |
P03BX06
|
etohexadiol |
| 1 |
R
|
RESPIRATORY SYSTEM |
| 2 |
R01
|
NASAL PREPARATIONS |
| 3 |
R01A
|
DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE |
| 4 |
R01AA
|
Sympathomimetics, plain |
| 5 |
R01AA02
|
cyclopentamine |
| 5 |
R01AA03
|
ephedrine |
| 5 |
R01AA04
|
phenylephrine |
| 5 |
R01AA05
|
oxymetazoline |
| 5 |
R01AA06
|
tetryzoline |
| 5 |
R01AA07
|
xylometazoline |
| 5 |
R01AA08
|
naphazoline |
| 5 |
R01AA09
|
tramazoline |
| 5 |
R01AA10
|
metizoline |
| 5 |
R01AA11
|
tuaminoheptane |
| 5 |
R01AA12
|
fenoxazoline |
| 5 |
R01AA13
|
tymazoline |
| 5 |
R01AA14
|
epinephrine |
| 5 |
R01AA15
|
indanazoline |
| 4 |
R01AB
|
Sympathomimetics, combinations excl. corticosteroids |
| 5 |
R01AB01
|
phenylephrine |
| 5 |
R01AB02
|
naphazoline |
| 5 |
R01AB03
|
tetryzoline |
| 5 |
R01AB05
|
ephedrine |
| 5 |
R01AB06
|
xylometazoline |
| 5 |
R01AB07
|
oxymetazoline |
| 5 |
R01AB08
|
tuaminoheptane |
| 4 |
R01AC
|
Antiallergic agents, excl. corticosteroids |
| 5 |
R01AC01
|
cromoglicic acid |
| 5 |
R01AC02
|
levocabastine |
| 5 |
R01AC03
|
azelastine |
| 5 |
R01AC04
|
antazoline |
| 5 |
R01AC05
|
spaglumic acid |
| 5 |
R01AC06
|
thonzylamine |
| 5 |
R01AC07
|
nedocromil |
| 5 |
R01AC08
|
olopatadine |
| 5 |
R01AC51
|
cromoglicic acid, combinations |
| 4 |
R01AD
|
Corticosteroids |
| 5 |
R01AD01
|
beclometasone |
| 5 |
R01AD02
|
prednisolone |
| 5 |
R01AD03
|
dexamethasone |
| 5 |
R01AD04
|
flunisolide |
| 5 |
R01AD05
|
budesonide |
| 5 |
R01AD06
|
betamethasone |
| 5 |
R01AD07
|
tixocortol |
| 5 |
R01AD08
|
fluticasone |
| 5 |
R01AD09
|
mometasone |
| 5 |
R01AD11
|
triamcinolone |
| 5 |
R01AD12
|
fluticasone furoate |
| 5 |
R01AD13
|
ciclesonide |
| 5 |
R01AD52
|
prednisolone, combinations |
| 5 |
R01AD53
|
dexamethasone, combinations |
| 5 |
R01AD57
|
tixocortol, combinations |
| 5 |
R01AD58
|
fluticasone, combinations |
| 5 |
R01AD59
|
mometasone, combinations |
| 5 |
R01AD60
|
hydrocortisone, combinations |
| 4 |
R01AX
|
Other nasal preparations |
| 5 |
R01AX01
|
calcium hexamine thiocyanate |
| 5 |
R01AX02
|
retinol |
| 5 |
R01AX03
|
ipratropium bromide |
| 5 |
R01AX05
|
ritiometan |
| 5 |
R01AX06
|
mupirocin |
| 5 |
R01AX07
|
hexamidine |
| 5 |
R01AX08
|
framycetin |
| 5 |
R01AX09
|
hyaluronic acid |
| 5 |
R01AX10
|
various |
| 5 |
R01AX30
|
combinations |
| 3 |
R01B
|
NASAL DECONGESTANTS FOR SYSTEMIC USE |
| 4 |
R01BA
|
Sympathomimetics |
| 5 |
R01BA01
|
phenylpropanolamine |
| 5 |
R01BA02
|
pseudoephedrine |
| 5 |
R01BA03
|
phenylephrine |
| 5 |
R01BA51
|
phenylpropanolamine, combinations |
| 5 |
R01BA52
|
pseudoephedrine, combinations |
| 5 |
R01BA53
|
phenylephrine, combinations |
| 2 |
R02
|
THROAT PREPARATIONS |
| 3 |
R02A
|
THROAT PREPARATIONS |
| 4 |
R02AA
|
Antiseptics |
| 5 |
R02AA01
|
ambazone |
| 5 |
R02AA02
|
dequalinium |
| 5 |
R02AA03
|
dichlorobenzyl alcohol |
| 5 |
R02AA05
|
chlorhexidine |
| 5 |
R02AA06
|
cetylpyridinium |
| 5 |
R02AA09
|
benzethonium |
| 5 |
R02AA10
|
myristyl-benzalkonium |
| 5 |
R02AA11
|
chlorquinaldol |
| 5 |
R02AA12
|
hexylresorcinol |
| 5 |
R02AA13
|
acriflavinium chloride |
| 5 |
R02AA14
|
oxyquinoline |
| 5 |
R02AA15
|
povidone-iodine |
| 5 |
R02AA16
|
benzalkonium |
| 5 |
R02AA17
|
cetrimonium |
| 5 |
R02AA18
|
hexamidine |
| 5 |
R02AA19
|
phenol |
| 5 |
R02AA20
|
various |
| 5 |
R02AA21
|
octenidine |
| 4 |
R02AB
|
Antibiotics |
| 5 |
R02AB01
|
neomycin |
| 5 |
R02AB02
|
tyrothricin |
| 5 |
R02AB03
|
fusafungine |
| 5 |
R02AB04
|
bacitracin |
| 5 |
R02AB30
|
gramicidin |
| 4 |
R02AD
|
Anesthetics, local |
| 5 |
R02AD01
|
benzocaine |
| 5 |
R02AD02
|
lidocaine |
| 5 |
R02AD03
|
cocaine |
| 5 |
R02AD04
|
dyclonine |
| 4 |
R02AX
|
Other throat preparations |
| 5 |
R02AX01
|
flurbiprofen |
| 5 |
R02AX02
|
ibuprofen |
| 5 |
R02AX03
|
benzydamine |
| 2 |
R03
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| 3 |
R03A
|
ADRENERGICS, INHALANTS |
| 4 |
R03AA
|
Alpha- and beta-adrenoreceptor agonists |
| 5 |
R03AA01
|
epinephrine |
| 4 |
R03AB
|
Non-selective beta-adrenoreceptor agonists |
| 5 |
R03AB02
|
isoprenaline |
| 5 |
R03AB03
|
orciprenaline |
| 4 |
R03AC
|
Selective beta-2-adrenoreceptor agonists |
| 5 |
R03AC02
|
salbutamol |
| 5 |
R03AC03
|
terbutaline |
| 5 |
R03AC04
|
fenoterol |
| 5 |
R03AC05
|
rimiterol |
| 5 |
R03AC06
|
hexoprenaline |
| 5 |
R03AC07
|
isoetarine |
| 5 |
R03AC08
|
pirbuterol |
| 5 |
R03AC09
|
tretoquinol |
| 5 |
R03AC10
|
carbuterol |
| 5 |
R03AC11
|
tulobuterol |
| 5 |
R03AC12
|
salmeterol |
| 5 |
R03AC13
|
formoterol |
| 5 |
R03AC14
|
clenbuterol |
| 5 |
R03AC15
|
reproterol |
| 5 |
R03AC16
|
procaterol |
| 5 |
R03AC17
|
bitolterol |
| 5 |
R03AC18
|
indacaterol |
| 5 |
R03AC19
|
olodaterol |
| 4 |
R03AH
|
Combinations of adrenergics |
| 4 |
R03AK
|
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics |
| 5 |
R03AK01
|
epinephrine and other drugs for obstructive airway diseases |
| 5 |
R03AK02
|
isoprenaline and other drugs for obstructive airway diseases |
| 5 |
R03AK04
|
salbutamol and sodium cromoglicate |
| 5 |
R03AK05
|
reproterol and sodium cromoglicate |
| 5 |
R03AK06
|
salmeterol and fluticasone |
| 5 |
R03AK07
|
formoterol and budesonide |
| 5 |
R03AK08
|
formoterol and beclometasone |
| 5 |
R03AK09
|
formoterol and mometasone |
| 5 |
R03AK10
|
vilanterol and fluticasone furoate |
| 5 |
R03AK11
|
formoterol and fluticasone |
| 5 |
R03AK12
|
salmeterol and budesonide |
| 5 |
R03AK13
|
salbutamol and beclometasone |
| 5 |
R03AK14
|
indacaterol and mometasone |
| 4 |
R03AL
|
Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids |
| 5 |
R03AL01
|
fenoterol and ipratropium bromide |
| 5 |
R03AL02
|
salbutamol and ipratropium bromide |
| 5 |
R03AL03
|
vilanterol and umeclidinium bromide |
| 5 |
R03AL04
|
indacaterol and glycopyrronium bromide |
| 5 |
R03AL05
|
formoterol and aclidinium bromide |
| 5 |
R03AL06
|
olodaterol and tiotropium bromide |
| 5 |
R03AL07
|
formoterol and glycopyrronium bromide |
| 5 |
R03AL08
|
vilanterol, umeclidinium bromide and fluticasone furoate |
| 5 |
R03AL09
|
formoterol, glycopyrronium bromide and beclometasone |
| 5 |
R03AL10
|
formoterol and tiotropium bromide |
| 5 |
R03AL11
|
formoterol, glycopyrronium bromide and budesonide |
| 5 |
R03AL12
|
indacaterol, glycopyrronium bromide and mometasone |
| 3 |
R03B
|
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| 4 |
R03BA
|
Glucocorticoids |
| 5 |
R03BA01
|
beclometasone |
| 5 |
R03BA02
|
budesonide |
| 5 |
R03BA03
|
flunisolide |
| 5 |
R03BA04
|
betamethasone |
| 5 |
R03BA05
|
fluticasone |
| 5 |
R03BA06
|
triamcinolone |
| 5 |
R03BA07
|
mometasone |
| 5 |
R03BA08
|
ciclesonide |
| 5 |
R03BA09
|
fluticasone furoate |
| 4 |
R03BB
|
Anticholinergics |
| 5 |
R03BB01
|
ipratropium bromide |
| 5 |
R03BB02
|
oxitropium bromide |
| 5 |
R03BB03
|
stramoni preparations |
| 5 |
R03BB04
|
tiotropium bromide |
| 5 |
R03BB05
|
aclidinium bromide |
| 5 |
R03BB06
|
glycopyrronium bromide |
| 5 |
R03BB07
|
umeclidinium bromide |
| 5 |
R03BB08
|
revefenacin |
| 5 |
R03BB54
|
tiotropium bromide, combinations |
| 4 |
R03BC
|
Antiallergic agents, excl. corticosteroids |
| 5 |
R03BC01
|
cromoglicic acid |
| 5 |
R03BC03
|
nedocromil |
| 4 |
R03BX
|
Other drugs for obstructive airway diseases, inhalants |
| 5 |
R03BX01
|
fenspiride |
| 3 |
R03C
|
ADRENERGICS FOR SYSTEMIC USE |
| 4 |
R03CA
|
Alpha- and beta-adrenoreceptor agonists |
| 5 |
R03CA02
|
ephedrine |
| 4 |
R03CB
|
Non-selective beta-adrenoreceptor agonists |
| 5 |
R03CB01
|
isoprenaline |
| 5 |
R03CB02
|
methoxyphenamine |
| 5 |
R03CB03
|
orciprenaline |
| 5 |
R03CB51
|
isoprenaline, combinations |
| 5 |
R03CB53
|
orciprenaline, combinations |
| 4 |
R03CC
|
Selective beta-2-adrenoreceptor agonists |
| 5 |
R03CC02
|
salbutamol |
| 5 |
R03CC03
|
terbutaline |
| 5 |
R03CC04
|
fenoterol |
| 5 |
R03CC05
|
hexoprenaline |
| 5 |
R03CC06
|
isoetarine |
| 5 |
R03CC07
|
pirbuterol |
| 5 |
R03CC08
|
procaterol |
| 5 |
R03CC09
|
tretoquinol |
| 5 |
R03CC10
|
carbuterol |
| 5 |
R03CC11
|
tulobuterol |
| 5 |
R03CC12
|
bambuterol |
| 5 |
R03CC13
|
clenbuterol |
| 5 |
R03CC14
|
reproterol |
| 5 |
R03CC53
|
terbutaline, combinations |
| 5 |
R03CC63
|
clenbuterol and ambroxol |
| 4 |
R03CK
|
Adrenergics and other drugs for obstructive airway diseases |
| 3 |
R03D
|
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| 4 |
R03DA
|
Xanthines |
| 5 |
R03DA01
|
diprophylline |
| 5 |
R03DA02
|
choline theophyllinate |
| 5 |
R03DA03
|
proxyphylline |
| 5 |
R03DA04
|
theophylline |
| 5 |
R03DA05
|
aminophylline |
| 5 |
R03DA06
|
etamiphylline |
| 5 |
R03DA07
|
theobromine |
| 5 |
R03DA08
|
bamifylline |
| 5 |
R03DA09
|
acefylline piperazine |
| 5 |
R03DA10
|
bufylline |
| 5 |
R03DA11
|
doxofylline |
| 5 |
R03DA12
|
mepyramine theophyllinacetate |
| 5 |
R03DA20
|
combinations of xanthines |
| 5 |
R03DA51
|
diprophylline, combinations |
| 5 |
R03DA54
|
theophylline, combinations excl. psycholeptics |
| 5 |
R03DA55
|
aminophylline, combinations |
| 5 |
R03DA57
|
theobromine, combinations |
| 5 |
R03DA74
|
theophylline, combinations with psycholeptics |
| 4 |
R03DB
|
Xanthines and adrenergics |
| 5 |
R03DB01
|
diprophylline and adrenergics |
| 5 |
R03DB02
|
choline theophyllinate and adrenergics |
| 5 |
R03DB03
|
proxyphylline and adrenergics |
| 5 |
R03DB04
|
theophylline and adrenergics |
| 5 |
R03DB05
|
aminophylline and adrenergics |
| 5 |
R03DB06
|
etamiphylline and adrenergics |
| 4 |
R03DC
|
Leukotriene receptor antagonists |
| 5 |
R03DC01
|
zafirlukast |
| 5 |
R03DC02
|
pranlukast |
| 5 |
R03DC03
|
montelukast |
| 5 |
R03DC04
|
ibudilast |
| 5 |
R03DC53
|
montelukast, combinations |
| 4 |
R03DX
|
Other systemic drugs for obstructive airway diseases |
| 5 |
R03DX01
|
amlexanox |
| 5 |
R03DX02
|
eprozinol |
| 5 |
R03DX03
|
fenspiride |
| 5 |
R03DX05
|
omalizumab |
| 5 |
R03DX06
|
seratrodast |
| 5 |
R03DX07
|
roflumilast |
| 5 |
R03DX08
|
reslizumab |
| 5 |
R03DX09
|
mepolizumab |
| 5 |
R03DX10
|
benralizumab |
| 2 |
R05
|
COUGH AND COLD PREPARATIONS |
| 3 |
R05C
|
EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS |
| 4 |
R05CA
|
Expectorants |
| 5 |
R05CA01
|
tyloxapol |
| 5 |
R05CA02
|
potassium iodide |
| 5 |
R05CA03
|
guaifenesin |
| 5 |
R05CA04
|
ipecacuanha |
| 5 |
R05CA05
|
althea root |
| 5 |
R05CA06
|
senega |
| 5 |
R05CA07
|
antimony pentasulfide |
| 5 |
R05CA08
|
creosote |
| 5 |
R05CA09
|
guaiacolsulfonate |
| 5 |
R05CA10
|
combinations |
| 5 |
R05CA11
|
levoverbenone |
| 5 |
R05CA12
|
Hederae helicis folium |
| 5 |
R05CA13
|
cineole |
| 4 |
R05CB
|
Mucolytics |
| 5 |
R05CB01
|
acetylcysteine |
| 5 |
R05CB02
|
bromhexine |
| 5 |
R05CB03
|
carbocisteine |
| 5 |
R05CB04
|
eprazinone |
| 5 |
R05CB05
|
mesna |
| 5 |
R05CB06
|
ambroxol |
| 5 |
R05CB07
|
sobrerol |
| 5 |
R05CB08
|
domiodol |
| 5 |
R05CB09
|
letosteine |
| 5 |
R05CB10
|
combinations |
| 5 |
R05CB11
|
stepronin |
| 5 |
R05CB13
|
dornase alfa (desoxyribonuclease) |
| 5 |
R05CB14
|
neltenexine |
| 5 |
R05CB15
|
erdosteine |
| 5 |
R05CB16
|
mannitol |
| 3 |
R05D
|
COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS |
| 4 |
R05DA
|
Opium alkaloids and derivatives |
| 5 |
R05DA01
|
ethylmorphine |
| 5 |
R05DA03
|
hydrocodone |
| 5 |
R05DA04
|
codeine |
| 5 |
R05DA05
|
opium alkaloids with morphine |
| 5 |
R05DA06
|
normethadone |
| 5 |
R05DA07
|
noscapine |
| 5 |
R05DA08
|
pholcodine |
| 5 |
R05DA09
|
dextromethorphan |
| 5 |
R05DA10
|
thebacon |
| 5 |
R05DA11
|
dimemorfan |
| 5 |
R05DA12
|
acetyldihydrocodeine |
| 5 |
R05DA20
|
combinations |
| 4 |
R05DB
|
Other cough suppressants |
| 5 |
R05DB01
|
benzonatate |
| 5 |
R05DB02
|
benproperine |
| 5 |
R05DB03
|
clobutinol |
| 5 |
R05DB04
|
isoaminile |
| 5 |
R05DB05
|
pentoxyverine |
| 5 |
R05DB07
|
oxolamine |
| 5 |
R05DB09
|
oxeladin |
| 5 |
R05DB10
|
clofedanol |
| 5 |
R05DB11
|
pipazetate |
| 5 |
R05DB12
|
bibenzonium bromide |
| 5 |
R05DB13
|
butamirate |
| 5 |
R05DB14
|
fedrilate |
| 5 |
R05DB15
|
zipeprol |
| 5 |
R05DB16
|
dibunate |
| 5 |
R05DB17
|
droxypropine |
| 5 |
R05DB18
|
prenoxdiazine |
| 5 |
R05DB19
|
dropropizine |
| 5 |
R05DB20
|
combinations |
| 5 |
R05DB21
|
cloperastine |
| 5 |
R05DB22
|
meprotixol |
| 5 |
R05DB23
|
piperidione |
| 5 |
R05DB24
|
tipepidine |
| 5 |
R05DB25
|
morclofone |
| 5 |
R05DB26
|
nepinalone |
| 5 |
R05DB27
|
levodropropizine |
| 5 |
R05DB28
|
dimethoxanate |
| 3 |
R05F
|
COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| 4 |
R05FA
|
Opium derivatives and expectorants |
| 5 |
R05FA01
|
opium derivatives and mucolytics |
| 5 |
R05FA02
|
opium derivatives and expectorants |
| 4 |
R05FB
|
Other cough suppressants and expectorants |
| 5 |
R05FB01
|
cough suppressants and mucolytics |
| 5 |
R05FB02
|
cough suppressants and expectorants |
| 3 |
R05X
|
OTHER COLD PREPARATIONS |
| 2 |
R06
|
ANTIHISTAMINES FOR SYSTEMIC USE |
| 3 |
R06A
|
ANTIHISTAMINES FOR SYSTEMIC USE |
| 4 |
R06AA
|
Aminoalkyl ethers |
| 5 |
R06AA01
|
bromazine |
| 5 |
R06AA02
|
diphenhydramine |
| 5 |
R06AA04
|
clemastine |
| 5 |
R06AA06
|
chlorphenoxamine |
| 5 |
R06AA07
|
diphenylpyraline |
| 5 |
R06AA08
|
carbinoxamine |
| 5 |
R06AA09
|
doxylamine |
| 5 |
R06AA10
|
trimethobenzamide |
| 5 |
R06AA52
|
diphenhydramine, combinations |
| 5 |
R06AA54
|
clemastine, combinations |
| 5 |
R06AA56
|
chlorphenoxamine, combinations |
| 5 |
R06AA57
|
diphenylpyraline, combinations |
| 5 |
R06AA59
|
doxylamine, combinations |
| 4 |
R06AB
|
Substituted alkylamines |
| 5 |
R06AB01
|
brompheniramine |
| 5 |
R06AB02
|
dexchlorpheniramine |
| 5 |
R06AB03
|
dimetindene |
| 5 |
R06AB04
|
chlorphenamine |
| 5 |
R06AB05
|
pheniramine |
| 5 |
R06AB06
|
dexbrompheniramine |
| 5 |
R06AB07
|
talastine |
| 5 |
R06AB51
|
brompheniramine, combinations |
| 5 |
R06AB52
|
dexchlorpheniramine, combinations |
| 5 |
R06AB54
|
chlorphenamine, combinations |
| 5 |
R06AB56
|
dexbrompheniramine, combinations |
| 4 |
R06AC
|
Substituted ethylene diamines |
| 5 |
R06AC01
|
mepyramine |
| 5 |
R06AC02
|
histapyrrodine |
| 5 |
R06AC03
|
chloropyramine |
| 5 |
R06AC04
|
tripelennamine |
| 5 |
R06AC05
|
methapyrilene |
| 5 |
R06AC06
|
thonzylamine |
| 5 |
R06AC52
|
histapyrrodine, combinations |
| 5 |
R06AC53
|
chloropyramine, combinations |
| 4 |
R06AD
|
Phenothiazine derivatives |
| 5 |
R06AD01
|
alimemazine |
| 5 |
R06AD02
|
promethazine |
| 5 |
R06AD03
|
thiethylperazine |
| 5 |
R06AD04
|
methdilazine |
| 5 |
R06AD05
|
hydroxyethylpromethazine |
| 5 |
R06AD06
|
thiazinam |
| 5 |
R06AD07
|
mequitazine |
| 5 |
R06AD08
|
oxomemazine |
| 5 |
R06AD09
|
isothipendyl |
| 5 |
R06AD52
|
promethazine, combinations |
| 5 |
R06AD55
|
hydroxyethylpromethazine, combinations |
| 4 |
R06AE
|
Piperazine derivatives |
| 5 |
R06AE01
|
buclizine |
| 5 |
R06AE03
|
cyclizine |
| 5 |
R06AE04
|
chlorcyclizine |
| 5 |
R06AE05
|
meclozine |
| 5 |
R06AE06
|
oxatomide |
| 5 |
R06AE07
|
cetirizine |
| 5 |
R06AE09
|
levocetirizine |
| 5 |
R06AE51
|
buclizine, combinations |
| 5 |
R06AE53
|
cyclizine, combinations |
| 5 |
R06AE55
|
meclozine, combinations |
| 4 |
R06AK
|
Combinations of antihistamines |
| 4 |
R06AX
|
Other antihistamines for systemic use |
| 5 |
R06AX01
|
bamipine |
| 5 |
R06AX02
|
cyproheptadine |
| 5 |
R06AX03
|
thenalidine |
| 5 |
R06AX04
|
phenindamine |
| 5 |
R06AX05
|
antazoline |
| 5 |
R06AX07
|
triprolidine |
| 5 |
R06AX08
|
pyrrobutamine |
| 5 |
R06AX09
|
azatadine |
| 5 |
R06AX11
|
astemizole |
| 5 |
R06AX12
|
terfenadine |
| 5 |
R06AX13
|
loratadine |
| 5 |
R06AX15
|
mebhydrolin |
| 5 |
R06AX16
|
deptropine |
| 5 |
R06AX17
|
ketotifen |
| 5 |
R06AX18
|
acrivastine |
| 5 |
R06AX19
|
azelastine |
| 5 |
R06AX21
|
tritoqualine |
| 5 |
R06AX22
|
ebastine |
| 5 |
R06AX23
|
pimethixene |
| 5 |
R06AX24
|
epinastine |
| 5 |
R06AX25
|
mizolastine |
| 5 |
R06AX26
|
fexofenadine |
| 5 |
R06AX27
|
desloratadine |
| 5 |
R06AX28
|
rupatadine |
| 5 |
R06AX29
|
bilastine |
| 5 |
R06AX31
|
quifenadine |
| 5 |
R06AX32
|
sequifenadine |
| 5 |
R06AX53
|
thenalidine, combinations |
| 5 |
R06AX58
|
pyrrobutamine, combinations |
| 2 |
R07
|
OTHER RESPIRATORY SYSTEM PRODUCTS |
| 3 |
R07A
|
OTHER RESPIRATORY SYSTEM PRODUCTS |
| 4 |
R07AA
|
Lung surfactants |
| 5 |
R07AA01
|
colfosceril palmitate |
| 5 |
R07AA02
|
natural phospholipids |
| 5 |
R07AA30
|
combinations |
| 4 |
R07AB
|
Respiratory stimulants |
| 5 |
R07AB01
|
doxapram |
| 5 |
R07AB02
|
nikethamide |
| 5 |
R07AB03
|
pentetrazol |
| 5 |
R07AB04
|
etamivan |
| 5 |
R07AB05
|
bemegride |
| 5 |
R07AB06
|
prethcamide |
| 5 |
R07AB07
|
almitrine |
| 5 |
R07AB08
|
dimefline |
| 5 |
R07AB09
|
mepixanox |
| 5 |
R07AB52
|
nikethamide, combinations |
| 5 |
R07AB53
|
pentetrazol, combinations |
| 4 |
R07AX
|
Other respiratory system products |
| 5 |
R07AX01
|
nitric oxide |
| 5 |
R07AX02
|
ivacaftor |
| 5 |
R07AX30
|
ivacaftor and lumacaftor |
| 5 |
R07AX31
|
ivacaftor and tezacaftor |
| 5 |
R07AX32
|
ivacaftor, tezacaftor and elexacaftor |
| 1 |
S
|
SENSORY ORGANS |
| 2 |
S01
|
OPHTHALMOLOGICALS |
| 3 |
S01A
|
ANTIINFECTIVES |
| 4 |
S01AA
|
Antibiotics |
| 5 |
S01AA01
|
chloramphenicol |
| 5 |
S01AA02
|
chlortetracycline |
| 5 |
S01AA03
|
neomycin |
| 5 |
S01AA04
|
oxytetracycline |
| 5 |
S01AA05
|
tyrothricin |
| 5 |
S01AA07
|
framycetin |
| 5 |
S01AA09
|
tetracycline |
| 5 |
S01AA10
|
natamycin |
| 5 |
S01AA11
|
gentamicin |
| 5 |
S01AA12
|
tobramycin |
| 5 |
S01AA13
|
fusidic acid |
| 5 |
S01AA14
|
benzylpenicillin |
| 5 |
S01AA15
|
dihydrostreptomycin |
| 5 |
S01AA16
|
rifamycin |
| 5 |
S01AA17
|
erythromycin |
| 5 |
S01AA18
|
polymyxin B |
| 5 |
S01AA19
|
ampicillin |
| 5 |
S01AA20
|
antibiotics in combination with other drugs |
| 5 |
S01AA21
|
amikacin |
| 5 |
S01AA22
|
micronomicin |
| 5 |
S01AA23
|
netilmicin |
| 5 |
S01AA24
|
kanamycin |
| 5 |
S01AA25
|
azidamfenicol |
| 5 |
S01AA26
|
azithromycin |
| 5 |
S01AA27
|
cefuroxime |
| 5 |
S01AA28
|
vancomycin |
| 5 |
S01AA30
|
combinations of different antibiotics |
| 4 |
S01AB
|
Sulfonamides |
| 5 |
S01AB01
|
sulfamethizole |
| 5 |
S01AB02
|
sulfafurazole |
| 5 |
S01AB03
|
sulfadicramide |
| 5 |
S01AB04
|
sulfacetamide |
| 5 |
S01AB05
|
sulfafenazol |
| 4 |
S01AD
|
Antivirals |
| 5 |
S01AD01
|
idoxuridine |
| 5 |
S01AD02
|
trifluridine |
| 5 |
S01AD03
|
aciclovir |
| 5 |
S01AD05
|
interferon |
| 5 |
S01AD06
|
vidarabine |
| 5 |
S01AD07
|
famciclovir |
| 5 |
S01AD08
|
fomivirsen |
| 5 |
S01AD09
|
ganciclovir |
| 4 |
S01AE
|
Fluoroquinolones |
| 5 |
S01AE01
|
ofloxacin |
| 5 |
S01AE02
|
norfloxacin |
| 5 |
S01AE03
|
ciprofloxacin |
| 5 |
S01AE04
|
lomefloxacin |
| 5 |
S01AE05
|
levofloxacin |
| 5 |
S01AE06
|
gatifloxacin |
| 5 |
S01AE07
|
moxifloxacin |
| 5 |
S01AE08
|
besifloxacin |
| 4 |
S01AX
|
Other antiinfectives |
| 5 |
S01AX01
|
mercury compounds |
| 5 |
S01AX02
|
silver compounds |
| 5 |
S01AX03
|
zinc compounds |
| 5 |
S01AX04
|
nitrofural |
| 5 |
S01AX05
|
bibrocathol |
| 5 |
S01AX06
|
resorcinol |
| 5 |
S01AX07
|
sodium borate |
| 5 |
S01AX08
|
hexamidine |
| 5 |
S01AX09
|
chlorhexidine |
| 5 |
S01AX10
|
sodium propionate |
| 5 |
S01AX14
|
dibrompropamidine |
| 5 |
S01AX15
|
propamidine |
| 5 |
S01AX16
|
picloxydine |
| 5 |
S01AX18
|
povidone-iodine |
| 3 |
S01B
|
ANTIINFLAMMATORY AGENTS |
| 4 |
S01BA
|
Corticosteroids, plain |
| 5 |
S01BA01
|
dexamethasone |
| 5 |
S01BA02
|
hydrocortisone |
| 5 |
S01BA03
|
cortisone |
| 5 |
S01BA04
|
prednisolone |
| 5 |
S01BA05
|
triamcinolone |
| 5 |
S01BA06
|
betamethasone |
| 5 |
S01BA07
|
fluorometholone |
| 5 |
S01BA08
|
medrysone |
| 5 |
S01BA09
|
clobetasone |
| 5 |
S01BA10
|
alclometasone |
| 5 |
S01BA11
|
desonide |
| 5 |
S01BA12
|
formocortal |
| 5 |
S01BA13
|
rimexolone |
| 5 |
S01BA14
|
loteprednol |
| 5 |
S01BA15
|
fluocinolone acetonide |
| 4 |
S01BB
|
Corticosteroids and mydriatics in combination |
| 5 |
S01BB01
|
hydrocortisone and mydriatics |
| 5 |
S01BB02
|
prednisolone and mydriatics |
| 5 |
S01BB03
|
fluorometholone and mydriatics |
| 5 |
S01BB04
|
betamethasone and mydriatics |
| 4 |
S01BC
|
Antiinflammatory agents, non-steroids |
| 5 |
S01BC01
|
indometacin |
| 5 |
S01BC02
|
oxyphenbutazone |
| 5 |
S01BC03
|
diclofenac |
| 5 |
S01BC04
|
flurbiprofen |
| 5 |
S01BC05
|
ketorolac |
| 5 |
S01BC06
|
piroxicam |
| 5 |
S01BC07
|
bendazac |
| 5 |
S01BC08
|
salicylic acid |
| 5 |
S01BC09
|
pranoprofen |
| 5 |
S01BC10
|
nepafenac |
| 5 |
S01BC11
|
bromfenac |
| 3 |
S01C
|
ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION |
| 4 |
S01CA
|
Corticosteroids and antiinfectives in combination |
| 5 |
S01CA01
|
dexamethasone and antiinfectives |
| 5 |
S01CA02
|
prednisolone and antiinfectives |
| 5 |
S01CA03
|
hydrocortisone and antiinfectives |
| 5 |
S01CA04
|
fluocortolone and antiinfectives |
| 5 |
S01CA05
|
betamethasone and antiinfectives |
| 5 |
S01CA06
|
fludrocortisone and antiinfectives |
| 5 |
S01CA07
|
fluorometholone and antiinfectives |
| 5 |
S01CA08
|
methylprednisolone and antiinfectives |
| 5 |
S01CA09
|
chloroprednisone and antiinfectives |
| 5 |
S01CA10
|
fluocinolone acetonide and antiinfectives |
| 5 |
S01CA11
|
clobetasone and antiinfectives |
| 4 |
S01CB
|
Corticosteroids/antiinfectives/mydriatics in combination |
| 5 |
S01CB01
|
dexamethasone |
| 5 |
S01CB02
|
prednisolone |
| 5 |
S01CB03
|
hydrocortisone |
| 5 |
S01CB04
|
betamethasone |
| 5 |
S01CB05
|
fluorometholone |
| 4 |
S01CC
|
Antiinflammatory agents, non-steroids and antiinfectives in combination |
| 5 |
S01CC01
|
diclofenac and antiinfectives |
| 5 |
S01CC02
|
indometacin and antiinfectives |
| 3 |
S01E
|
ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| 4 |
S01EA
|
Sympathomimetics in glaucoma therapy |
| 5 |
S01EA01
|
epinephrine |
| 5 |
S01EA02
|
dipivefrine |
| 5 |
S01EA03
|
apraclonidine |
| 5 |
S01EA04
|
clonidine |
| 5 |
S01EA05
|
brimonidine |
| 5 |
S01EA51
|
epinephrine, combinations |
| 4 |
S01EB
|
Parasympathomimetics |
| 5 |
S01EB01
|
pilocarpine |
| 5 |
S01EB02
|
carbachol |
| 5 |
S01EB03
|
ecothiopate |
| 5 |
S01EB04
|
demecarium |
| 5 |
S01EB05
|
physostigmine |
| 5 |
S01EB06
|
neostigmine |
| 5 |
S01EB07
|
fluostigmine |
| 5 |
S01EB08
|
aceclidine |
| 5 |
S01EB09
|
acetylcholine |
| 5 |
S01EB10
|
paraoxon |
| 5 |
S01EB51
|
pilocarpine, combinations |
| 5 |
S01EB58
|
aceclidine, combinations |
| 4 |
S01EC
|
Carbonic anhydrase inhibitors |
| 5 |
S01EC01
|
acetazolamide |
| 5 |
S01EC02
|
diclofenamide |
| 5 |
S01EC03
|
dorzolamide |
| 5 |
S01EC04
|
brinzolamide |
| 5 |
S01EC05
|
methazolamide |
| 5 |
S01EC54
|
brinzolamide, combinations |
| 4 |
S01ED
|
Beta blocking agents |
| 5 |
S01ED01
|
timolol |
| 5 |
S01ED02
|
betaxolol |
| 5 |
S01ED03
|
levobunolol |
| 5 |
S01ED04
|
metipranolol |
| 5 |
S01ED05
|
carteolol |
| 5 |
S01ED06
|
befunolol |
| 5 |
S01ED51
|
timolol, combinations |
| 5 |
S01ED52
|
betaxolol, combinations |
| 5 |
S01ED54
|
metipranolol, combinations |
| 5 |
S01ED55
|
carteolol, combinations |
| 4 |
S01EE
|
Prostaglandin analogues |
| 5 |
S01EE01
|
latanoprost |
| 5 |
S01EE02
|
unoprostone |
| 5 |
S01EE03
|
bimatoprost |
| 5 |
S01EE04
|
travoprost |
| 5 |
S01EE05
|
tafluprost |
| 5 |
S01EE06
|
latanoprostene bunod |
| 5 |
S01EE51
|
latanoprost and netarsudil |
| 4 |
S01EX
|
Other antiglaucoma preparations |
| 5 |
S01EX01
|
guanethidine |
| 5 |
S01EX02
|
dapiprazole |
| 5 |
S01EX05
|
netarsudil |
| 5 |
S01EX06
|
omidenepag |
| 3 |
S01F
|
MYDRIATICS AND CYCLOPLEGICS |
| 4 |
S01FA
|
Anticholinergics |
| 5 |
S01FA01
|
atropine |
| 5 |
S01FA02
|
scopolamine |
| 5 |
S01FA03
|
methylscopolamine |
| 5 |
S01FA04
|
cyclopentolate |
| 5 |
S01FA05
|
homatropine |
| 5 |
S01FA06
|
tropicamide |
| 5 |
S01FA54
|
cyclopentolate, combinations |
| 5 |
S01FA56
|
tropicamide, combinations |
| 4 |
S01FB
|
Sympathomimetics excl. antiglaucoma preparations |
| 5 |
S01FB01
|
phenylephrine |
| 5 |
S01FB02
|
ephedrine |
| 5 |
S01FB03
|
ibopamine |
| 5 |
S01FB51
|
phenylephrine and ketorolac |
| 3 |
S01G
|
DECONGESTANTS AND ANTIALLERGICS |
| 4 |
S01GA
|
Sympathomimetics used as decongestants |
| 5 |
S01GA01
|
naphazoline |
| 5 |
S01GA02
|
tetryzoline |
| 5 |
S01GA03
|
xylometazoline |
| 5 |
S01GA04
|
oxymetazoline |
| 5 |
S01GA05
|
phenylephrine |
| 5 |
S01GA06
|
oxedrine |
| 5 |
S01GA07
|
brimonidine |
| 5 |
S01GA51
|
naphazoline, combinations |
| 5 |
S01GA52
|
tetryzoline, combinations |
| 5 |
S01GA53
|
xylometazoline, combinations |
| 5 |
S01GA55
|
phenylephrine, combinations |
| 5 |
S01GA56
|
oxedrine, combinations |
| 4 |
S01GX
|
Other antiallergics |
| 5 |
S01GX01
|
cromoglicic acid |
| 5 |
S01GX02
|
levocabastine |
| 5 |
S01GX03
|
spaglumic acid |
| 5 |
S01GX04
|
nedocromil |
| 5 |
S01GX05
|
lodoxamide |
| 5 |
S01GX06
|
emedastine |
| 5 |
S01GX07
|
azelastine |
| 5 |
S01GX08
|
ketotifen |
| 5 |
S01GX09
|
olopatadine |
| 5 |
S01GX10
|
epinastine |
| 5 |
S01GX11
|
alcaftadine |
| 5 |
S01GX51
|
cromoglicic acid, combinations |
| 3 |
S01H
|
LOCAL ANESTHETICS |
| 4 |
S01HA
|
Local anesthetics |
| 5 |
S01HA01
|
cocaine |
| 5 |
S01HA02
|
oxybuprocaine |
| 5 |
S01HA03
|
tetracaine |
| 5 |
S01HA04
|
proxymetacaine |
| 5 |
S01HA05
|
procaine |
| 5 |
S01HA06
|
cinchocaine |
| 5 |
S01HA07
|
lidocaine |
| 5 |
S01HA30
|
combinations |
| 3 |
S01J
|
DIAGNOSTIC AGENTS |
| 4 |
S01JA
|
Colouring agents |
| 5 |
S01JA01
|
fluorescein |
| 5 |
S01JA02
|
rose bengal sodium |
| 5 |
S01JA51
|
fluorescein, combinations |
| 4 |
S01JX
|
Other ophthalmological diagnostic agents |
| 3 |
S01K
|
SURGICAL AIDS |
| 4 |
S01KA
|
Viscoelastic substances |
| 5 |
S01KA01
|
hyaluronic acid |
| 5 |
S01KA02
|
hypromellose |
| 5 |
S01KA51
|
hyaluronic acid, combinations |
| 4 |
S01KX
|
Other surgical aids |
| 5 |
S01KX01
|
chymotrypsin |
| 3 |
S01L
|
OCULAR VASCULAR DISORDER AGENTS |
| 4 |
S01LA
|
Antineovascularisation agents |
| 5 |
S01LA01
|
verteporfin |
| 5 |
S01LA02
|
anecortave |
| 5 |
S01LA03
|
pegaptanib |
| 5 |
S01LA04
|
ranibizumab |
| 5 |
S01LA05
|
aflibercept |
| 5 |
S01LA06
|
brolucizumab |
| 5 |
S01LA07
|
abicipar pegol |
| 3 |
S01X
|
OTHER OPHTHALMOLOGICALS |
| 4 |
S01XA
|
Other ophthalmologicals |
| 5 |
S01XA01
|
guaiazulen |
| 5 |
S01XA02
|
retinol |
| 5 |
S01XA03
|
sodium chloride, hypertonic |
| 5 |
S01XA04
|
potassium iodide |
| 5 |
S01XA05
|
sodium edetate |
| 5 |
S01XA06
|
ethylmorphine |
| 5 |
S01XA07
|
alum |
| 5 |
S01XA08
|
acetylcysteine |
| 5 |
S01XA09
|
iodoheparinate |
| 5 |
S01XA10
|
inosine |
| 5 |
S01XA11
|
nandrolone |
| 5 |
S01XA12
|
dexpanthenol |
| 5 |
S01XA13
|
alteplase |
| 5 |
S01XA14
|
heparin |
| 5 |
S01XA15
|
ascorbic acid |
| 5 |
S01XA18
|
ciclosporin |
| 5 |
S01XA19
|
limbal stem cells, autologous |
| 5 |
S01XA20
|
artificial tears and other indifferent preparations |
| 5 |
S01XA21
|
mercaptamine |
| 5 |
S01XA22
|
ocriplasmin |
| 5 |
S01XA23
|
sirolimus |
| 5 |
S01XA24
|
cenegermin |
| 5 |
S01XA25
|
lifitegrast |
| 5 |
S01XA26
|
riboflavin |
| 5 |
S01XA27
|
voretigene neparvovec |
| 2 |
S02
|
OTOLOGICALS |
| 3 |
S02A
|
ANTIINFECTIVES |
| 4 |
S02AA
|
Antiinfectives |
| 5 |
S02AA01
|
chloramphenicol |
| 5 |
S02AA02
|
nitrofural |
| 5 |
S02AA03
|
boric acid |
| 5 |
S02AA04
|
aluminium acetotartrate |
| 5 |
S02AA05
|
clioquinol |
| 5 |
S02AA06
|
hydrogen peroxide |
| 5 |
S02AA07
|
neomycin |
| 5 |
S02AA08
|
tetracycline |
| 5 |
S02AA09
|
chlorhexidine |
| 5 |
S02AA10
|
acetic acid |
| 5 |
S02AA11
|
polymyxin B |
| 5 |
S02AA12
|
rifamycin |
| 5 |
S02AA13
|
miconazole |
| 5 |
S02AA14
|
gentamicin |
| 5 |
S02AA15
|
ciprofloxacin |
| 5 |
S02AA16
|
ofloxacin |
| 5 |
S02AA30
|
antiinfectives, combinations |
| 3 |
S02B
|
CORTICOSTEROIDS |
| 4 |
S02BA
|
Corticosteroids |
| 5 |
S02BA01
|
hydrocortisone |
| 5 |
S02BA03
|
prednisolone |
| 5 |
S02BA06
|
dexamethasone |
| 5 |
S02BA07
|
betamethasone |
| 5 |
S02BA08
|
fluocinolone acetonide |
| 3 |
S02C
|
CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| 4 |
S02CA
|
Corticosteroids and antiinfectives in combination |
| 5 |
S02CA01
|
prednisolone and antiinfectives |
| 5 |
S02CA02
|
flumetasone and antiinfectives |
| 5 |
S02CA03
|
hydrocortisone and antiinfectives |
| 5 |
S02CA04
|
triamcinolone and antiinfectives |
| 5 |
S02CA05
|
fluocinolone acetonide and antiinfectives |
| 5 |
S02CA06
|
dexamethasone and antiinfectives |
| 5 |
S02CA07
|
fludrocortisone and antiinfectives |
| 3 |
S02D
|
OTHER OTOLOGICALS |
| 4 |
S02DA
|
Analgesics and anesthetics |
| 5 |
S02DA01
|
lidocaine |
| 5 |
S02DA02
|
cocaine |
| 5 |
S02DA03
|
phenazone |
| 5 |
S02DA04
|
cinchocaine |
| 5 |
S02DA30
|
combinations |
| 4 |
S02DC
|
Indifferent preparations |
| 2 |
S03
|
OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| 3 |
S03A
|
ANTIINFECTIVES |
| 4 |
S03AA
|
Antiinfectives |
| 5 |
S03AA01
|
neomycin |
| 5 |
S03AA02
|
tetracycline |
| 5 |
S03AA03
|
polymyxin B |
| 5 |
S03AA04
|
chlorhexidine |
| 5 |
S03AA05
|
hexamidine |
| 5 |
S03AA06
|
gentamicin |
| 5 |
S03AA07
|
ciprofloxacin |
| 5 |
S03AA08
|
chloramphenicol |
| 5 |
S03AA30
|
antiinfectives, combinations |
| 3 |
S03B
|
CORTICOSTEROIDS |
| 4 |
S03BA
|
Corticosteroids |
| 5 |
S03BA01
|
dexamethasone |
| 5 |
S03BA02
|
prednisolone |
| 5 |
S03BA03
|
betamethasone |
| 3 |
S03C
|
CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| 4 |
S03CA
|
Corticosteroids and antiinfectives in combination |
| 5 |
S03CA01
|
dexamethasone and antiinfectives |
| 5 |
S03CA02
|
prednisolone and antiinfectives |
| 5 |
S03CA04
|
hydrocortisone and antiinfectives |
| 5 |
S03CA05
|
fludrocortisone and antiinfectives |
| 5 |
S03CA06
|
betamethasone and antiinfectives |
| 3 |
S03D
|
OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| 1 |
V
|
VARIOUS |
| 2 |
V01
|
ALLERGENS |
| 3 |
V01A
|
ALLERGENS |
| 4 |
V01AA
|
Allergen extracts |
| 5 |
V01AA01
|
feather |
| 5 |
V01AA02
|
grass pollen |
| 5 |
V01AA03
|
house dust mites |
| 5 |
V01AA04
|
mould fungus and yeast fungus |
| 5 |
V01AA05
|
tree pollen |
| 5 |
V01AA07
|
insects |
| 5 |
V01AA08
|
food |
| 5 |
V01AA09
|
textiles |
| 5 |
V01AA10
|
flowers |
| 5 |
V01AA11
|
animals |
| 5 |
V01AA20
|
various |
| 2 |
V03
|
ALL OTHER THERAPEUTIC PRODUCTS |
| 3 |
V03A
|
ALL OTHER THERAPEUTIC PRODUCTS |
| 4 |
V03AB
|
Antidotes |
| 5 |
V03AB01
|
ipecacuanha |
| 5 |
V03AB02
|
nalorphine |
| 5 |
V03AB03
|
edetates |
| 5 |
V03AB04
|
pralidoxime |
| 5 |
V03AB05
|
prednisolone and promethazine |
| 5 |
V03AB06
|
thiosulfate |
| 5 |
V03AB08
|
sodium nitrite |
| 5 |
V03AB09
|
dimercaprol |
| 5 |
V03AB13
|
obidoxime |
| 5 |
V03AB14
|
protamine |
| 5 |
V03AB15
|
naloxone |
| 5 |
V03AB16
|
ethanol |
| 5 |
V03AB17
|
methylthioninium chloride |
| 5 |
V03AB18
|
potassium permanganate |
| 5 |
V03AB19
|
physostigmine |
| 5 |
V03AB20
|
copper sulfate |
| 5 |
V03AB21
|
potassium iodide |
| 5 |
V03AB22
|
amyl nitrite |
| 5 |
V03AB23
|
acetylcysteine |
| 5 |
V03AB24
|
digitalis antitoxin |
| 5 |
V03AB25
|
flumazenil |
| 5 |
V03AB26
|
methionine |
| 5 |
V03AB27
|
4-dimethylaminophenol |
| 5 |
V03AB29
|
cholinesterase |
| 5 |
V03AB31
|
prussian blue |
| 5 |
V03AB32
|
glutathione |
| 5 |
V03AB33
|
hydroxocobalamin |
| 5 |
V03AB34
|
fomepizole |
| 5 |
V03AB35
|
sugammadex |
| 5 |
V03AB36
|
phentolamine |
| 5 |
V03AB37
|
idarucizumab |
| 5 |
V03AB38
|
andexanet alfa |
| 4 |
V03AC
|
Iron chelating agents |
| 5 |
V03AC01
|
deferoxamine |
| 5 |
V03AC02
|
deferiprone |
| 5 |
V03AC03
|
deferasirox |
| 4 |
V03AE
|
Drugs for treatment of hyperkalemia and hyperphosphatemia |
| 5 |
V03AE01
|
polystyrene sulfonate |
| 5 |
V03AE02
|
sevelamer |
| 5 |
V03AE03
|
lanthanum carbonate |
| 5 |
V03AE04
|
calcium acetate and magnesium carbonate |
| 5 |
V03AE05
|
sucroferric oxyhydroxide |
| 5 |
V03AE06
|
colestilan |
| 5 |
V03AE07
|
calcium acetate |
| 5 |
V03AE08
|
ferric citrate |
| 5 |
V03AE09
|
patiromer calcium |
| 5 |
V03AE10
|
sodium zirconium cyclosilicate |
| 4 |
V03AF
|
Detoxifying agents for antineoplastic treatment |
| 5 |
V03AF01
|
mesna |
| 5 |
V03AF02
|
dexrazoxane |
| 5 |
V03AF03
|
calcium folinate |
| 5 |
V03AF04
|
calcium levofolinate |
| 5 |
V03AF05
|
amifostine |
| 5 |
V03AF06
|
sodium folinate |
| 5 |
V03AF07
|
rasburicase |
| 5 |
V03AF08
|
palifermin |
| 5 |
V03AF09
|
glucarpidase |
| 5 |
V03AF10
|
sodium levofolinate |
| 5 |
V03AF11
|
arginine and lysine |
| 4 |
V03AG
|
Drugs for treatment of hypercalcemia |
| 5 |
V03AG01
|
sodium cellulose phosphate |
| 4 |
V03AH
|
Drugs for treatment of hypoglycemia |
| 5 |
V03AH01
|
diazoxide |
| 4 |
V03AK
|
Tissue adhesives |
| 4 |
V03AM
|
Drugs for embolisation |
| 4 |
V03AN
|
Medical gases |
| 5 |
V03AN01
|
oxygen |
| 5 |
V03AN02
|
carbon dioxide |
| 5 |
V03AN03
|
helium |
| 5 |
V03AN04
|
nitrogen |
| 5 |
V03AN05
|
medical air |
| 4 |
V03AX
|
Other therapeutic products |
| 5 |
V03AX02
|
nalfurafine |
| 5 |
V03AX03
|
cobicistat |
| 4 |
V03AZ
|
Nerve depressants |
| 5 |
V03AZ01
|
ethanol |
| 2 |
V04
|
DIAGNOSTIC AGENTS |
| 3 |
V04B
|
URINE TESTS |
| 3 |
V04C
|
OTHER DIAGNOSTIC AGENTS |
| 4 |
V04CA
|
Tests for diabetes |
| 5 |
V04CA01
|
tolbutamide |
| 5 |
V04CA02
|
glucose |
| 4 |
V04CB
|
Tests for fat absorption |
| 5 |
V04CB01
|
vitamin A concentrates |
| 4 |
V04CC
|
Tests for bile duct patency |
| 5 |
V04CC01
|
sorbitol |
| 5 |
V04CC02
|
magnesium sulfate |
| 5 |
V04CC03
|
sincalide |
| 5 |
V04CC04
|
ceruletide |
| 4 |
V04CD
|
Tests for pituitary function |
| 5 |
V04CD01
|
metyrapone |
| 5 |
V04CD03
|
sermorelin |
| 5 |
V04CD04
|
corticorelin |
| 5 |
V04CD05
|
somatorelin |
| 5 |
V04CD06
|
macimorelin |
| 4 |
V04CE
|
Tests for liver functional capacity |
| 5 |
V04CE01
|
galactose |
| 5 |
V04CE02
|
sulfobromophthalein |
| 5 |
V04CE03
|
methacetin (13C) |
| 4 |
V04CF
|
Tuberculosis diagnostics |
| 5 |
V04CF01
|
tuberculin |
| 4 |
V04CG
|
Tests for gastric secretion |
| 5 |
V04CG01
|
cation exchange resins |
| 5 |
V04CG02
|
betazole |
| 5 |
V04CG03
|
histamine phosphate |
| 5 |
V04CG04
|
pentagastrin |
| 5 |
V04CG05
|
methylthioninium chloride |
| 5 |
V04CG30
|
caffeine and sodium benzoate |
| 4 |
V04CH
|
Tests for renal function and ureteral injuries |
| 5 |
V04CH01
|
inulin and other polyfructosans |
| 5 |
V04CH02
|
indigo carmine |
| 5 |
V04CH03
|
phenolsulfonphthalein |
| 5 |
V04CH04
|
alsactide |
| 5 |
V04CH30
|
aminohippuric acid |
| 4 |
V04CJ
|
Tests for thyreoidea function |
| 5 |
V04CJ01
|
thyrotropin |
| 5 |
V04CJ02
|
protirelin |
| 4 |
V04CK
|
Tests for pancreatic function |
| 5 |
V04CK01
|
secretin |
| 5 |
V04CK02
|
pancreozymin (cholecystokinin) |
| 5 |
V04CK03
|
bentiromide |
| 4 |
V04CL
|
Tests for allergic diseases |
| 4 |
V04CM
|
Tests for fertility disturbances |
| 5 |
V04CM01
|
gonadorelin |
| 4 |
V04CX
|
Other diagnostic agents |
| 5 |
V04CX01
|
indocyanine green |
| 5 |
V04CX02
|
folic acid |
| 5 |
V04CX03
|
methacholine |
| 5 |
V04CX04
|
mannitol |
| 5 |
V04CX05
|
13C-urea |
| 5 |
V04CX06
|
hexaminolevulinate |
| 5 |
V04CX07
|
edrophonium |
| 5 |
V04CX08
|
carbon monoxide |
| 5 |
V04CX09
|
patent blue |
| 2 |
V06
|
GENERAL NUTRIENTS |
| 3 |
V06A
|
DIET FORMULATIONS FOR TREATMENT OF OBESITY |
| 4 |
V06AA
|
Low-energy diets |
| 3 |
V06B
|
PROTEIN SUPPLEMENTS |
| 3 |
V06C
|
INFANT FORMULAS |
| 4 |
V06CA
|
Nutrients without phenylalanine |
| 3 |
V06D
|
OTHER NUTRIENTS |
| 4 |
V06DA
|
Carbohydrates/proteins/minerals/vitamins, combinations |
| 4 |
V06DB
|
Fat/carbohydrates/proteins/minerals/vitamins, combinations |
| 4 |
V06DC
|
Carbohydrates |
| 5 |
V06DC01
|
glucose |
| 5 |
V06DC02
|
fructose |
| 4 |
V06DD
|
Amino acids, incl. combinations with polypeptides |
| 4 |
V06DE
|
Amino acids/carbohydrates/minerals/vitamins, combinations |
| 4 |
V06DF
|
Milk substitutes |
| 4 |
V06DX
|
Other combinations of nutrients |
| 2 |
V07
|
ALL OTHER NON-THERAPEUTIC PRODUCTS |
| 3 |
V07A
|
ALL OTHER NON-THERAPEUTIC PRODUCTS |
| 4 |
V07AA
|
Plasters |
| 4 |
V07AB
|
Solvents and diluting agents, incl. irrigating solutions |
| 4 |
V07AC
|
Blood transfusion, auxiliary products |
| 4 |
V07AD
|
Blood tests, auxiliary products |
| 4 |
V07AN
|
Incontinence equipment |
| 4 |
V07AR
|
Sensitivity tests, discs and tablets |
| 4 |
V07AS
|
Stomi equipment |
| 4 |
V07AT
|
Cosmetics |
| 4 |
V07AV
|
Technical disinfectants |
| 4 |
V07AX
|
Washing agents etc. |
| 4 |
V07AY
|
Other non-therapeutic auxiliary products |
| 4 |
V07AZ
|
Chemicals and reagents for analysis |
| 2 |
V08
|
CONTRAST MEDIA |
| 3 |
V08A
|
X-RAY CONTRAST MEDIA, IODINATED |
| 4 |
V08AA
|
Watersoluble, nephrotropic, high osmolar X-ray contrast media |
| 5 |
V08AA01
|
diatrizoic acid |
| 5 |
V08AA02
|
metrizoic acid |
| 5 |
V08AA03
|
iodamide |
| 5 |
V08AA04
|
iotalamic acid |
| 5 |
V08AA05
|
ioxitalamic acid |
| 5 |
V08AA06
|
ioglicic acid |
| 5 |
V08AA07
|
acetrizoic acid |
| 5 |
V08AA08
|
iocarmic acid |
| 5 |
V08AA09
|
methiodal |
| 5 |
V08AA10
|
diodone |
| 4 |
V08AB
|
Watersoluble, nephrotropic, low osmolar X-ray contrast media |
| 5 |
V08AB01
|
metrizamide |
| 5 |
V08AB02
|
iohexol |
| 5 |
V08AB03
|
ioxaglic acid |
| 5 |
V08AB04
|
iopamidol |
| 5 |
V08AB05
|
iopromide |
| 5 |
V08AB06
|
iotrolan |
| 5 |
V08AB07
|
ioversol |
| 5 |
V08AB08
|
iopentol |
| 5 |
V08AB09
|
iodixanol |
| 5 |
V08AB10
|
iomeprol |
| 5 |
V08AB11
|
iobitridol |
| 5 |
V08AB12
|
ioxilan |
| 4 |
V08AC
|
Watersoluble, hepatotropic X-ray contrast media |
| 5 |
V08AC01
|
iodoxamic acid |
| 5 |
V08AC02
|
iotroxic acid |
| 5 |
V08AC03
|
ioglycamic acid |
| 5 |
V08AC04
|
adipiodone |
| 5 |
V08AC05
|
iobenzamic acid |
| 5 |
V08AC06
|
iopanoic acid |
| 5 |
V08AC07
|
iocetamic acid |
| 5 |
V08AC08
|
sodium iopodate |
| 5 |
V08AC09
|
tyropanoic acid |
| 5 |
V08AC10
|
calcium iopodate |
| 4 |
V08AD
|
Non-watersoluble X-ray contrast media |
| 5 |
V08AD01
|
ethyl esters of iodised fatty acids |
| 5 |
V08AD02
|
iopydol |
| 5 |
V08AD03
|
propyliodone |
| 5 |
V08AD04
|
iofendylate |
| 3 |
V08B
|
X-RAY CONTRAST MEDIA, NON-IODINATED |
| 4 |
V08BA
|
Barium sulfate containing X-ray contrast media |
| 5 |
V08BA01
|
barium sulfate with suspending agents |
| 5 |
V08BA02
|
barium sulfate without suspending agents |
| 3 |
V08C
|
MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
| 4 |
V08CA
|
Paramagnetic contrast media |
| 5 |
V08CA01
|
gadopentetic acid |
| 5 |
V08CA02
|
gadoteric acid |
| 5 |
V08CA03
|
gadodiamide |
| 5 |
V08CA04
|
gadoteridol |
| 5 |
V08CA05
|
mangafodipir |
| 5 |
V08CA06
|
gadoversetamide |
| 5 |
V08CA07
|
ferric ammonium citrate |
| 5 |
V08CA08
|
gadobenic acid |
| 5 |
V08CA09
|
gadobutrol |
| 5 |
V08CA10
|
gadoxetic acid |
| 5 |
V08CA11
|
gadofosveset |
| 4 |
V08CB
|
Superparamagnetic contrast media |
| 5 |
V08CB01
|
ferumoxsil |
| 5 |
V08CB02
|
ferristene |
| 5 |
V08CB03
|
iron oxide, nanoparticles |
| 4 |
V08CX
|
Other magnetic resonance imaging contrast media |
| 5 |
V08CX01
|
perflubron |
| 3 |
V08D
|
ULTRASOUND CONTRAST MEDIA |
| 4 |
V08DA
|
Ultrasound contrast media |
| 5 |
V08DA01
|
perflutren, human albumin microspheres |
| 5 |
V08DA02
|
microparticles of galactose |
| 5 |
V08DA03
|
perflenapent |
| 5 |
V08DA04
|
perflutren, phospholipid microspheres |
| 5 |
V08DA05
|
sulfur hexafluoride, phospholipid microspheres |
| 5 |
V08DA06
|
perflubutane, phospholipid microspheres |
| 2 |
V09
|
DIAGNOSTIC RADIOPHARMACEUTICALS |
| 3 |
V09A
|
CENTRAL NERVOUS SYSTEM |
| 4 |
V09AA
|
Technetium (99mTc) compounds |
| 5 |
V09AA01
|
technetium (99mTc) exametazime |
| 5 |
V09AA02
|
technetium (99mTc) bicisate |
| 4 |
V09AB
|
Iodine (123I) compounds |
| 5 |
V09AB01
|
iodine iofetamine (123I) |
| 5 |
V09AB02
|
iodine iolopride (123I) |
| 5 |
V09AB03
|
iodine ioflupane (123I) |
| 4 |
V09AX
|
Other central nervous system diagnostic radiopharmaceuticals |
| 5 |
V09AX01
|
indium (111In) pentetic acid |
| 5 |
V09AX03
|
iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane |
| 5 |
V09AX04
|
flutemetamol (18F) |
| 5 |
V09AX05
|
florbetapir (18F) |
| 5 |
V09AX06
|
florbetaben (18F) |
| 3 |
V09B
|
SKELETON |
| 4 |
V09BA
|
Technetium (99mTc) compounds |
| 5 |
V09BA01
|
technetium (99mTc) oxidronic acid |
| 5 |
V09BA02
|
technetium (99mTc) medronic acid |
| 5 |
V09BA03
|
technetium (99mTc) pyrophosphate |
| 5 |
V09BA04
|
technetium (99mTc) butedronic acid |
| 3 |
V09C
|
RENAL SYSTEM |
| 4 |
V09CA
|
Technetium (99mTc) compounds |
| 5 |
V09CA01
|
technetium (99mTc) pentetic acid |
| 5 |
V09CA02
|
technetium (99mTc) succimer |
| 5 |
V09CA03
|
technetium (99mTc) mertiatide |
| 5 |
V09CA04
|
technetium (99mTc) gluceptate |
| 5 |
V09CA05
|
technetium (99mTc) gluconate |
| 5 |
V09CA06
|
technetium (99mTc) ethylenedicysteine |
| 4 |
V09CX
|
Other renal system diagnostic radiopharmaceuticals |
| 5 |
V09CX01
|
sodium iodohippurate (123I) |
| 5 |
V09CX02
|
sodium iodohippurate (131I) |
| 5 |
V09CX03
|
sodium iothalamate (125I) |
| 5 |
V09CX04
|
chromium (51Cr) edetate |
| 3 |
V09D
|
HEPATIC AND RETICULO ENDOTHELIAL SYSTEM |
| 4 |
V09DA
|
Technetium (99mTc) compounds |
| 5 |
V09DA01
|
technetium (99mTc) disofenin |
| 5 |
V09DA02
|
technetium (99mTc) etifenin |
| 5 |
V09DA03
|
technetium (99mTc) lidofenin |
| 5 |
V09DA04
|
technetium (99mTc) mebrofenin |
| 5 |
V09DA05
|
technetium (99mTc) galtifenin |
| 4 |
V09DB
|
Technetium (99mTc), particles and colloids |
| 5 |
V09DB01
|
technetium (99mTc) nanocolloid |
| 5 |
V09DB02
|
technetium (99mTc) microcolloid |
| 5 |
V09DB03
|
technetium (99mTc) millimicrospheres |
| 5 |
V09DB04
|
technetium (99mTc) tin colloid |
| 5 |
V09DB05
|
technetium (99mTc) sulfur colloid |
| 5 |
V09DB06
|
technetium (99mTc) rheniumsulfide colloid |
| 5 |
V09DB07
|
technetium (99mTc) phytate |
| 4 |
V09DX
|
Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals |
| 5 |
V09DX01
|
selenium (75Se) tauroselcholic acid |
| 3 |
V09E
|
RESPIRATORY SYSTEM |
| 4 |
V09EA
|
Technetium (99mTc), inhalants |
| 5 |
V09EA01
|
technetium (99mTc) pentetic acid |
| 5 |
V09EA02
|
technetium (99mTc) technegas |
| 5 |
V09EA03
|
technetium (99mTc) nanocolloid |
| 4 |
V09EB
|
Technetium (99mTc), particles for injection |
| 5 |
V09EB01
|
technetium (99mTc) macrosalb |
| 5 |
V09EB02
|
technetium (99mTc) microspheres |
| 4 |
V09EX
|
Other respiratory system diagnostic radiopharmaceuticals |
| 5 |
V09EX01
|
krypton (81mKr) gas |
| 5 |
V09EX02
|
xenon (127Xe) gas |
| 5 |
V09EX03
|
xenon (133Xe) gas |
| 3 |
V09F
|
THYROID |
| 4 |
V09FX
|
Various thyroid diagnostic radiopharmaceuticals |
| 5 |
V09FX01
|
technetium (99mTc) pertechnetate |
| 5 |
V09FX02
|
sodium iodide (123I) |
| 5 |
V09FX03
|
sodium iodide (131I) |
| 5 |
V09FX04
|
sodium iodide (124I) |
| 3 |
V09G
|
CARDIOVASCULAR SYSTEM |
| 4 |
V09GA
|
Technetium (99mTc) compounds |
| 5 |
V09GA01
|
technetium (99mTc) sestamibi |
| 5 |
V09GA02
|
technetium (99mTc) tetrofosmin |
| 5 |
V09GA03
|
technetium (99mTc) teboroxime |
| 5 |
V09GA04
|
technetium (99mTc) human albumin |
| 5 |
V09GA05
|
technetium (99mTc) furifosmin |
| 5 |
V09GA06
|
technetium (99mTc) stannous agent labelled cells |
| 5 |
V09GA07
|
technetium (99mTc) apcitide |
| 4 |
V09GB
|
Iodine (125I) compounds |
| 5 |
V09GB01
|
fibrinogen (125I) |
| 5 |
V09GB02
|
iodine (125I) human albumin |
| 4 |
V09GX
|
Other cardiovascular system diagnostic radiopharmaceuticals |
| 5 |
V09GX01
|
thallium (201Tl) chloride |
| 5 |
V09GX02
|
indium (111In) imciromab |
| 5 |
V09GX03
|
chromium (51Cr) chromate labelled cells |
| 5 |
V09GX04
|
rubidium (82Rb) chloride |
| 3 |
V09H
|
INFLAMMATION AND INFECTION DETECTION |
| 4 |
V09HA
|
Technetium (99mTc) compounds |
| 5 |
V09HA01
|
technetium (99mTc) human immunoglobulin |
| 5 |
V09HA02
|
technetium (99mTc) exametazime labelled cells |
| 5 |
V09HA03
|
technetium (99mTc) antigranulocyte antibody |
| 5 |
V09HA04
|
technetium (99mTc) sulesomab |
| 4 |
V09HB
|
Indium (111In) compounds |
| 5 |
V09HB01
|
indium (111In) oxinate labelled cells |
| 5 |
V09HB02
|
indium (111In) tropolonate labelled cells |
| 4 |
V09HX
|
Other diagnostic radiopharmaceuticals for inflammation and infection detection |
| 5 |
V09HX01
|
gallium (67Ga) citrate |
| 3 |
V09I
|
TUMOUR DETECTION |
| 4 |
V09IA
|
Technetium (99mTc) compounds |
| 5 |
V09IA01
|
technetium (99mTc) antiCarcinoEmbryonicAntigen antibody |
| 5 |
V09IA02
|
technetium (99mTc) antimelanoma antibody |
| 5 |
V09IA03
|
technetium (99mTc) pentavalent succimer |
| 5 |
V09IA04
|
technetium (99mTc) votumumab |
| 5 |
V09IA05
|
technetium (99mTc) depreotide |
| 5 |
V09IA06
|
technetium (99mTc) arcitumomab |
| 5 |
V09IA07
|
technetium (99mTc) hynic-octreotide |
| 5 |
V09IA08
|
technetium (99mTc) etarfolatide |
| 5 |
V09IA09
|
technetium (99mTc) tilmanocept |
| 4 |
V09IB
|
Indium (111In) compounds |
| 5 |
V09IB01
|
indium (111In) pentetreotide |
| 5 |
V09IB02
|
indium (111In) satumomab pendetide |
| 5 |
V09IB03
|
indium (111In) antiovariumcarcinoma antibody |
| 5 |
V09IB04
|
indium (111In) capromab pendetide |
| 4 |
V09IX
|
Other diagnostic radiopharmaceuticals for tumour detection |
| 5 |
V09IX01
|
iobenguane (123I) |
| 5 |
V09IX02
|
iobenguane (131I) |
| 5 |
V09IX03
|
iodine (125I) CC49-monoclonal antibody |
| 5 |
V09IX04
|
fludeoxyglucose (18F) |
| 5 |
V09IX05
|
fluorodopa (18F) |
| 5 |
V09IX06
|
sodium fluoride (18F) |
| 5 |
V09IX07
|
fluorocholine(18F) |
| 5 |
V09IX08
|
fluoroethylcholine (18F) |
| 5 |
V09IX09
|
gallium (68Ga) edotreotide |
| 5 |
V09IX10
|
fluoroethyl-L-tyrosine (18F) |
| 5 |
V09IX11
|
fluoroestradiol (18F) |
| 5 |
V09IX12
|
fluciclovine (18F) |
| 5 |
V09IX13
|
methionine (11C) |
| 3 |
V09X
|
OTHER DIAGNOSTIC RADIOPHARMACEUTICALS |
| 4 |
V09XA
|
Iodine (131I) compounds |
| 5 |
V09XA01
|
iodine (131I) norcholesterol |
| 5 |
V09XA02
|
iodocholesterol (131I) |
| 5 |
V09XA03
|
iodine (131I) human albumin |
| 4 |
V09XX
|
Various diagnostic radiopharmaceuticals |
| 5 |
V09XX01
|
cobalt (57Co) cyanocobalamine |
| 5 |
V09XX02
|
cobalt (58Co) cyanocobalamine |
| 5 |
V09XX03
|
selenium (75Se) norcholesterol |
| 5 |
V09XX04
|
ferric (59Fe) citrate |
| 2 |
V10
|
THERAPEUTIC RADIOPHARMACEUTICALS |
| 3 |
V10A
|
ANTIINFLAMMATORY AGENTS |
| 4 |
V10AA
|
Yttrium (90Y) compounds |
| 5 |
V10AA01
|
yttrium (90Y) citrate colloid |
| 5 |
V10AA02
|
yttrium (90Y) ferrihydroxide colloid |
| 5 |
V10AA03
|
yttrium (90Y) silicate colloid |
| 4 |
V10AX
|
Other antiinflammatory therapeutic radiopharmaceuticals |
| 5 |
V10AX01
|
phosphorous (32P) chromicphosphate colloid |
| 5 |
V10AX02
|
samarium (153Sm) hydroxyapatite colloid |
| 5 |
V10AX03
|
dysprosium (165Dy) colloid |
| 5 |
V10AX04
|
erbium (169Er) citrate colloid |
| 5 |
V10AX05
|
rhenium (186Re) sulfide colloid |
| 5 |
V10AX06
|
gold (198Au) colloidal |
| 3 |
V10B
|
PAIN PALLIATION (BONE SEEKING AGENTS) |
| 4 |
V10BX
|
Various pain palliation radiopharmaceuticals |
| 5 |
V10BX01
|
strontium (89Sr) chloride |
| 5 |
V10BX02
|
samarium (153Sm) lexidronam |
| 5 |
V10BX03
|
rhenium (186Re) etidronic acid |
| 3 |
V10X
|
OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
| 4 |
V10XA
|
Iodine (131I) compounds |
| 5 |
V10XA01
|
sodium iodide (131I) |
| 5 |
V10XA02
|
iobenguane (131I) |
| 5 |
V10XA53
|
tositumomab/iodine (131I) tositumomab |
| 4 |
V10XX
|
Various therapeutic radiopharmaceuticals |
| 5 |
V10XX01
|
sodium phosphate (32P) |
| 5 |
V10XX02
|
ibritumomab tiuxetan (90Y) |
| 5 |
V10XX03
|
radium (223Ra) dichloride |
| 5 |
V10XX04
|
lutetium (177Lu) oxodotreotide |
| 2 |
V20
|
SURGICAL DRESSINGS |